FOR AUTHORS
Vol. 77 No. s1 (2025): Abstract book of the 62th Conference of the Italian Society for Rheumatology, Rimini, 26-29 November 2025
Published:
25 November 2025
62nd National Congress of the Italian Society of Rheumatology
-
CO:01:1 | Efficacy and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients Marco Lanzillotta1, Jens Vikse2, Elisabetta Goni3, Veronica Batani1, Jasmin Mahajne1, Lorenzo Dagna1, Emanuel Della Torre1. | 1Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale San Raffaele, Milano, Italy; 2Department of Rheumatology, Stavanger University Hospital, Norway; 3Department of Medicine II, University Hospital, Ludwig Maximilian University, Munich, Germany
287 -
CO:01:2 | BAG3 in systemic sclerosis: possible therapeutic target and biomarker for pulmonary fibrosis Claudia Iannone1|2, Margot De Marco3, Antonina Minniti1, Paola Manzo3, Angela D'Ardia3, Antonia Falco3, Liberato Marzullo3, Angela Rosato3, Maria Caterina Turco3, Roberto Caporali1|2, Nicoletta Del Papa1|2. | 1ASST G. Pini-CTO. UOC Clinica Reumatologica, Milano; 2Department of Clinical Sciences and Community Health, University of Milano; 3Department of Medicine, Surgery and Dentistry Schola Medica Salernitana, Baronissi (SA), Italy
221 -
CO:01:3 | Which PRO reflects remission best? Bridging the gap between patient and physician in systemic lupus erythematosus Elena Ragusa1, Elisabetta Chessa2, Marta Paola Pireddu1, Fabio Congiu1, Giulia Rizzo1, Marianna Salis1, Alessandra Oliva1, Mattia Congia2, Alberto Cauli1|2, Matteo Piga1|2. | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; 2SC Reumatologia, AOU Cagliari, Italy
206 -
CO:01:4 | Identify predictors of relapse in idiopathic inflammatory myopathies: insights from an international cohort Cristina Bochicchio1|2, Maria Rosa Pellico1|2, Claudia Iannone1|2, Lekshmi Minikumari Rahulan3, Marco Fornaro4, Ilaria Cavazzana5, Edoardo Conticini6, Musataka Musataka7, Akira Yoshida7, Silvia Cavalli1|2, Silvia Grazzini6, Giulio Fraticelli8, Alessia Gatti5, Giulio Lopinto4, Paolo Semeraro5, Veronica Batani8, Thomas Patric Sheeran9, Florenzo Iannone4, Giacomo De Luca8, Roberto Caporali1|2, Latika Gupta9|10|11, Nicoletta Del Papa2. | 1Department of Clinical Sciences and Community Health, University of Milano; 2Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milano, Italy; 3Rheumatology "Sanjay Gandhi" Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India; 4Unit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica, University of Bari; 5Rheumatology and Clinical Immunology Unit, ASST Spedali Civili di Brescia; 6Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy; 7Department of Allergy and Rheumatology Nippon Medical School Graduate School of Medicine, Tokyo, Japan; 8Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; 9Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK; 10Francis Crick Institute, London, UK; 11School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, UK
194 -
CO:02:1 | Frequency and predictors of disease progression in contemporary seronegative undifferentiated arthritis in a treated-to-target early arthritis clinic Elena Manna1, Ludovico De Stefano1|2, Domenico Sorace1|2, Jacopo Pelizza1|2, Blerina Xoxi1|2, Antonio Manzo1|2, Carlomaurizio Montecucco1|2, Serena Bugatti1|2. | 1Department of Internal Medicine and Therapeutics, University of Pavia; 2Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
176 -
CO:02:2 | Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis: real world data from an Italian National Registry Valerio Fiorilli1, Francesca Romana Spinelli1, Florenzo Iannone2, Chiara Bazzani3, Alberto Cauli4, Rosario Foti5, Marcello Govoni6, Francesco Paolo Cantatore7, Fabiola Atzeni8, Roberto Caporali9, Marco Sebastiani10, Roberta Ramonda11, Serena Bugatti12, Elisa Gremese13, Maria Sole Chimenti14, Bruno Frediani15, Maurizio Rossini16, Angelo Semeraro17, Leonardo Santo18, Gianfranco Ferraccioli19, Giovanni Lapadula20, Fabrizio Conti1. | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica, Università degli Studi Aldo Moro, Bari; 3ASST Spedali Civili di Brescia, Unità di Reumatologia ed Immunologia Clinica, Brescia; 4Dipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari; 5A.O.U. Policlinico S. Marco, UOS Reumatologia, Catania; 6Dipartimento di Scienze Mediche, Università di Ferrara; 7Unità di Reumatologia, Dipartimento di Medicina Specialistica, Università di Foggia; 8Dipartimento di Medicina Interna e Terapia Medica, UOC di Reumatologia, Università di Messina; 9Dipartimento di Scienze Cliniche e di Comunità, Università di Milano; 10Dipartimento di Medicina e Chirurgia, Università di Parma; 11Unità di Reumatologia, Dipartimento di Medicina, Università di Padova; 12Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, ; 13IRCCS Istituto Clinico Humanitas, Dipartimento di Scienze Biomediche, Milano; 14Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma-Tor Vergata, ; 15Dipartimento di Medicina Clinica e Scienze Immunologiche, Università di Siena; 16Dipartimento di Medicina, Università di Verona; 17Presidio Ospedaliero Valle d'Itria, Unità Operativa di Reumatologia, Martina Franca; 18Presidio Ospedaliero "Mons. Dimiccoli", Unità Operativa Semplice di Reumatologia, Barletta; 19Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Roma; 20Gruppo Italiano di Studio sulla early Arthritis, GISEA, Bari, Italy.
178 -
CO:02:4 | Whole blood hypercoagulable profiles in patients with rheumatoid arthritis Lorenzo Di Luozzo1, Alessandro Giollo1, Mariangela Salvato1, Francesca Frizzera1, Kiren Khalid1, Luca Spiezia2, Andrea Benetti2, Chiara Samà2, Paolo Simioni2, Andrea Doria1. | 1Unità di Reumatologia, Azienda Ospedaliera di Padova; 2Dipartimento di Medicina, Università di Padova, Italy
193 -
CO:03:1 | Distinct breath metabolomic signature in systemic sclerosis patients with pulmonary arterial hypertension Martina Iacubino1, Lorenzo Rocco1, Marco Vicenzi2|3, Chiara Bellocchi2|4, Marta Mozzo4, Adriana Severino3, Monica Caronni3, Alessandro Santaniello3, Gaia Montanelli3, Barbara Vigone3, Liam Grimmett5, Matthew Kerr5, Lorenzo Beretta3. | 1Scuola di specializzazione in Allergologia e Immunologia clinica, Università degli Studi di Milano; 2Dipartimento di Scienze Cliniche e Salute di Comunità, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano; 3Dipartimento di Malattie Cardio-Toraciche-Vascolari, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano; 4Dipartimento di Immunologia Clinica e Medicina Interna, Scleroderma Unit - Fondazione IRCCS Ca' Granda Ospedale Maggiore, Milano, Italy; 5Owlstone Medical, Cambridge, UK
198 -
CO:03:3 | Contribution of mitochondrial DNA to the onset and maintenance of inflammation in Systemic Sclerosis patients Martina Orlandi1, Giorgia Sinigaglia2, Amelia Spinella1, Isabella Martusciello2, Marco De Pinto1, Giorgia Roveta1, Luca Keller1, Marcello Pinti2, Dilia Giuggioli1 | 1Dipartimento di scienze mediche e chirurgiche dei bambini e degli adulti, Università di Modena e Reggio Emilia, Italy; 2Università degli Studi di Modena e Reggio Emilia, Italy
35 -
CO:04:1 | Bone properties and biomechanics in patients with psoriatic disease: a cross-sectional study with high-resolution peripheral quantitative computed tomography Anna Piccinelli1, Francesco Bellinato2, Francesco Pollastri1, Francesco Giorgio1, Martina Teoni1, Angelo Fassio1, Camilla Benini1, Carmela Dartizio1, Mattia Tugnolli1, Davide Gatti1, Maurizio Rossini1, Ombretta Viapiana1, Paolo Gisondi2, Giovanni Adami1. | 1Rheumatology Unit, University of Verona; 2Dermatology Unit, University of Verona, Italy
179 -
CO:05:1 | Predicting one-year disease activity in systemic lupus erythematosus using machine learning and explainable AI Pier Giacomo Cerasuolo1, Augusta Ortolan1, Livia Lilli2, Laura Antenucci2, Carlotta Maschiocchi2, Jacopo Lenkowicz2, Lucia Lanzo1, Luca Petricca1, Maria Rita Gigante1, Vivianaantonella Pacucci1, Pierluigi Rizzuti1, Rebecca Ventura1, Silvia Piunno1, Cesare Gavotti1, Marco Gorini3, Gabriella Castellino3, Alfredo Cesario2, Stefano Patarnello2, Silvia Laura Bosello1, Maria Antonietta D'Agostino1. | 1UOC di Reumatologia ed Immunologia Clinica, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma; 2Gemelli Generator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma; 3AstraZeneca Italy, MIND, Milano, Italy
190 -
CO:05:2 | An OMERACT study for the development of an algorithm for automatic identification of calcium pyrophosphate deposition by ultrasound: the Crystal Artificial Intelligence Monitoring Study Daniele Cirillo1, Tito Bassani2, Silvia Sirotti1|2, Greta Pellegrino1|2, Alessandro Lucia1, Rodolfo Fabbri1, Laura Pezzoni1, Piercarlo Sarzi Puttini1|2, Georgios Filippou1|2. | 1Università degli Studi di Milano; 2IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milano, Italy
189 -
CO:05:3 | Radiomics and machine learning for differentiating rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis with usual interstitial pneumonia pattern Vincenzo Venerito1, Chiara Nani2, Andreina Manfredi3, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1, Cecilia Burattini2, Marco Sebastiani4. | 1Rheumatology Unit, University of Bari; 2Respiratory Unit, Guglielmo da Saliceto Civil Hospital, Piacenza; 3Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia; 4Rheumatology Unit, AUSL Piacenza, University of Parma, Italy
190 -
CO:05:4 | Natural language processing reveals demographic features, comorbidities, and clinical domains to predict treatment longevity of b/tsDMARDs in psoriatic arthritis Antonio Tonutti1|2, Pierandrea Morandini3, Cosimo Faeti3, Nicoletta Luciano1|2, Saverio D'Amico3, Victor Savevski3, Carlo Selmi1|2 | 1Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3Artificial Intelligence Unit, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy
23 -
CO:06:1 | Predictors of damage accrual in a monocentric cohort of patients with Behçet’s syndrome (BS) evaluated with BS overall damage index in real-life clinical practice Giulia Voltarel1|2, Francesca Crisafulli1|2, Alba Chiara Pozzi1|2, Anita Melzani2, Micol Frassi1, Ilaria Cavazzana1|2, Franco Franceschini1|2, Paolo Airò1. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia; 2Department of Clinical and Experimental Sciences, University of Brescia, Italy
159 -
CO:06:2 | Deep immunophenotyping in patients with juvenile localized scleroderma reveals two distinct immunological endophenotypes Emiliano Marasco1, Angela Aquilani1, Rebecca Nicolai1, Ivan Caiello1, Fabrizio De Benedetti1. | 1Unità di Reumatologia, Ospdeale Pediatrico Bambino Gesù, Roma, Italy
157 -
CO:06:3 | Clinical and laboratory markers for distinguishing VEXAS from Schnitzler's syndrome in male patients with skin involvement: insights from the International AIDA Network Registries Valeria Caggiano1, Jessica Sbalchiero1, Micol Frassi2, Andrea Hinojosa-Azaola3, Francesca Crisafulli2, Franco Franceschini2, Paolo Sfriso4, Sara Bindoli4, José Hernández-Rodríguez5, Henrique A. Mayrink Giardini6, Giuseppe Lopalco7, Florenzo Iannone7, Ombretta Viapiana8, Amato De Paulis9, Lorenzo Dagna10, Antonio Gidaro11, Serena Bugatti12, Matteo Piga13, Fabrizio Conti14, Rosetta Vitetta15, Cecilia Chighizola16, Marcello Govoni17, Giacomo Emmi18, Paola Triggianese19, Carmelo Gurnari19, Bruno Frediani1, Claudia Fabiani1, Luca Cantarini1, Antonio Vitale1, for the AIDA Network1 | 1Department of Medical Sciences, Surgery and Neurosciences, University of Siena; 2University of Brescia, Italy; 3Department of Immunology and Rheumatology, Mexico City, Mexico; 4Rheumatology Unit, University of Padova, Italy; 5Clinical Unit of Autoinflammatory Diseases, Hospital Clínic of Barcelona, Spain; 6Rheumatology Division, Universidade de São Paulo, Brazil; 7University of Bari; 8Rheumatology Unit, University and Azienda Ospedaliera Universitaria Integrata of Verona; 9University of Napoli "Federico II"; 10Università Vita-Salute San Raffaele, Milano; 11Luigi Sacco Hospital, University of Milano; 12Università di Pavia; 13University and AOU of Cagliari; 14AOU Policlinico Umberto I, Sapienza University of Rome; 15Unit of Rheumatology, ASL Sant' Andrea Hospital, Vercelli; 16University of Milano; 17Azienda Ospedaliero-Universitaria S. Anna, Ferrara; 18University of Trieste; 19University of Rome-Tor Vergata, Rome, Italy.
198 -
CO:07:1 | Assessing bone fragility in systemic sclerosis: results of the Sclerobone multicentric study Giammarco De Mattia1, Cristina Di Nicola2, Davide Rozza2, Manuel Sette3, Veronica Gerli3, Ludovica Pisapia1, Chiara Sgorbini1, Giulia Botticella4, Pamela Bernardini5, Francesca Bottazzi6, Francesca Lalli8, Luca Idolazzi7, Laura Bogliolo6, Monica Cesarotti8, Alessandra Rossi1, Alessandra Della Rossa1, Andrea Giusti4, Serena Guiducci5, Carlo Alberto Scirè2, Addolorata Corrado9, Nicoletta Del Papa3, Marta Mosca1, Chiara Crotti3, Maurizio Rossini7, Maurizio Mazzantini1. | 1UO Reumatologia, Dipartimento di Specialità Mediche e Chirurgiche, Azienda Ospedaliero-Universitaria Pisana, Pisa; 2Centro Studi SIR, Società Italiana di Reumatologia, Milano; 3UO Reumatologia, ASST Gaetano Pini-CTO, Milano; 4SC Reumatologia, Ospedale La Colletta, Azienda Sanitaria Locale 3 Liguria, Arenzano (GE); 5SOD Reumatologia, Azienda Ospedaliero-Universitaria Careggi, Firenze; 6SC Reumatologia, Fondazione IRCCS Policlinico San Matteo, Pavia; 7UOC Reumatologia, Azienda Ospedaliera Universitaria Integrata di Verona; 8SSD Reumatologia, Azienda Sanitaria Locale Perugia; 9Clinica Reumatologica Universitaria, Azienda Ospedaliero Universitaria di Foggia, Italy
200 -
CO:07:2 | Quantitative computed tomography analysis of pulmonary disease in systemic sclerosis: correlation between radiomics and pulmonary function tests Francesco Pollastri1, Loredana Carobene2, Giovanni Adami1, Michele Pernigotto3, Federico Aldegheri1, Angela Ventura3, Claudio Micheletto2, Susanna Baltieri3, Marco Sebastiani4|6, Andreina Manfredi5, Davide Gatti1, Maurizio Rossini1, Angelo Fassio1. | 1UOC Reumatologia, Università degli Studi di Verona; 2UOC Pneumologia, Università degli Studi di Verona; 3 UOC Radiologia, Università degli Studi di Verona; 4Universita degli Studi di Parma; 5UUOC Reumatologia, Università degli Studi di Modena e Reggio Emilia; 6UOC Reumatologia, Azienda Unita' Sanitaria Locale, Piacenza, Italy
164 -
CO:07:3 | Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in difficult-to-treat psoriatic arthrtis patients? Results from a cross-sectional study Fabio Massimo Perrotta1, Alen Zabotti2, Mauro Fatica1, Nicola Cabas2, Andrea Guiotto2, Nicoletta Franzolini3, Giovanni Striani2, Maria De Martino4, Cristina De Nicola5, Miriam Isola4, Andrea Di Matteo6, Gabriele De Marco6, Denis McGonagle6, Ennio Lubrano1, Luca Quartuccio4. | 1Università degli studi del Molise, Campobasso; 2University Hospital Santa Maria della Misericordia, Udine; 3Presidio Ospedaliero S. Antonio, San Daniele del Friuli (UD); 4University of Udine; 5Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy; 6University of Leeds, Leeds, UK
138 -
CO:07:4 | Clinical and psychosocial domains in fibromyalgia: a multidimensional questionnaire approach for personalized management. Results from an Italian monocentric study Eleonora Pedretti1, Francesca Regola1, Giulia Fontana1|2, Giulia Voltarel1|2, Michela Riolfo1|2, Anna Scalvini1, Ilaria Cavazzana1|2, Franco Franceschini1|2, Roberto Gorla1. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia; 2Department of Clinical and Experimental Sciences, University of Brescia, Italy
193 -
CO:07:5 | Enhanced fibroblast signatures in females with early rheumatoid arthritis highlights a potential basis for poorer treatment outcomes Benedetta Monosi1, James Perera2, Alessandra Nerviani2|3, Maria Sole Chimenti1, Felice Rivellese2|3, Costantino Pitzalis2|3|4. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; 3Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research, London, UK; 4Department of Biomedical Sciences Humanitas University and IRCCS Humanitas Research Hospital, Milano, Italy
167 -
CO:07:6 | Hidden in plain sight: fibromyalgia prevalence and correlates in 3,000 non-clinical Italian subjects Sergio Del Vescovo1, Vincenzo Venerito1, Maria Giannotta1, Maria Grazia Anelli1, Maria Morrone1, Angelo Troiano1, Marco Capodiferro1, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1. | 1UOC Reumatologia, DiMePre-J, Policlinico di Bari, Italy
149 -
CO:08:1 | Aquaporin-4 downregulation in dysphagic idiopathic inflammatory myopathies: association with Type 2 fiber damage and inflammation Marco Fornaro1, Margherita Giannini2, Dario D'Abbicco3, Maria Luisa Fiorella4, Antonio Frigeri5, Francesco Girolamo6, Florenzo Iannone1. | 1Unit of Rheumatology, Department of Precision and Regenerative Medicine and Ionian Area, Bari, Italy; 2Physiologie et Explorations Fonctionnelles Musculaires, University Hospital of Strasbourg, Strasburgo, France; 3Institute of General Surgery G Marinaccio, Department of Precision and Regenerative Medicine and Ionian Area, Bari; 4Unit of Otolaryngology, Department of Translational Biomedicine and Neuroscience DiBraiN, Bari; 5Unit of Human Physiology, Department of Translational Biomedicine and Neuroscience DiBraiN, Bari; 6Unit of Human Anatomy and Histology, Department of Translational Biomedicine and Neuroscience DiBraiN, Bari, Italy
134 -
CO:08:2 | Impact of comorbidities on clinical-serological phenotype of primary Sjögren's disease: a retrospective analysis of a multicenter cohort Roberto Dal Pozzolo1, Maria Letizia Currò2, Giacomo Cafaro1, Valeria Manfrè3, Gaetano La Rocca4, Alessia Alunno5, Francesco Carubbi5, Nicoletta Del Papa6, Viktoriya Pavlych7, Ilenia Fischetti8, Letizia Pia Di Corcia9, Pamela Bernardini10, Luca Quartuccio3, Chiara Baldini4, Paola Cipriani7, Roberta Priori8, Onorina Berardicurti9, Serena Guiducci10, Serena ColaFrancesco11, Fabiola Atzeni2, Elena Bartoloni1. | 1SC Reumatologia. Università di Perugia; 2Unità di Reumatologia. Università di Messina; 3Unità di Reumatologia, Università di Udine; 4Unità di Reumatologia. Università di Pisa; 5Divisione di Medicina Interna e Nefrologia. Università di L'Aquila; 6Dipartimento di Reumatologia. Università di Milano; 7Unità di Reumatologia, Università di L'Aquila; 8UOC Reumatologia. Università Sapienza, Roma; 9Unità di Reumatologia. Università Campus Biomedico, Roma; 10Unità di Reumatologia. Università di Firenze; 11Reumatologia e Immunologia Clinica. IRCCS Humanitas, Milano, Italy
128 -
CO:08:4 | Paraproteinemias in Sjögren’s disease: cryoglobulinemia and monoclonal component define distinct phenotypes with a synergistic lymphoproliferative risk Maria Teresa Rizzo1, Simone Longhino1, Giacomo Cafaro2, Valeria Manfrè1, Francesco Carubbi3, Alessia Alunno3, Piera Altieri3, Nicoletta Del Papa4, Paola Cipriani5, Fabiola Atzeni6, Francesca Cracò6, Onorina Berardicurti7, Andrea Pilato7, Roberta Priori8, Angelica Gattamelata8, Serena Guiducci9, Chiara Baldini10, Beatrice Dei10, Pamela Bernardini9, Elena Bartoloni2, Luca Quartuccio1 | 1Clinica di Reumatologia, Ospedale Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale AS Udine; 2SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; 3Unità operativa di Medicina Interna e Nefrologia, Dipartimento delle Scienze della Vita, della Salute e dell Ambiente L'Aquila; 4Unità operativa di Sclerodermia, Dipartimento di Reumatologia, ASST G. Pini-CTO, Università degli Studi di Milano; 5Unità operativa di Reumatologia, Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università dell'Aquila; 6UOC di Reumatologia, Dipartimento di Medicina Interna e Sperimentale, Università di Messina; 7UOC di Immuno-Reumatologia, Dipartimento di Medicina e Chirurgia, Università Campus Bio-Medico di Roma; 8UOC Reumatologia, Sapienza Università di Roma; 9SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; 10Clinica di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Italy
137 -
CO:08:5 | Clinical impact of anti-Ro52 antibodies in idiopathic inflammatory myopathies: insights from a multicenter Italian cohort Paola Bizioli1, Cesare Tomasi2, Francesca Bellisai3, Francesca Buzzulini4, Antonio Tonutti5|6, Angela Ceribelli5|6, Edoardo Conticini3, Anna Ghirardello7, Luca Iaccarino7, Danilo Villalta4, Franco Franceschini1, Ilaria Cavazzana1. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia; 2Department of Clinical and Experimental Sciences, University of Brescia; 3Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena; 4Department of Laboratory Immunology and Allergology, Santa Maria degli Angeli Hospital, Pordenone; 5Department of Biomedical Sciences, Humanitas University, Rozzano (MI); 6Rheumatology and Clinical Immunology, Istituti di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Rozzano (MI); 7Division of Rheumatology, Department of Medical and Surgical Sciences, University of Padova, Italy
137 -
CO:08:6 | Prevalence, incidence and survival in interstitial lung disease secondary to primary Sjögren’s syndrome. Results from the “EMERGE” longitudinal study Alessandra Rai1, Caterina Vacchi2, Stefania Cerri3, Roberta Eufrasia Ledda4, Giulia Cassone2, Dario Andrisani3, Filippo Gozzi3, Lucia Dardani1, Fabiola Atzeni5, Athina Patsoura3, Francesca Cozzini1, Marco Sebastiani6, Andreina Manfredi1. | 1USL-IRCCS Reggio Emilia, University of Modena and Reggio Emilia; 2Azienda Ospedaliero Universitaria Policlinico di Modena; 3 Pulmonology Unit, AOU Policlinico di Modena, University of Modena and Reggio Emilia; 4Radiology Unit, Azienda Ospedaliera di Parma, University of Parma; 5 Policlinico Gaetano Martino, University of Messina; 6Azienda Ospedaliera di Piacenza,University of Parma, Italy
149 -
CO:09:1 | The impact of sex and gender on fibromyalgia syndrome: data from the Italian Fibromyalgia Registry Martina Favretti1, Cristina Iannuccelli2, Giulio Dolcini1, Sonia Farah3, Marco Di Carlo3, Giuseppina Tramontano4, Giorgia Ferrari4, Fabiola Atzeni5, Greta Pellegrino6|7, Piercarlo Sarzi-Puttini6|7, Fausto Salaffi3, Manuela Di Franco8. | 1Dipartimento di Medicina Molecolare, Sapienza Università di Roma; 2UOC Reumatologia, Policlinico Umberto I, Roma; 3Unità di Reumatologia, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Jesi (AN); 4Unità di Reumatologia, Dipartimento di Specialità Mediche, Regional Health Trust 3, Genova; 5Unità di Reumatologia, Dipartimento di Medicina Interna, Università di Messina; 6Unità di Reumatologia, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milano; 7Dipartimento di Scienze Biomediche e Cliniche, Università degli studi di Milano; 8UOC Reumatologia, Dipartimento di Scienze Cliniche Internistiche Anestesiologiche e Cardiovascolari, La Sapienza, Roma, Italy
160 -
CO:09:2 | Mapping Emotional Function in Fibromyalgia: Integrating Alexithymia, Pain Catastrophizing and Self-Compassion Francesca Trunfio1, Damiano Currado1|2, Rosa Bruni3, Barbara Biticchi1, Francesca Saracino1, Erika Corberi1, Ludovica Lamberti1, Annalisa Marino1|2, Lyubomyra Kun1, Leonardo Frasca'1, Sebastiano Lorusso1, Marta Vomero2, Onorina Berardicurti1|2, Roberto Giacomelli1|2, Luca Navarini1|2 | 1Rheumatology and Clinical Immunology, Department of Medicine, University of Rome Campus Biomedico, School of Medicine, Rome, Italy; 2Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Biomedico, Rome, Italy; 3Psychiatrist, Psychotherapist, certified Teacher Mindful Self-Compassion Program, contract Professor at University Campu Rome, Italy
22 -
CO:09:3 | Effectiveness and safety of nintedanib in autoimmune systemic diseases: real life data from an Italian multicentre study (Island group) of the Italian Society of Rheumatology Corrado Campochiaro1, Paola Conigliaro2, Gianluca Sambataro3, Marco Matucci-Cerinic1, Marco Sebastiani4, Gianluca Bajocchi5, Angelo Fassio6, Elena Treppo7, Elisabetta Zanatta8, Elena Bartolini9, Francesco Ferro10, Chiara Bazzini11, Nicoletta Del Papa12, Gemma Lepri13, Andrea Lo Monaco14, Marta Favero15, Annamaria Iuliano16, Francesca Li Gobbi17, Maria Sole Chimenti2, Giuseppe Muscato18, Giacomo De Luca1, Francesca Cozzini4, Lucia Dardani5, Francesco Pollastri6, Alessandro Gattron7, Beatrice Moccaldi8, Caterina Antonini9, Gaetano La Rocca10, Ilaria Cavazzana11, Andreina Manfredi5|19. | 1IRCCS San Raffaele Hospital, Vita-Salute San Raffaele, Milano; 2U.O.C. Reumatologia Dipartimento di Medicina dei Sistemi Università di Roma-Tor Vergata, Roma; 3Università Kore, Enna; 4University of Parma, Azienda Ospedaliera di Piacenza; 5UOC Reumatologia, AUSL IRCCS Reggio Emilia; 6UOC Reumatologia Università degli Studi di Verona; 7Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; 8UOC Reumatologia, Dipartimento di Medicina DIMED, Azienda Ospedale Università di Padova; 9SC Interaziendale di Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia, Azienda Integrata Università; 10Dipartimento di Medicina Clinica e Sperimentale UO Reumatologia-Universitaria AOU Pisa; 11U.O. Reumatologia e Immunologia Clinica ASST Spedali Civili di Brescia; 12Clinica Reumatologica, Milano; 13S.O.D. di Reumatologia AOU Careggi, Firenze; 14UOC Reumatologia Azienda Ospedaliero-Universitaria Sant'Anna, Ferrara; 15Internal Medicine I, Department of Medicine, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Treviso; 16UOC Reumatologia, AO San Camillo Forlanini, Roma; 17Rheumatology Unit, S.Giovanni di Dio Hospital, Firenze; 18Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico, Catania; 19Università degli Studi di Modena e Reggio Emilia, Italy
127 -
CO:09:4 | Erosive hand osteoarthritis: the impact of comorbidities in the context of joint disease Sara Bindoli1, Clarissa Benvoluti1, Giacomo Cozzi1, Marta Favero1, Mariagrazia Lorenzin1, Andrea Doria1, Paolo Sfriso1, Roberta Ramonda1. | 1UOC Reumatologia, Dipartimento di Medicina , Università degli studi di Padova, Italy
146 -
CO:09:5 | LDL-cholesterol goal attainment with ezetimibe and bempedoic acid in patients with rheumatoid arthritis: a simulation study in the Italian CORDIS cohort Alessandro Giollo1, Kiren Khalid1, Luca Bonanni2, Nicola Ferri3, Gianluca Erre4, Matteo Piga5, Elena Bartoloni6, Andreina Manfredi7, Enno Giulio Favalli8, Maria Sole Chimenti9, Serena Guiducci10, Eleonora Celletti11, Addolorata Corrado12, Simone Parisi20, Ivan Giovannini13, Elisa Gremese14, Garifallia Sakellariou15, Ombretta Viapiana16, Marco Fornaro19, Fabiola Atzeni17, Francesca Romana Spinelli18, Fabio Cacciapaglia19 | 1Università di Padova Padova, Italy; 2UO Medicina Interna ULSS3 Mestre, Italy; 3Università di Padova, Department of Pharmaceutical and Pharmacological Sciences, University of Padova Padova, Italy; 4Università di Sassari Sassari, Italy; 5Università di Cagliari Cagliari, Italy; 6Univeristà degli studi di Perugia Perugia, Italy; 7Università di Modena e Reggio Emilia, UO di Reumatologia Ospedale Policlinico di Modena Reggio Emilia, Italy; 8IRCCS Humanitas Research Hospital, Rozzano Milano, Italy; 9Università Tor Vergata Roma, Italy; 10Università di Firenze Firenze, Italy; 11Ospedale SS. Annunziata Chieti, Italy; 12Università degli studi di Foggia Foggia, Italy; 13Università di Udine, Clinica di Reumatologia Udine, Italy; 14Università degli studi di Milano Milano, Italy; 15Università degli Studi di Pavia Pavia, Italy; 16Università di Verona Verona, Italy; 17Università degli Studi di Messina Messina, Italy; 18Università La Sapienza Roma, Italy; 19Università di Bari, Reumatologia Universitaria Policlinico di Bari Bari, Italy; 20S.C. di Reumatologia A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette Torino, Italy
17 -
CO:09:6 | Risk of disease flare during pregnancy and postpartum in inflammatory arthritis: association with therapy discontinuation in the prospective P-RHEUM.it study Dina Zucchi1, Chiara Tani1, Francesca Crisafulli2, Alessia Gatti2, Maria Gerosa3, Cecilia Chighizola3, Melissa Padovan4, Salvatore D'Angelo5, Florenzo Iannone6, Maria Sole Chimenti7, Claudia Lomater8, Francesca Serale9, Veronique Ramoni10, Oscar Epis11, Bernd Raffeiner12, Ariela Hoxha13, Andrea Doria14, Leonardo Santo15, Valentina Canti16, Francesca Bellisai17, Giovanna Cuomo18, on behalf of the P-Rheumit Investigators19, Greta Carrara20, Cristina Di Nicola20, Davide Rozza20, Carlo Alberto Scirè20, Maria Chiara Gerardi11, Angela Tincani2, Laura Andreoli2, Marta Mosca1. | 1Rheumatology Unit, University of Pisa and Azienda Ospedaliero Universitaria Pisana; 2Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia; 3Clinical Rheumatology Division, ASST Gaetano Pini-CTO and University of Milano; 4Rheumatology Unit, Azienda Ospedaliero-Universitaria S. Anna and University of Ferrara; 5Rheumatology Department of Lucania - San Carlo Hospital, Potenza; 6Rheumatology Unit, DiMePRE-J, University of Bari; 7Department of Systems Medicine, Rheumatology, Allergology and Clinical Immunology, University of Rome-Tor Vergata, Roma; 8Torino Academic Rheumatology Center, A.O. Mauriziano di Torino, University of Torino; 9Rheumatology Unit, ASL CN1 Cuneo; 10Internal Medicine Department, ASST Lodi - Ospedale Maggiore di Lodi; 11Division of Rheumatology, Multispecialist Medical Department, Grande Ospedale Metropolitano Niguarda, Milano; 12Department of Rheumatology, Central Hospital of Bolzano SABES-ASDAA, Bolzano; 13General Medicine and Thrombosis and Hemorrhagic Unit, Department of Medicine, University of Padova; 14Rheumatology Unit, Department of Medicine, University of Padova; 15Rheumatology Unit, Mons. Dimiccoli Hospital, Barletta; 16Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano; 17Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena; 18Precision Medicine Department, University of Campania L. Vanvitelli, Napoli; 19The Italian Society for Rheumatology; 20Epidemiology Research Unit of the Italian Society for Rheumatology, Milano, Italy
148 -
CO:10:1 | High-grade synovitis and histological pathotype distribution in patients with advanced osteoarthritis undergoing joint replacement: a more inflammatory disease than we thought? Jacopo Ciaffi1, Lorenzo Bianchi1, Luana Mancarella2, Federica Pignatti2, Veronica Brusi2, Lucia Lisi2, Simona Neri2, Elisa Assirelli2, Alberto Righi3, Marco Gambarotti3, Francesco Ursini1. | 1SSD Medicina e Reumatologia, IRCCS Istituto Ortopedico Rizzoli, Alma Mater Studiorum Università di Bologna; 2SSD Medicina e Reumatologia, IRCCS Istituto Ortopedico Rizzoli, Bologna; 3SSD di Anatomia e Istologia Patologica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
133 -
CO:10:2 | Common variable immunodeficiency patients complicated by autoimmune and inflammatory rheumatic manifestations reveal high frequency of genetic variants potentially linked to inborn errors of immunity Paolo Semeraro1, Micol Frassi1, Silvia Clara Giliani2, Franco Franceschini1, Paolo Airò1. | 1Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia; 2Medical Genetic Laboratory, ASST Spedali Civili of Brescia and University of Brescia, Italy
140 -
CO:10:3 | Clinical response to JAK inhibitors or non-TNFi-targeted biologicals according to synovial tissue characteristics in patients with difficult-to-treat rheumatoid arthritis Mariangela Salvato1, Alessandro Giollo1, Francesca Frizzera1, Kiren Khalid1, Lorenzo Di Luozzo1, Maria Capita1, Marianna Tamussin1, Carlo Garaffoni2, Marny Fedrigo3, Annalisa Angelini3, Ettore Silvagni2, Andrea Doria1. | 1Rheumatology Unit, Department of Medicine - DIMED, University of Padova; 2Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna; 3Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy
150 -
CO:10:4 | Lung vasculature quantification on computed tomography predicts new onset of interstitial lung disease in systemic sclerosis Maria Iacovantuono1|2, Nicholas Landini2|3, Lisa Jungblut4, Gesa Sauer2, Rucsandra Dobrota2, Maria Sinziana Muraru-Carbune2, Muriel Elhai2, Carmen-Marina Mihai2, Mike Oliver Becker2, Maria Sole Chimenti1, Thomas Frauenfelder4, Anna-Maria Hoffmann-Vold5, Oliver Distler2, Cosimo Bruni2. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy; 2Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland; 3Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Policlinico Umberto I, Rome, Italy; 4Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Switzerland; 5Department of Rheumatology, Oslo University Hospital, Norway
140 -
CO:10:5 | Beyond major glands: high-resolution ultrasound mapping of labial salivary and lacrimal gland involvement in Sjögren’s disease Giovanni Fulvio1, Rossana Izzetti2, Valentina Donati3, Caterina Porciani4, Silvia Fonzetti1, Gaetano La Rocca1, Beatrice Dei1, Francesco Ferro1, Marta Mosca1, Chiara Baldini1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa; 2Unit of Dentist, Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine University of Pisa; 3Azienda Ospedaliero-Universitaria Pisana, Unit of Pathological Anatomy, Pisa; 4Immunology and Allergology Unit, Department of Clinical and Experimental Medicine, Pisa, Italy
149 -
CO:10:6 | Impact of pregnancy on organ damage in systemic lupus erythematosus: a prospective multicenter study Giancarlo Cascarano1, Greta Hulej2, Dina Zucchi1, Antonia Calligaro2, Elena Elefante1, Luca Iaccarino2, Sabrina Gori1, Margherita Zen2, Chiara Tani1, Andrea Doria2, Marta Mosca1. | 1Università degli Studi di Pisa; 2Università degli Studi di Padova, Italy
140 -
CO:11:2 | Systemic lupus erythematosus with major neuropsychiatric involvement treated with anifrolumab: literature review and a case report Giulia Rizzo1, Fabio Congiu1, Elisabetta Chessa2, Marta Paola Pireddu1, Elena Ragusa1, Alessandra Oliva1, Marianna Salis1, Alberto Cauli1|2, Matteo Piga1|2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari Italy; 2SC Reumatologia, AOU Cagliari Italy
219 -
CO:11:3 | Belimumab for lupus nephritis patients with poor kidney function: a post-hoc analysis of the bliss-ln trial Giacomo Emmi1|2, Ersilia Lucenteforte3, Giorgio Limoncella3, Emanuele Chiara1|2, Marta Calatroni4|5, Gabriella Moroni4|5 | 1Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; 2Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; 3Department of Statistics, Informatics and Applications Giuseppe Parenti, University of Florence, Florence, Italy; 4Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; 5Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy
17 -
CO:11:4 | Unveiling frailty in active systemic lupus erythematosus in the modern era of rheumatology: first real-life use of the SLICC-FI in a cohort diagnosed after 2000 Angela Elia1, Dina Zucchi2, Michele Moretti1, Elena Elefante2, Chiara Cardelli1, Linda Carli2, Viola Signorini2, Chiara Stagnaro2, Chiara Tani1, Marta Mosca1. | 1U.O. di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa; 2U.O Reumatologia, Azienza Ospedaliero Universitaria Pisana, Pisa, Italy
164 -
CO:11:5 | Laboratory preliminary results from an open label, prospective, phase ii descriptive pilot trial of belimumab therapy for refractory and/or non criteria manifestations of antiphospholipid syndrome Alice Barinotti1, Massimo Radin1, Irene Cecchi1, Beatrice Ala1, Chiara Raymondi1, Elena Rubini1, Silvia G. Foddai1, Lois Ira Maniulit Capulong1, Alessio Conti1, Alessandro Morotti1, Dario Roccatello1, Roberta Fenoglio1, Savino Sciascia1. | 1Università di Torino, Italy.
158 -
CO:11:6 | Off-therapy remission in systemic lupus erythematosus: the BLys lupus flare index (BLyFI) as a decision tool for immunosuppressive therapy withdrawal in remitted patients Noemi Merra1, Anna Giorgia Osele1, Davide Ragno1, Greta Hulej1, Zahrà Rahmé1, Ilenia Anna Gennaio1, Filippo Vesentini1, Margherita Zen1, Luca Iaccarino1, Andrea Doria1 | Università degli Studi di Padova, Italy
156 -
CO:12:1 | Inside the Heterogeneity of Primary Central Nervous System Vasculitis: A single-centre 40-year experience Carlo Salvarani1, Gene G Hunder2, Caterina Giannini2, Teresa Jh Christianson2, Robert D Brown2 | 1Azienda USL-IRCCS di Reggio Emilia e UNIMORE Reggio Emilia, Italy; 2Mayo Clinic Rochester, USA
15 -
CO:12:2 | Circulating cell signatures of disease activity in ANCA-associated vasculitis using automated hematologic profiling analysis with Sysmex XN-9000®: preliminary results from a monocentric cohort Federica Davanzo1, Luca Iorio1, Veronica Davanzo2, Michela Pelloso2, Eleonora Fiorin1, Roberta Prevedello1, Francesca Tosato2, Martina Montagnana3, Roberto Padoan1, Andrea Doria1 | 1Rheumatology Unit, Department of Medicine DIMED, University of Padua Padova, Italy; 2Laboratory Medicine Unit, Biomedical Sciences Department-DSB, University of Padua Padova, Italy; 3Department of Medicine DIMED, University of Padua Padova, Italy
14 -
CO:12:4 | Predicting 12-month clinical relapse in Takayasu arteritis using [18F]FDG PET and convolutional neural networks Alessandro Tomelleri1, Carolina Bezzi2, Sara Resta2, Corrado Campochiaro1, Federico Fallanca2, Elena Baldissera1, Samuele Ghezzo2, Nicola Farina1, Arturo Chiti2, Paola Mapelli2, Marco Matucci-Cerinic1, Maria Picchio2, Lorenzo Dagna1. | 1IRCCS Ospedale San Raffaele, Unità di Immunologia Reumatologia Allergologia e Malattie Rare, Milano; 2IRCCS Ospedale San Raffaele, Unità di Medicina Nucleare, Milano, Italy
151 -
CO:12:5 | Aortic inflammation and aneurysm risk in giant cell arteritis: a multicenter imaging study Caterina Ricordi1, Chiara Marvisi1, Konstanze V. Guggenberger2, Rudolf A. Werner3, Pamela Mancuso8, Giulia Besutti4, Sebastian E. Serfling5, Roberto Farì4, Matthias Frohlich6, Rexhep Durmo7, Michael Gernert6, Lucia Spaggiari4, Annibale Versari7, Paolo Giorgi Rossi8, Pierpaolo Pattacini4, Marc Schmalzing6, Carlo Salvarani1, Thorsten Bley9, Francesco Muratore1. | 1Rheumatology Unit, AUSL IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Italy; 2Department of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Germany; 3Department of Nuclear Medicine, University of Frankfurt, Germany; 4Department of Radiology, AUSL IRCCS di Reggio Emilia, Italy; 5Department of Nuclear Medicine, University Hospital Wuerzburg, Germany; 6Rheumatology and Clinical Immunology, Department of Internal Medicine II, University Hospital Wuerzburg, Germany; 7Nuclear Medicine Unit, AUSL IRCCS di Reggio Emilia, Italy; 8Epidemiology Unit, AUSL-IRCCS di Reggio Emilia, Italy; 9Department of Diagnostic and Interventional Radiology, University Hospital Wuerzburg, Germany
140 -
PO:01:001 | Clinical and histopathological features of refractory psoriatic arthritis undergoing ultrasound-guided synovial biopsy: comparison between non-inflammatory and persistent inflammatory profiles Marianna Tamussin1, Carlo Garaffoni1, Maria Capita1, Serena Ceccato1, Giovanni Lanza2, Mariangela Salvato3, Kiren Khalid3, Francesca Frizzera3, Lorenzo Di Luozzo3, Annalisa Angelini4, Roberta Ramonda3, Alessandra Bortoluzzi1, Andrea Doria3, Marcello Govoni1, Alessadro Giollo3, Ettore Silvagni1 | 1Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna Ferrara, Italy; 2Pathology Unit, Department of Translational Medicine, University of Ferrara, Ferrara Ferrara, Italy; 3Rheumatology Unit, Department of Medicine , DIMED, University of Padua Padova, Italy; 4Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Pulic Health, University of Padua, Padova, Italy
15 -
PO:01:003 | Sex-based differences in 2 years treatment outcomes with b/ts-DMARDs in psoriatic arthritis: from real-world evidence to predictive modeling from the Gruppo Italiano Studio Early Arthritis (GISEA) prospective registry Simone Perniola1, Florenzo Iannone1, Francesco Paolo Cantatore2, Angelo Semeraro3, Leonardo Santo4, Roberto Gorla5, Alberto Cauli6, Roberto Felice Caporali7, Bruno Frediani8, Rosario Foti9, Fabrizio Conti10, Marco Sebastiani11, Maria Sole Chimenti12, Roberta Ramonda13, Fabiola Atzeni14, Maurizio Rossini15, Serena Bugatti16, Serena Guiducci17, Giovanni Lapadula1, Gianfranco Ferraccioli18, Francesca Romana Spinelli10, Elisa Gremese19. | 1Rheumatology Unit, DiMePReJ, University of Bari, Bari; 2Rheumatology Unit, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria Policlinico Riuniti, Foggia; 3Rheumatology Unit, Martina Franca Hospital; 4Rheumatology Unit, ASL BT, P.O. Barletta; 5Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia; 6Rheumatology Unit, Department of Medical Science and Public Health, University of Cagliari, Monserrato (CA); 7Rheumatology Unit, Dipartimento di Reumatologia e Scienze Mediche, ASST PINI-CTO, University of Milano, Milano; 8Rheumatology Unit, Azienda Ospedaliero Universitaria Senese, Siena; 9Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania; 10Rheumatology Unit, Department of Clinical Internal, Anesthesiologic and CV Sciences, Sapienza University of Rome, Roma; 11Rheumatology Unit, AUSL Piacenza, University of Parma, Parma; 12Rheumatology, Department of Systems Medicine, University of Rome Tor Vergata, Roma; 13Rheumatology Unit, DIMED, University of Padua, Padova; 14Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina; 15Rheumatology Unit, Department of Medicine, University of Verona, Verona; 16Division of Rheumatology, Dept. of Internal Medicine and Therapy, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia; 17Division of Rheumatology, Department of Experimental and Clinical Medicine, University of Firenze, Firenze; 18Department of Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli IRCCS, Roma; 19Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Humanitas University, Rozzano (MI), Italy
192 -
PO:01:004 | Real-world retention of IL-17 inhibitors in psoriatic arthritis: impact of prior IL-17 exposure across multiple treatment lines in the “BIRRA” multicentre cohort Valentino Paci1, Alarico Ariani2, Eleonora Celletti3, Alberto Lo Gullo4, Camilla Mazzanti5, Valeria Nucera6, Natalia Mansueto7, Rosalba Caccavale8, Patrizia Del Medico9, Antonella Farina10, Palma Scolieri11, Cecilia Giampietro12, Olga Addimanda13, Riccardo Bixio14, Maddalena Larosa15, Viviana Ravagnani16, Federica Lumetti17, Aldo Biagio Molica Colella17, Elena Bravi17, Rosetta Vitetta17, Bernd Raffeiner17, Gilda Sandri18, Rosario Foti19, Simone Parisi20, Michele Maria Luchetti Gentiloni1, Gianluca Moroncini1. | 1Clinical Medicine, Department of Clinical and Molecular Sciences, Marche Polytechnic University, AOU delle Marche, Ancona, Italy; 2Internal Medicine and Rheumatology Unit, University Hospital of Parma, Parma, Italy; 3Rheumatology Unit, Clinica Medica Institute, Ospedale SS. Annunziata di Chieti, G.d'Annunzio University of Chieti, Chieti, Italy; 4Rheumatology Unit, ARNAS Garibaldi di Catania, Catania, Italy; 5Center for the Diagnosis and Therapy of Autoimmune Rheumagological Diseases, Ospedale Santa Rosa, ASL Viterbo Viterbo Italy; 6Rheumatology Outpatient Unit, ASL Novara, Novara, Italy; 7Ambulatori di Reumatologia ASL1 Liguria, Imperia Hospitall Imperia Italy; 8Department of Clinical, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Polo Pontino, Roma, Italy; 9Rheumatology outpatient clinic - Internal Medicine Unit, Civitanova Marche Hospital, Civitanova Marche, Italy; 10Internal Medicine Unit, Rheumatology outpatient clinic, Ospedale A. Murri di Fermo, Fermo, Italy; 11Department of Medical Specialties, Nuovo Regina Margherita Hospital, Rome, Roma, Italy; 12Rheumatology Outpatient Clinic, Azienda ULSS 6 Euganea, Padova, Padova, Italy; 13Rheumatology Unit, Azienda Unità Sanitaria Locale di Bologna -- Policlinico S.Orsola- AOU di Bologna, Bologna, Italy; 14Rheumatology Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy; 15Division of Rheumatology - Medical Specialties Department, Ospedale La Colletta-Azienda Sanitaria Locale 3, Genova, Italy; 16Rheumatology Unit, Santa Chiara Hospital APSS Trento Italy; 17BIRRA - BIologic Retention Rate in chronic Arthritis - study group, Parma, Italy; 18Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy; 19Rheumatology Unit, Policlinico San Marco Hospital, Catania, Italy; 20Rheumatology Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
203 -
PO:01:005 | Exploring the relationship between alexithymia, pain perception, and disease burden in a cohort of patients with psoriatic arthritis Michelina Turri1, Eugenio Capparelli1, Sergio Del Vescovo2, Maria Iacovantuono1, Benedetta Monosi1, Giulia Mori1, Ilaria Cristiano1, Paola Conigliaro1, Elisabetta Greco1, Giuseppe Lopalco2, Maria Sole Chimenti1. | 1Reumatologia, Allergologia e Immunologia Clinica, Dipartimento di Medicina dei Sistemi, Università di, Roma, Tor Vergata, Roma, Italy; 2Dipartimento di Medicina di Precisione e Rigenerativa e Area Ionica DiMePRe-J, Università di Bari, Bari, Italy.
166 -
PO:01:006 | Increased risk of cancer recurrence or mortality associated with DMARDs? Laura Scagnellato1, Giacomo Cozzi1, Mariagrazia Lorenzin1, Mariangela Salvato1, Alessandro Giollo1, Bernd Raffeiner1, Antonia Calligaro1, Teresa Del Ross1, Sara Bindoli1, Margherita Zen1, Paolo Sfriso1, Andrea Doria1, Roberta Ramonda1. | 1UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Padova, Italy.
163 -
PO:01:007 | Modulation of cellular senescence in psoriatic arthritis: exploring the potential impact of b/tsDMARDs treatment on telomere length, mtDNA copy number, and oxidative damage Eneida Cela1, Giada De Benedittis2, Arianna D'Antonio1, Andrea Latini3, Chiara Morgante2, Cinzia Cicacci3, Paola Conigliaro1, Mauro Fatica1, Giulia Mori1, Giuseppe Novelli2, Paola Borgiani2, Maria Sole Chimenti1. | 1Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy; 2Department of Biomedicine and Prevention, Section of Genetics, University of Rome Tor Vergata, Rome, Italy; 3UniCamillus Saint Camillus International University of Health Sciences, Rome, Italy.
158 -
PO:01:008 | Active sacroiliitis at magnetic resonance enterography increases the risk of axial spondyloarthritis in Crohn’s disease patients, while greater age and disease duration are protective factors: a monocentric retrospective cohort study Gabriele Amati1, Gilda Sandri1|2, Giovanni Ciancio2, Benedetta Bongiovanni1|2, Martina Orlandi1|2, Ottavio Secchi1|2, Davide Vaccari3, Annarita Pecchi4, Angela Bertani5, Maddalena Pecchini5, Pietro Torricelli4, Antonio Colecchia5, Dilia Giuggioli1|2. | 1Struttura Complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 2Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia, Modena, Italy; 3Unità Operativa di Radiologia, Ospedale di Pavullo, AUSL di Modena, Modena, Italy; 4Struttura Complessa di Radiologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 5Struttura Complessa di Gastroenterologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.
179 -
PO:01:010 | Survival of second-line treatment with TNF inhibitors vs. IL-23 inhibitors after failure of a first TNF inhibitor: a real-life observational study from the Italian multicenter BIRRA cohort in patients with psoriatic arthritis Francesca Ometto1, Olga Addimanda2, Bernd Raffeiner3, Alberto Lo Gullo4, Elisa Visalli5, Eleonora Celletti6, Antonella Farina7, Maddalena Larosa8, Romina Andracco9, Marino Paroli10, Patrizia Del Medico11, Aldo Biagio Molica Collella12, Federica Lumetti13, Gilda Sandri14, Marta Priora15, Aurora Ianiello16, Elena Bravi17, Alessandra Bezzi18, Palma Scolieri19, Simone Parisi20, Viviana Ravagnani20, Rosetta Vitetta20, Luca Idolazzi20, Riccardo Bixio20, Gianluca Santoboni20, Francesco Girelli20, Alarico Ariani20 | 1Azienda ULSS 6 Euganea, Padova; 2UOC Interaziendale di Medicina Interna ad Indirizzo Reumatologico, AUSL BO - IRCCS AOU Bologna; 3Unità di Reumatologia, Teaching Hospital of the Paracelsius Medical University, Central Hospital of Bolzano (ASAA-SABES) Bolzano; 4UOD Reumatologia, ARNAS Garibaldi Catania; 5UO Reumatologia, Policlinico San Marco Hospital Catania; 6UOS Reumatologia, Ospedale SS. Annunziata, Università G. d'Annunzio, Chieti; 7UOC Medicina Interna- Ambulatorio Reumatologico, Ospedale A. Murri, Fermo; 8S.C. Reumatologia, Dipartimento Specialità Mediche, Ospedale La Colletta-Azienda Sanitaria Locale 3 Genova; 9Ambulatorio Reumatologia, Ospedale di Imperia; 10Sapienza Università Polo Pontino, Latina; 11Ambulatorio di Reumatologia, UO Medicina Interna, Civitanova Marche Hospital, Civitanova (MC); 12UOSD di Reumatologia, Azienda Ospedaliera Papardo Messina; 13Unità di Reumatologia, Azienda USL di Modena e Ospedale Universitario Policlinico di Modena; 14Unità di Reumatologia, Università di Modena e Reggio Emilia Modena; 15Ambulatorio e Day Hospital di Reumatologia, ASL CN1, Mondovì (CN); 16Poliambulatorio specialistico di reumatologia e Day Hospital multidisciplinare di area Medica, ASL Novara; 17UOSD Reumatologia, Ospedale G. Da Saliceto, Piacenza; 18UO Medicina Interna e Reumatologia, SS Reumatologia, ASL Romagna, Rimini; 19UOC Medicina Interna e Reumatologia, Ospedale Nuovo Regina Margherita, Roma; 20Gruppo BIRRA Italy
177 -
PO:01:011 | Achievement of Remission Defined by Absence of Objective Signs of Inflammation Versus ASDAS ID in Patients with Active Axial Spondyloarthritis Treated with Bimekizumab: 52-Week Results from Two Phase 3 Studies Lianne S Gensler1, Helena Marzo-Ortega2, Vanessa Taieb3, Diana Voiniciuc4, Alexander Marten5, George Stojan6, Mindy Kim6, Paolo Marsico7, Martin Rudwaleit8 | 1Department of Medicine/Rheumatology, University of California San Francisco, USA; 2NIHR Leeds Biomedical Research Centre, University of Leeds Leeds, United Kingdom; 3UCB Colombes, France; 4UCB Slough, United Kingdom; 5UCB Monheim am Rhein Germany; 6UCB Atlanta, USA; 7UCB Milan, Italy; 8University of Bielefeld, Klinikum Bielefeld Bielefeld Germany
20 -
PO:01:014 | Differential inflammatory responses of CD14+ and CD14– synoviocytes in psoriatic arthritis: implications for pathogenesis and targeted therapies Monia Maccaferri1, Monica Montanari2, Francesco Zambianchi3|4, Carlo Salvarani1|5, Elisa Pignatti1|4 | 1Dipartimento CHIMOMO; 2Dipartimento di Scienze e Vita; 3Dipartimento SMECHIMAI Università di Modena e Reggio Emilia; 4Azienda Ospedaliero Universitaria di Modena; 5Struttura Complessa di Reumatologia, Azienda Unità Sanitaria Locale di Reggio Emilia-IRCCS, Italy
142 -
PO:01:015 | Assessment of the impact of the co-occurrence of psoriasis on the clinical and therapeutic pattern of a single-centre cohort of patients with spondyloarthritis associated with chronic inflammatory bowel disease Andrea Pace1, Marcella Falconi1, Alberto Floris1|2, Leonardo Sichi1, Francesca Onnis3, Lorenzo Meli3, Raffaela Piras3, Nicola Lutzu3, Federica Olla3, Agnese Favale3, Sara Onali3, Massimo Claudio Fantini3, Matteo Piga1|2, Alberto Cauli1|2. | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari, Cagliari, Italy; 2SC Reumatologia, AOU Cagliari, Cagliari, Italy; 3SC Gastroenterologia, AOU Cagliari, Cagliari, Italy.
162 -
PO:01:015 | Evaluation of the impact of concomitant psoriasis on the clinical and therapeutic pattern of a monocentric cohort of patients affected by spondyloarthritis associated with inflammatory bowel diseases Andrea Pace1, Marcella Falconi1, Alberto Floris1|2, Leonardo Sichi1, Francesca Onnis3, Lorenzo Meli3, Raffaela Piras3, Nicola Lutzu3, Federica Olla3, Agnese Favale3, Sara Onali3, Massimo Claudio Fantini3, Matteo Piga1|2, Alberto Cauli1|2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; 2SC Reumatologia, AOU Cagliari; 3SC Gastroenterologia, AOU Cagliari, Italy
127 -
PO:02:016 | Real-world evidence of upadacitinib over two years in Italian patients with axial spondyloarthritis Mariagrazia Lorenzin1, Giacomo Cozzi1, Stefano Gentileschi2, Michele Maria Luchetti Gentiloni3, Antonio Carletto4, Maria Sole Chimenti5, Maria Manara6, Luca Quartuccio7, Rosario Foti8, Salvatore D'Angelo9, Ariela Hoxha10, Carlo Selmi11, Bernd Raffeiner12, Alessandro Giollo1, Alberto Cauli13, Carlo Salvarani14, Fabiola Atzeni15, Roberta Ramonda1, Sir Study Group Spa E Psa Antonio Spadaro16. | 1Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy; 2Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy; 3Clinica Medica, Ospedali Riuniti Ancona University Hospital, Ancona; Department of Clinical and Molecular Sciences, Ancona, Italy; 4Rheumatology Unit, Department of Medicine, AOUI University of Verona, Verona, Italy; 5Rheumatology, allergology and clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy; 6Humanitas San Pio X, Milano, Italy; 7University of Udine, Academic Hospital Santa Maria della Misericordia, Udine, Italy; 8Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Italy; 9Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy; 10Internal Medicine Unit, Thrombotic and Hemorrhagic Center, Department of Medicine-DIMED, University of Padua, Padova, Italy; 11Department of Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; 12Department of Rheumatology, Teaching Hospital of the Paracelsius Medical Hospital of Bolzano ASAA-SABES, Bolzano, Italy; 13Rheumatology Unit, Department of Medical Sciences, AOU and University of Cagliari, Monserrato, Cagliari, Italy; 14Department of Rheumatology, Azienda USL-IRCCS di Reggio Emilia and Università di Modena and Reggio Emilia, Reggio Emilia, Italy; 15Rheumatology Unit, University of Messina, Messina, Italy; 16Società Italiana di Reumatologia, Milano, Italy.
170 -
PO:02:017 | Difficult-to-treat psoriatic arthritis: clinical and ultrasonographic predictors in a real-life cohort Federico Favaro1, Elisa Bellis1, Claudio Cruciani1, Gloria Crepaldi1, Valeria Data1, Claudia Garulli1, Claudia Lomater1, Elena Marucco1, Marta Saracco1, Mariele Gatto1, Annamaria Iagnocco1. | 1Academic Rheumatology Centre, Departement of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.
144 -
PO:02:018 | After-SECs: clinical predictors of secukinumab retention in psoriatic arthritis patients with inadequate response to anti-tumor necrosis factor therapy Francesco Cristiano1, Davide Gaspare Patti1, Valentina Boni1, Stefano Di Murro1, Cesare Gavotti1, Roberta Masnata1, Giulia Calabrese2, Gerlando Natalello2, Giusy Peluso2, Augusta Ortolan1|2, Enrico De Lorenzis1|2, Maria Antonietta D'Agostino1|2. | 1Università Cattolica del Sacro Cuore, Roma, Italy; 2Divisione di Reumatologia ed Immunologia clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
147 -
PO:02:019 | Incidence of Spondyloarthritis in a Cohort of Italian patients presenting with Acute Non-granulomatous Anterior Uveitis during a five-years follow-up period Alessandra Rai1, Niccolò Possemato1|2, Giorgia Citriniti2, Filippo Crescentiini2, Marianna Oliva2, Elena Bolletta3, Pietro Gentile3, Luca De Simone3, Fabrizio Gozzi3, Luca Cimino1|3, Pierluigi Macchioni2, Carlo Salvarani1|2 | 1Università di Modena e Reggio Emilia Modena, Italy; 2Unità di Reumatologia, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy; 3Unità di Immunologia Oculare, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy
22 -
PO:02:021 | Sustained Improvements with Bimekizumab in Pain, Morning Stiffness, Fatigue, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 3-Year Results from Two Phase 3 Studies Victoria Navarro-Compán1, Uta Kiltz2|3, Philip J Mease4, Maureen Dubreuil5, Karl Gaffney6, Atul Deodhar7, Christine De La Loge8, Diana Voiniciuc9, Jason Coarse10, Ilaria Spadafora11, Helena Marzo-Ortega12 | 1La Paz University Hospital, IdiPaz, Department of Rheumatology Madrid Spain; 2Ruhr-University Bochum Bochum Germany; 3Rheumazentrum Ruhrgebiet Herne, Germany; 4Department of Rheumatology, Swedish Medical Center and Providence St. Joseph Health and University of Washington Seattle, USA; 5Boston University School of Medicine, Department of Rheumatology Boston, USA; 6Norfolk and Norwich University Hospital NHS Trust, Department of Rheumatology Norfolk, United Kingdom; 7Oregon Health and Science University, Division of Arthritis and Rheumatic Diseases Portland, USA; 8UCB Brussels, Belgium; 9UCB Slough, United Kingdom; 10UCB Morrisville, USA; 11UCB Milan, Italy; 12NIHR Leeds Biomedical Research Centre, University of Leeds Leeds, United Kingdom
20 -
PO:02:022 | Bimekizumab Maintained Stringent Clinical Responses over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies Fabian Proft1, Désirée Van Der Heijde2, Sergio Schwartzman3|4|5, Joerg Ermann6, Alexander Marten7, Ute Massow7, George Stojan8, Vanessa Taieb9, Diana Voiniciuc10, Astrid Van Tubergen11, Victoria Navarro-Compán12, Simone Angioni13, Xenofon Baraliakos14 | 1Charité-Universitätsmedizin Berlin; Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 2Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; 3Weill Cornell Medical Center New York, USA; 4New York Presbyterian Hospital New York, USA; 5Hospital for Special Surgery New York, USA; 6Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School Boston, USA; 7UCB Monheim am Rhein Germany; 8UCB Atlanta, USA; 9UCB Colombes, France; 10UCB Slough, United Kingdom; 11Department of Medicine, Division of Rheumatology, Maastricht University Medical Center Maastricht, The Netherlands; 12Department of Rheumatology, La Paz University Hospital, IdiPaz Madrid, Spain; 13UCB Milan, Italy; 14Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Germany
20 -
PO:02:023 | Monocentric analysis of systemic glucocorticoids in PsA: the art of balancing prescriptive appropriateness and risk factor management Chiara Crotti1 2, Gilberto Cincinelli1, Giorgia Trignani13, Luca Ingrao13, Miriam Perino13, Roberto Caporali13 | 1Dipartimento di Reumatologia e Scienze Mediche - UOC Clinica Reumatologica, ASST Pini-CTO, Milano; 2Dipartimento di Reumatologia e Scienze Mediche - UOC Osteoporosi e Malattie Metaboliche dell Osso - ASST Pini-CTO, Milano; 3Dipartimento di Scienze Cliniche e di Comunità - Università degli Studi di Milano, Italy
167 -
PO:02:024 | Development of anti-drug antibodies in patients with peripheral and/or axial spondyloarthritis treated with infliximab or adalimumab: a monocentric cross-sectional study Gabriele Amati1, Gilda Sandri1|2, Alessandra Melegari3, Benedetta Bongiovanni1|2, Giovanni Ciancio2, Martina Orlandi1|2, Ottavio Secchi1, Dilia Giuggioli1|2 | 1Struttura complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena; 2Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia; 3Dipartimento di medicina di laboratorio, Ospedale di Baggiovara, AUSL di Modena, Italy
153 -
PO:02:025 | Real-World Comparative Effectiveness of Upadacitinib in Psoriatic Arthritis: Evaluation of Switching to Upadacitinib Versus Tumor Necrosis Factor Inhibitors or Interleukin-17 Inhibitors After First-Line Tumor Necrosis Factor Inhibitors Valentina Carlini1, Philip Mease2, William Tillett3, Xiaolan Ye4, Christopher Saffore4, Molly Edwards5, Isabel Truman5, Sophie Barlow5, Jayne Stigler4, Bhumik Parikh4, Daniel Aletaha6 | 1Abbvie srl Roma, Italy; 2University of Washington School of Medicine Seattle, United States Minor Outlying Islands; 3Department of Rheumatology, Royal National Hospital for Rheumatic Diseases Bath, United Kingdom; 4Abbvie Inc. North Chicago, United States Minor Outlying Islands; 5Adelphi Real World Bollington, United Kingdom; 6Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria
20 -
PO:02:027 | Fast food, slow damage: ultra-processed foods, Western diet and inflammatory arthritis. A systematic scoping review Gianluca Poncina1, Federica Gardin2, Giacomo Cozzi1, Laura Scagnellato1, Mariagrazia Lorenzin1, Stefano Rizzetto1, Caterina Robusto1, Francesca Oliviero1, Valérie Tikhonoff2, Roberta Ramonda1. | 1Rheumatology Unit, Department of Medicine-DIMED, University - Padova University Hospital, Padova, Italy; 2Department of Medicine-DIMED, University - Padova University Hospital, Padova, Italy.
258 -
PO:02:028 | Dal Pain Catastrophizing al Distress Psicologico Multidimensionale: esplorando la complessità dell’Artrite Psoriasica Difficult- to-Treat Francesca Saracino1, Damiano Currado1|2, Francesco De Vincenzo3, Francesca Trunfio1, Annalisa Marino1, Lyubomyra Kun1, Erika Corberi1, Ludovica Lamberti1, Leonardo Frascà1, Onorina Berardicurti1|2, Marta Gatti1, Marta Vomero1|2, Roberto Giacomelli1|2, Luca Navarini1|2 | 1Reumatologia e Immunologia Clinica, Dipartimento di Medicina, Università Campus Bio-Medico di Roma, Facoltà di Medicina Roma, Italy; 2Sezione Clinica e di Ricerca di Reumatologia e Immunologia Clinica, Fondazione Policlinico Campus Bio-Medico Roma, Italy; 3Dipartimento di Scienze Umane, Università Europea di Roma Roma, Italy
14 -
PO:02:030 | Retention Rate of Non-anti-TNF Therapies and primary failure in monocentric cohort of patients with Psoriatic Arthritis Alba Chiara Pozzi1, Sofia Barezzani2, Andrea Galli2, Cesare Tomasi1, Micol Frassi1, Ilaria Cavazzana1, Franco Franceschini1 | 1Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, University of Brescia Brescia, Italy; 2Facoltà di Medicina e Chirurgia, University of Brescia Brescia, Italy
17 -
PO:03:033 | Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2b/3 Trials Irene E Van Der Horst-Bruinsma1, Matthew A Brown2, Floris A Van Gaalen3, Nigil Haroon4, Lianne S Gensler5, Alexander Marten6, Myriam Manente7, George Stojan8, Thomas Vaux9, Katy White9, Atul Deodhar10, Nicola Boffini11, Martin Rudwaleit12 | 1Department of Rheumatology, Radboud University Medical Centre Nijmegen, The Netherlands; 2Genomics England London, United Kingdom; 3Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; 4Department of Medicine/Rheumatology, University Health Network, Schroeder Arthritis Institute, University of Toronto Toronto, Canada; 5Department of Medicine/Rheumatology, University of California San Francisco, USA; 6UCB Monheim am Rhein Germany; 7UCB Braine-lAlleud, Belgium; 8UCB Atlanta, USA; 9UCB Slough, United Kingdom; 10Division of Arthritis and Rheumatic Diseases, Oregon Health and Science University Portland, USA; 11IRCCS Ospedale San Raffaele Milan, Italy; 12Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany
19 -
PO:03:034 | Inhibition of Radiographic Progression with Bimekizumab Treatment Observed in bDMARD-Naïve Patients with Active Psoriatic Arthritis at 2 Years: Results from a Phase 3 Study and its Open-Label Extension Laura C Coates1, M Elaine Husni2, Mitsumasa Kishimoto3, Proton Rahman4, Philipp Sewerin5, Enrique R Soriano6, Barbara Ink7, Rajan Bajracharya7, Jason Coarse8, Philip J Mease9, Emanuela Mazzola10, Peter Nash11 | 1NDORMS, University of Oxford and Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust Oxford, United Kingdom; 2Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Cleveland, USA; 3Department of Nephrology and Rheumatology, Kyorin University School of Medicine Tokyo, Japan; 4Division of Rheumatology, Craig L. Dobbin Genetics Research Centre, Memorial University of Newfoundland St. Johns, Canada; 5Rheumazentrum Ruhrgebiet, University Hospital of the Ruhr University Bochum Herne Germany; 6Hospital Italiano de Buenos Aires and University Institute Hospital Italiano de Buenos Aires Buenos Aires, Argentina; 7UCB Slough, United Kingdom; 8UCB Morrisville, USA; 9Department of Rheumatology, Providence-Swedish Medical Center and University of Washington Seattle, USA; 10UCB Milan, Italy; 11School of Medicine, Griffith University, Brisbane, Australia
45 -
PO:03:035 | Biomarkers of Gut Epithelial Damage, Microbial Translocation, and Innate Immune Activation Characterize Patients with Axial Psoriatic Arthritis from Psoriasis Patients: Soluble Biomarker Analysis Insights from the ATTRACT Study Giulia Marchionni1, Valentino Paci1, Silvia Svegliati1, Raffaella Sordillo1, Federico Fiorini1, Melania Giannoni1, Anna Campanati1, Raissa Di Zio1, Devis Benfaremo1, Giuseppe Lopalco2, Florenzo Iannone2, Ennio Lubrano3, Alberto Cauli4, Gianluca Moroncini1, Dennis Poddubnyy5, Fabian Proft6, Michele M Luchetti Gentiloni1 | 1Marche Polytechnic University and Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy; 2University of Bari, Bari, Italy; 3Molise University, Campobasso, Italy; 4University of Cagliari, Azienda Ospedaliero Universitaria di Cagliari, Monserrato, Italy; 5University of Toronto, Toronto, Canada; 6Charité-Universitätsmedizin, Berlino, Germany
14 -
PO:03:036 | Psoriatic arthritis: does pre-existing treatment with cs/bDMARDs for psoriasis influence the characteristics and outcomes of joint disease? Ilenia Marchesini1, Alberto Floris1, Cristina Mugheddu2, Laura Li Volsi1, Maria Teresa Paladino1, Roberta Origa1, Jessica Sorgia1, Mattia Congia1, Elisabetta Chessa1, Matteo Piga1, Caterina Ferreli2, Laura Atzori2, Alberto Cauli1 | 1Unità di Reumatologia, AOU e Università di Cagliari-Monserrato; 2Unità di Dermatologia, AOU e Università di Cagliari, Italy
171 -
PO:03:037 | The Impact of Peripheral Joint Involvement, Pain, and Inflammatory Bowel Diseases on Drug Persistence in Axial Psoriatic Arthritis Giuseppe Lopalco1, Sergio Del Vescovo1, Maria Sole Chimenti2, Giuliana Guggino3, Serena Guiducci4, Eleonora Celletti5, Alberto Cauli6, Luca Cantarini7, Valentino Paci8, Eneida Cela2, Lidia La Barbera3, Gemma Lepri4, Myriam Di Penta5, Alberto Floris6, Alice Agostinelli8, Vincenzo Venerito1, Michele Maria Luchetti8, Florenzo Iannone1 | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, Bari, Italy; 2Reumatology, Allergology and Clinical Immunology University of Rome Tor Vergata, Roma, Italy; 3Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, Palermo, Italy; 4Divisions of Internal Medicine and Rheumatology AOUC, Department of Experimental and Clinical Medicine, Firenze, Italy; 5Rheumatology Unit, SS. Annunziata Hospital of Chieti, G. D'Annunzio, Chieti, Italy; 6Department of Medical Science and Public Health, Cagliari, Italy; 7Policlinico Le Scotte, Siena, Italy; 8Clinical Medicine, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy
13 -
PO:03:039 | Extraintestinal manifestations of enteropathic arthritis vary in relation to inflammatory bowel disease behaviour, localization, and extent Bernardo D'Onofrio1, Nicoletta Luciano2|3, Simone Parisi1, Maria Chiara Ditto1, Cristina Bezzio2|4, Enrico Fusaro1, Alessandro Armuzzi2|4, Carlo Selmi2|3 | 1Division of Rheumatology, AOU Città della Salute e della Scienza, Torino, Italy; 2Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; 3Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Italy; 4Inflammatory Bowel Disease Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy
15 -
PO:03:044 | Impact of Inflammatory Bowel Disease on Clinical Phenotype and Treatment Response in Patients with Psoriatic Arthritis Maria Morrone1, Maria Giannotta1, Vincenzo Venerito1, Greta Giulia Dipietrangelo1, Stefano Stano1, Florenzo Iannone1, Giuseppe Lopalco1 | 1Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J University of Bari, Bari, Italy
28 -
PO:04:046 | Achieving Early Clinical Response was Associated with Cumulative Benefits on Disease Impact up to 2 Years in Patients with Active Psoriatic Arthritis Treated with Bimekizumab William Tillett1|2, Joseph F Merola3, Iain B Mcinnes4, Kenneth B Gordon5, Richard B Warren6, Patrick Healy7, Jérémy Lambert8, Heather Edens9, Barbara Ink10, Paola Volpe11, Laure Gossec12 | 1Royal National Hospital of Rheumatic Diseases Bath, United Kingdom; 2Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath Bath, United Kingdom; 3Department of Dermatology and Department of Medicine, Division of Rheumatology, Utah Southwestern Medical Center Dallas, USA; 4College of Medical Veterinary and Life Sciences, University of Glasgow Glasgow, United Kingdom; 5Department of Dermatology, Medical College of Wisconsin Milwaukee, USA; 6Northern Care Alliance, NHS Foundation Trust and Manchester Academic Health Science Centre, University of Manchester Manchester, United Kingdom; 7UCB Morrisville, USA; 8UCB Colombes, France; 9UCB Smyrna, USA; 10UCB Slough, United Kingdom; 11UOC Reumatologia, P.O. Spirito Santo Pescara, Italy; 12Sorbonne Universite and Pitie-Salpetriere Hospital Paris, France
29 -
PO:04:048 | Assessment of chronic and residual pain in axial spondyloarthritis in a single-center cohort of patients treated with anti-tnf agents Valentina Fornero1|2, Niccolò Melis1, Emanuela Salustro1, Mattia Congia1, Elisabetta Chessa1, Alberto Floris1, Matteo Piga1, Alberto Cauli1 | 1Rheumatology unit, AOU e Università di Cagliari; 2Asl Biella, Ospedale degli Infermi, Ponderano (BI), Italy
129 -
PO:04:050 | Cluster-Based Endotyping of Psoriatic Arthritis in a Monocentric Italian Cohort: A Real-World study Eneida Cela1, Arianna D'Antonio1, Luigi Fiannacca1, Alberto Bergamini1, Maxime Breban2, Felicie Costantino2, Maria Sole Chimenti1 | 1Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata Rome, Italy; 2Rheumatology Department, AP-HP, Ambroise-Paré Hospital Paris, France
10 -
PO:04:051 | Application of REMS in the assessment of fragility score and bone mineral density in axial spondyloarthritis and psoriatic arthritis with axial involvement Silvia Valentini1, Stefano Gentileschi1, Pamela Bernardini2, Jurgen Sota1, Caterina Baldi1, Sara Torracchi2, Daniela Melchiorre2, Sabrina Aliberti2, Emilio D'Ignazio1, Carla Caffarelli3, Luca Cantarini1, Serena Guiducci2, Bruno Frediani1 | 1UOC Reumatologia, Dipartimento di Scienze mediche, chirurgiche e neuroscienze, Università degli Studi di Siena; 2SOD Reumatologia, Dipartimento di Medicina Sperimentale e clinica, Università degli studi di Firenze, AOU Careggi; 3UOC Medicina Interna e della Complessità, Dipartimento di Scienze Mediche, chirurgiche e neuroscienze, Università degli Studi di Siena, Italy
133 -
PO:04:054 | Clinical efficacy and drug retention rate of upadacitinib in patients with axial spondyloarthritis: results from a single-center observational study Simona Buonanno1, Carla Gaggiano1, Caterina Baldi1, Marco Bardelli1, Cristiana Barreca1, Francesca Bellisai1, Marta Fabbroni1, Paolo Falsetti1, Anna Paola Pata1, Enrico Selvi1, Jurgen Sota1, Antonio Vitale1, Luca Cantarini1, Bruno Frediani1, Stefano Gentileschi1 | U.O.C. Reumatologia, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, A.O.U. Senese, Italy
154 -
PO:04:056 | Willingness of patients with psoriatic arthritis to participate in pharmacological and nutritional clinical trials: a cross-sectional study Miriam Perino1|2, Francesca Ingegnoli1|2, Luca Ingrao1|2, Debora Piredu1|2, Antonio Varvaro1|2, Camilla Riboldi1|2, Gilberto Cincinelli2, Francesca Desiati2, Martina Biggioggero2, Orazio De Lucia2, Silvia Casari2, Maria Manara2, Ennio Giulio Favalli1|2, Roberto Caporali1|2 | 1Università degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunità, Milano; 2ASST G. Pini-CTO, UOC di Clinica Reumatologica, Milano, Italy
136 -
PO:04:061 | Higher prevalence of baseline comorbidities in patients developing difficult to treat psoriatic arthritis Mario Ferraioli1, Michelina Turri1, Eneida Çela1, Mauro Fatica1, Paola Conigliaro1, Elisabetta Greco1, Alberto Bergamini1, Maria Sole Chimenti1. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome, Tor Vergata, Rome, Italy.
134 -
PO:05:066 | Atypical diagnosis and manifestation of spondyloarthritis: a case report Adele Del Giudice1, Filippo Crescentini2, Giorgia Citriniti2, Luca Cimino1|3, Carlo Salvarani1|2 | 1Department of Rheumatology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; 2Department of Medicine, University of Melbourne at St Vincent's Hospital Melbourne, Australia; 3Department of Rheumatology, Division of Medicine, University College, London, UK
116 -
PO:05:069 | Risankizumab efficacy in peripheral and axial involvement: monocentric experience Roberta Foti1, Ylenia Dal Bosco1, Giorgio Amato1, Elisa Visalli1, Francesco De Lucia1, Gabriella Paolí1, Rosario Foti1. | 1UOSD Reumatologia AOU Policlinico G. Rodolico-S. Marco, Catania, Italy.
150 -
PO:05:071 | Impact of age at onset on Spondyloarthritis clinical profile and quality of life: a monocentric cohort analysis Federico Fattorini1, Marco Di Battista1, Lorenzo Esti1, Cosimo Cigolini2, Andrea Delle Sedie2, Marta Mosca1|2, Linda Carli1 | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology Unit, AOUP, Pisa, Italy
29 -
PO:05:074 | A clinical case of a patient affected by long-standing psoriatic arthritis and multiple comorbidities treated with an anti-IL-23 therapy Maria Letizia Currò1, Angelo Tropea1, Alessandra Burgio1, Francesca Cracò1, Antonio Pezzano1, Federica Rapisarda1, Antonino Palumbo1, Valeria D'Amico1, Fabiola Atzeni1 | 1Clinica Reumatologica di Udine, Dipartimento di Medicina, ASUFC, Udine, Italy
133 -
PO:06:078 | Is difficult-to-treat rheumatoid arthritis less severe in patients with autoantibody-negative disease? retrospective analysis from a monocentric cohort. Bernardo D'Onofrio1, Maria Chiara Ditto1, Francesco Ghellere1, Giacomo Tanti1, Salvatore Panaro1, Enrico Fusaro1, Simone Parisi1. | 1AOU Città della Salute e della Scienza, Torino, Italy.
123 -
PO:06:079 | Weighing the burden: how body mass index shapes clinical outcomes in rheumatoid arthritis. Insights from a large Italian cohort Marco Capodiferro1, Marco Fornaro1, Gian Luca Erre2, Matteo Piga3, Elena Bartoloni Bocci4, Andreina Manfredi5, Ennio Giulio Favalli6, Maria Sole Chimenti7, Serena Guiducci8, Eleonora Celletti9, Addolorata Corrado10, Alessandro Giollo11, Simone Parisi12, Ivan Giovannini13, Elisa Gremese14, Garifallia Sakellariou15, Ombretta Viapiana16, Fabiola Atzeni17, Francesca Romana Spinelli18, Fabio Cacciapaglia1|19. | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J University of Bari, Bari, Italy; 2Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy; 3Rheumatology Unit, AOU Cagliari, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; 4Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 5Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico of Modena, Modena, Italy; 6Dpt of Rheumatology, G. Pini Institute, Milano, Italy; 7Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 8Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Firenze, Italy; 9Rheumatology Unit, SS Annunziata Hospital, Chieti, Italy; 10Rheumatology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy; 11Rheumatology Unit, Department of Medicine, University of Padova Hospital Trust, Padova, Italy; 12Rheumatology Department, A.O.U. Città della Salute e della Scienza, Torino, Italy; 13Rheumatology Department, Santa Maria della Misericordia Hospital, Udine, Italy; 14Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy; 15Department of Internal Medicine and Therapeutics, University of Pavia, Istituti Clinici Scientifici Maugeri, Pavia, Italy; 16Rheumatology Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy; 17Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy; 18Reumatology Unit, Department of Internal, Anesthesiological, and Cardiovascular Clinical Sciences, Sapienza University, Roma, Italy; 19Miulli General Hospital Acquaviva - Department of Medicine and Surgery, LUM F. De Gennaro University, Casamassima (BA), Acquaviva delle Fonti (BA), Italy.
162 -
PO:06:081 | Safety of JAK inhibitors compared to non-TNF-targeted biologic therapies in rheumatoid arthritis patients who are inadequate responders to TNF inhibitors Lorenzo Di Luozzo1, Alessandro Giollo1, Mariangela Salvato1, Francesca Frizzera1, Kiren Khalid1, Margherita Zen1, Andrea Doria1 | 1Azienda ospedaliera universitaria di Padova, unità di Reumatologia, Padova, Italy
39 -
PO:06:082 | Correlation between ultrasonographic parameters and the Krenn synovitis score in patients with chronic infiammatory arthropathy undergoing ultrasound-guided synovial biopsy: a prospective cohort study Maria Capita1, Carlo Garaffoni1, Marianna Tamussin1, Serena Ceccato1, Giovanni Lanza2, Alessandra Bortoluzzi1, Marcello Govoni1, Ettore Silvagni1 | 1Unità di Reumatologia, Azienda Ospedaliero - Universitaria S. Anna, Cona (FE); 2Anatomia Patologica, Dipartimento di Medicina Traslazionale Università di Ferrara, Cona (FE), Italy
133 -
PO:06:083 | Clinical characteristics and outcomes of late- and young-onset rheumatoid arthritis in relation to autoantibody status Federica Sabatelli1|2, Ludovico De Stefano1|2, Clelia Zampaglione1|2, Lisa Bergianti1|2, Blerina Xoxi1|2, Antonio Manzo1|2, Carlomaurizio Montecucco1|2, Serena Bugatti1|2. | 1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 2Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
125 -
PO:06:084 | Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational study Francesca Cozzini1|2, Andreina Manfredi2|3, Antonio Carletto4, Elisa Bellis5, Laura Cometi6, Vincenzo Venerito7, Caterina Vacchi8, Fabiola Atzeni9, Antonio Carriero10, Rosaria Foti11, Mariagrazia Catanoso3, Ennio Favalli12, Chiara Bazzani13, Arianna Belvedere3, Cecilia Burattini1, Andrea Morciano4, Annamaria Iagnocco5, Gemma Lepri6, Florenzo Iannone7, Antonio Pezzano9, Salvatore D'Angelo10, Valentina Cateni4, Serena Guiducci6, Marco Sebastiani1|14. | 1Ospedale Guglielmo da Saliceto, Piacenza, Italy; 2Università degli studi di Modena e Reggio Emilia, Modena, Italy; 3IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; 4AOUI, Università degli studi di Verona, Verona, Italy; 5A.O. Mauriziano di Torino, Università degli studi di Torino, Torino, Italy; 6AOU di Careggi, Università degli studi di Firenze, Firenze, Italy; 7AOU Policlinico di Bari, università degli studi di Bari Aldo Moro, Bari, Italy; 8AOU Policlinico di Modena, Modena, Italy; 9AOU Gaetano Martino, Università degli studi di Messina, Messina, Italy; 10Azienda Ospedaliera Regionale San Carlo, Potenza, Italy; 11AO Vittorio Emanuele, Catania, Italy; 12ASST Gaetano Pini, Milano, Italy; 13ASST Spedali Civili, Brescia, Italy; 14Università degli studi di Parma, Parma, Italy.
140 -
PO:06:086 | Updated Systematic Literature Review and meta-analysis to Inform the Italian Society of Rheumatology Recommendations on the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease Angelo Fassio1, Marco Sebastiani9|10, Francesco Pollastri1, Chiara Crotti4, Nicola Ughi5, Enrico De Lorenzis6, Silvia Mancuso7, Massimo Radin8, Francesca Cozzini9, Greta Carrara11, Gianpiero Landolfi11, Roberto Rozza11, Andreina Manfredi2|3 | 1Rheumatology Unit, University of Verona, Verona, Italy; 2University of Modena and Reggio Emilia, Reggio Emilia, Italy; 3Rheumatology Unit, AUSL-IRCCS, Reggio Emilia, Italy; 4Bone Disease Unit, Department of Rheumatology and Medical Science, ASST-G.Pini-CTO, Milan, Italy; 5Division of Rheumatology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; 6Department of Aging Diseases, Orthopedic and Rheumatology, Rheumatology Division, P. Gemelli, Roma, Italy; 7Rheumatology Unit, Department of Clinical, Internal, Anaesthesiologic and Cardiovascular, Sciences, Sapienza, Roma, Italy; 8CMID, San Giovanni Bosco Hub Hospital ASL Città di Torino and Department of Clinical and Biological Sciences, Turin, Italy; 9Department of Medicine and Surgery, University of Parma, Parma, Italy; 10Rheumatology Unit, AUSL Piacenza, Piacenza, Italy; 11Unità Epidemiologica, SIR, Società Italiana di Reumatologia, Milano, Italy
20 -
PO:06:088 | Are all Difficult-To-Treat RA patients the same? Insights into clinical features and drug discontinuation Silvia Di Noto1, Cristina Garufi1, Letizia Caruso1, Fulvia Ceccarelli1, Cristiano Alessandri1, Federica Ucci1, Valerio Fiorilli1, Fabrizio Conti1, Francesca Romana Spinelli1 | 1Sapienza University of Rome, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Roma, Italy
40 -
PO:06:089 | Heat-not-burn cigarettes induce protein post-translational modifications (PTM): possible role in the pathogenesis of rheumatoid arthritis Claudia Ciancarella1, Federica Maria Ucci1, Valeria Manganelli2, Elena Fasciolo2, Roberta Priori1, Fulvia Ceccarelli1, Manuel Sergi3, Camilla Montesano3, Francesco Bartolini3, Maurizio Sorice2, Cristiano Alessandri1, Fabrizio Conti1 | 1Rheumatology Unit, Department of Internal Medicine, Anesthesiology and Cardiovascular Sciences, La Sapienza, Roma, Italy; 2Department of Experimental Medicine, La Sapienza University of Rome, Italy; 3Department of Chemistry, La Sapienza University Of Rome, Italy
19 -
PO:06:090 | Validation of 'Clinical Red Flags' for RA-ILD in an Italian cohort: the role fo Dyspnea, Cough and Crackles Eneida Cela1, Chiara Bonini1, Francesco Cavalli2, Alessandra Luciano3, Barbara Kroegler1, Josuel Ora2, Alberto Bergamini1, Marcello Chiocchi3, Paola Rogliani2, Paola Conigliaro1, Maria Sole Chimenti1 | 1Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy; 2Division of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy; 3Department of Diagnostic Imaging and Interventional Radiology, University of Rome, Tor Vergata, Rome, Italy
16 -
PO:06:092 | Early achievement of remission confers better outcomes than low disease activity in both seropositive and seronegative patients with new-onset rheumatoid arthritis Clelia Zampaglione1|2, Ludovico De Stefano1|2, Federica Sabatelli1|2, Alessio D'Isanto1|2, Blerina Xoxi1|2, Antonio Manzo1|2, Carlomaurizio Montecucco1|2, Serena Bugatti1|2. | 1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 2Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
148 -
PO:06:093 | Clinical and ultrasound phenotyping comparison between Difficult-To-Treat Rheumatoid Arthritis (D2TRA) and non-D2TRA patients: experience from a monocentric cohort Silvia Perrone1, Claudio Cruciani1, Silvia Mascolo1, Elisa Bellis1, Gloria Crepaldi1, Valeria Data1, Claudia Garulli1, Claudia Lomater1, Elena Marucco1, Marta Saracco1, Mariele Gatto1, Annamaria Iagnocco1. | 1Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Turin, Italy.
127 -
PO:06:094 | Exploring the relationship between inflammation and collagen deposition in synovial tissue and clinical outcomes in active arthritis: insights from a monocentric pilot study Dario Bruno1, Barbara Tolusso1, Daniela Renna1, Mohamed Hegazi2, Fabio Pasqualini2, Marta Caprioli1, Giacomo Maria Guidelli1, Tommaso Hubert3, Nicoletta Luciano1|3, Marzia Monferini3, Natasa Isailovic3, Fabio Grizzi2|3, Salvatorelorenzo Renne3, Costantino Pitzalis1|3|4, Elisa Gremese1|3. | 1Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI); 2Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Milano; 3Department of Biomedical Sciences, Humanitas University, Rozzano (MI), Italy; 4Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, London, UK
126 -
PO:07:095 | Clinical impact of therapeutic modification following changes in AIFA reimbursement criteria for JAK inhibitors in patients with RA in remission/low disease activity: analysis of the multicenter JAK-SWAP RER study in Emilia-Romagna Marta Raschella1, Giulia Furia1, Martina Di Nunzio1, Francesco Luca Renzullo2, Francesco Girelli2, Federica Pignatti3, Francesco Ursini3, Licia Vultaggio4, Pierluigi Cataleta4, Elena Bravi5, Eugenio Arrigoni5, Francesca Bergossi6, Enrica Vandelli7, Massimo Reta6|7, Viola Magnani8, Andreina Manfredi8|9, Giuseppe Germanò8, Alessandra Bortoluzzi1, Marcello Govoni1, Ettore Silvagni1 | 1Unità Operativa Complessa di Reumatologia, Dipartimento di Scienze Mediche, Università degli Studi di Ferrara e Azienda Ferrara; 2UOS Reumatologia, Ospedale GB Morgagni, Forlì; 3UOC Reumatologia, Istituto ortopedico Rizzoli, Bologna; 4UO Reumatologia, AUSL Romagna Ospedale di Ravenna; 5UO Reumatologia, Azienda USL di Piacenza; 6Reumatologia Osp. Maggiore, Bologna; 7UO Medicina Interna ad Indirizzo Reumatologico Interaziendale SC AUSL Bologna, IRCCS Policlinico di SantOrsola, Bologna; 8U.O Reumatologia, Santa Maria Nuova di Reggio Emilia; 9Università degli studi di Modena e Reggio Emilia, Italy
156 -
PO:07:096 | Safety of filgotinib in the treatment of rheumatoid arthritis: results from the multicentre SOFIA study Anna Giorgia Osele1, Matteo Filippini2, Eugenio Capparelli3, Eleonora Bruschi4, Bernd Raffeiner5, Silvano Bettio6, Mariangela Salvato1, Federico Arru7, Massimiliano Limonta4, Paola Faggioli3, Elda Piovani2, Eleonora Zaccara3, Alessandro Giollo1, Margherita Zen1 | 1UOC Reumatologia, Azienda Ospedale-Università di Padova; 2UO Reumatologia e Immunologia Clinica, ASST Spedali Civili, Brescia; 3UOC Ruematologia, ASST Ovest Milanese, Legnano MI; 4SSD Reumatologia, ASST Papa Giovanni XXIII, Bergamo; 5Dipartimento di Reumatologia, Ospedale di Formazione Paracelsus ASDAA-SABES, Bolzano; 6Medicina Generale Unità 1^, Centro Regionale per le Malattie Rare Immunologiche e Reumatologiche, Ospedale Universitario Treviso; 7UO Medicina, ASL 3 Nuoro, Italy
141 -
PO:07:097 | CGRP and CALCRL localization supports the role of fibroblast-like synoviocytes in rheumatoid arthritis pain pathways Giada La Spina1, Cristina Garufi2, Mattia Caliste2, Martina Leopizzi3, Valeria Di Maio3, Cristiano Alessandri2, Fabrizio Conti2, Francesca Romana Spinelli2 | 1Sapienza University of Rome, Dipartimento di Medicina Molecolare, Roma, Italy; 2Sapienza University of Rome, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Roma, Italy; 3Sapienza University of Rome, Dipartimento di Scienze e Biotecnologie Medico-Chirurgiche, Roma, Italy
15 -
PO:07:098 | Reasons for treatment failure and their synovial correlate among patients with difficult-to-treat rheumatoid arthritis Alessandro Giollo1, Mariangela Salvato1, Francesca Frizzera1, Kiren Khalid1, Lorenzo Di Luozzo1, Carlo Garaffoni2, Maria Capita2, Marianna Tamussin2, Giovanni Lanza2, Marny Fedrigo3, Annalisa Angelini3, Roberta Ramonda1, Ettore Silvagni2, Andrea Doria1 | 1UOC Reumatologia Padova, Italy; 2UOC Reumatologia Ferrara, Italy; 3UOC Patologia cardiovascolare Padova, Italy; 4UOC Anatomia Patologica Ferrara, Italy
19 -
PO:07:099 | Survival on therapy of certolizumab pegol in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: 8-year data from an Italian multicenter register Maria Manara1, Gilberto Cincinelli1|2, Marco Fornaro3, Simone Perniola4, Elisa Gremese5, Chiara Bazzani6, Serena Bugatti7, Francesca Romana Spinelli8, Rosario Foti9, Marco Sebastiani10, Alberto Cauli11, Fabiola Atzeni12, Giovanni Lapadula13, Gianfranco Ferraccioli14, Fabrizio Conti8, Florenzo Iannone3, Roberto Caporali1|2 | 1Department of Rheumatology and Medical Sciences, ASST G. Pini-CTO Milano; 2Department of Clinical Sciences and Community Health, University of Milan; 3Department of Precision and Regenerative Medicine and Ionian Area, University of Bari; 4Clinical Immunology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma; 5Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI); 6Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili Brescia; 7Department of Internal Medicine and Therapeutics, Università di Pavia; 8Rheumatology Unit, Dipartimento Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza University, Roma; 9Rheumatology Unit, San Marco Hospital, Policlinico University of Catania; 10Rheumatology Unit, AUSL Piacenza, University of Parma; 11UOC di Reumatologia, Dipartimento di Scienze Mediche e Sanità Pubblica, Azienda Ospedaliero-Universitaria di Cagliari; 12Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina; 13Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Bari; 14Department of Medicine, Università Cattolica del Sacro Cuore, Fondazione IRCCS Policlinico Gemelli, Roma, Italy
156 -
PO:07:101 | Efficacy and safety of methotrexate in a cohort of patients affected by early-onset rheumatoid arthritis: a monocentric real-life study Carlo Cauli1, Martina Favretti2, Giulio Dolcini2, Vincenzo Ferraro1, Cristina Iannuccelli3, Fabrizio Conti1, Manuela Di Franco1 | 1UOC Reumatologia, Dipartimento di scienze cliniche internistiche anestesiologiche e cardiovascolari, Sapienza, Roma; 2Dipartimento di Medicina Molecolare, La Sapienza, Roma; 3UOC Reumatologia, AOU Policlinico Umberto I, La Sapienza, Roma, Italy
155 -
PO:07:102 | Predicting success with baricitinib in rheumatoid arthritis: efficacy across ages and serological profiles Daniele Lini1, Matteo Colina2, Romina Andracco3, Francesca Ometto4, Viviana Ravagnani5, Alberto Lo Gullo6, Simone Parisi7, Antonella Farina8, Patrizia Del Medico9, Marino Paroli10, Olga Addimanda1, Alessandra Bezzi11, Federica Lumetti12, Aldo Biagio Molica Colella13, Davide Murgia14, Maddalena Larosa15, Aurora Ianniello16, Elena Bravi17, Marta Priora18, Palma Scolieri19, Alessandro Volpe20. | 1Azienda Unità Sanitaria Locale di Bologna -- Policlinico S.Orsola- Azienda Ospedaliera Universitaria-IRCCS di Bologna, Bologna; 2Rheumatology Service. Department of Medicine and Oncology, Ospedale Santa Maria della Scaletta, Imola; 3Imperia Hospital, Internal Medicine Unit, Rheumatology outpatient clinic, Imperia; 4Azienda ULSS 6 Euganea, Rheumatology Outpatient Clinic, Padova; 5Santa Chiara Hospital APSS Trento, Rheumatology Unit, Trento; 6ARNAS Garibaldi di Catania, Rheumatology Unit, Catania; 7Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Rheumatology Department, Torino; 8Ospedale A. Murri di Fermo, Internal Medicine Unit, Rheumatology outpatient clinic, Fermo; 9Civitanova Marche Hospital, Rheumatology outpatient clinic - Internal Medicine Unit, Civitanova Marche; 10Sapienza University of Rome, Polo Pontino, Department of Clinical, Anesthesiological and Cardiovascular Sciences, Latina; 11ASL Romagna Rimini, Internal Medicine and Rheumatology Unit, Rimini; 12Azienda USL of Modena and University Hospital Policlinico di Modena, Rheumatology Unit, Modena; 13Rheumatology Unit, Azienda Ospedaliera Papardo, Messina; 14ASL VC Ospedale S. Andrea, Unit of Rheumatology, Vercelli; 15Azienda Sanitaria Locale 3 Genova, Division of Rheumatology - Medical Specialties Department, Genova; 16ASL Novara, Rheumatology Outpatient Unit, Novara; 17Ospedale G. Da Saliceto, Rheumatology Unit, Piacenza; 18ASL CN1, Rheumatology Day Hospital and outpatient clinic, Mondovì (CN); 19Nuovo Regina Margherita Hospital, Department of Medical Specialties, Roma; 20IRCCS Sacro Cuore Don Calabria Hospital, Unit of Rheumatology, Negrar, Italy.
137 -
PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience Vittorio Dibenedetto1|2|3, Nicola Farina1|2, Nicola Boffini1|2, Alessandro Tomelleri1|2, Adriana Cariddi1|2, Elena Baldissera1|2, Marco Matucci-Cerinic1|2|3, Lorenzo Dagna1|2|3. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and Ageing Intitiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; 3Vita-Salute San Raffaele University, Milano, Italy.
135 -
PO:07:107 | Performance of the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis in a group of elderly onset patients Alessandra Rai1, Pierluigi Macchioni1, Giovanni Barausse2, Luigi Boiardi1, Giuseppe Paolazzi2, Carlo Salvarani1, Andreina Manfredi1 | 1University of Modena and Reggio Emilia, USL-IRCCS Reggio Emilia, Italy; 2Rheumatology Unit, Ospedale di Trento, Italy
30 -
PO:07:108 | Achievement of Treatment Targets and Maintenance of Response with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in a Real-world Setting: Final 2-year Outcomes from the UPHOLD Study Enrico Marchetta1, Andrew Östör2|8, Eugen Feist3, Prodromos Sidiropoulos4, Jérôme Avouac5, Martin Rebella6|7, Rajaie Namas9, Erin Mcdearmon Blondell10, Ivan Lagunes10, Tianming Gao10, Tim Shaw10, Suzan Attar11 | 1AbbVie Srl Roma, Italy; 2Monash University and Emeritus Research, Melbourne, Victoria, Melbourne, Australia; 3Helios Department of Rheumatology and Clinical Immunology, Vogelsang-Gommern, Vogelsang Gommern, Germany; 4Faculty of Medicine, University of Crete, Heraklion, Heraklion, Greece; 5Service de Rhumatologie, Hôpital Cochin, AP HP Centre Université Paris Cité, Parigi, France; 6Departamento de Medicina, Facultad de Medicina, Universidad de la República, Montevideo, Montevideo, Uruguay; 7Unidad de Enfermedades Autoinmunes Sistémicas, MUCAM, Montevideo, Montevideo, Uruguay; 8Australian National University, Camberra, Australia; 9Medical Subspecialties Institute, Division of Rheumatology, Cleveland Clinic Abu Dhabi, United Arab Emirates; 10AbbVie Inc., North Chicago, Illinois, United States of America Chicago, USA; 11King Abdulaziz University, Jeddah, Saudi Arabia
22 -
PO:07:111 | Worsening of patient-reported outcomes is an early predictor of disease flare in patients with rheumatoid arthritis in course of treatment with conventional synthetic disease modifying anti-rheumatic drugs Ludovico De Stefano1|2, Federica Sabatelli1|2, Clelia Zampaglione1|2, Blerina Xoxi2, Antonio Manzo1|2, Carlomaurizio Montecucco1|2, Serena Bugatti1|2. | 1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; 2Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
144 -
PO:08:113 | Shaping rheumatoid arthritis treatment: clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors - insights from the AMBI-RA study Riccardo Bertola1, Beatrice Maranini1, Carlo Garaffoni1, Maria Pozzuto1, Anna Laura Riva Cambrino1, Alessandro Spinelli1, Letizia Mamprin1, Federico Agostini1, Martina Di Nunzio1, Marcello Govoni1, Alessandra Bortoluzzi1, Ettore Silvagni1 | 1Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Italy
164 -
PO:08:114 | The adjuvanted recombinant zoster vaccine is effective in preventing herpes zoster among patients ≥50 years of age with selected autoimmune diseases in the united states: a real-world database analysis (2018–2021) Rosaria Silvestri1, Dagna Constenla2, Germain Lonnet3, Emmanuel Aris3, Nathalie Servotte3, Ramsanjay Rk4, Agnes Mwakingwe-Omari2, Huifeng Yun2 | 1GSK Verona, Italy; 2GSK Rockville, USA; 3GSK Wavre, Belgium; 4GSK Bengaluru, India
159 -
PO:08:116 | Rheumatoid nodulosis: incidence, clinical/instrumental description, and phenotypic correlations in patients with rheumatoid arthritis treated with b-DMARDs. A real-life analysis from a monocentric cohort Stefano Ruggiero1, Elisa Montebelli3, Simone Bernardi2, Marcello Natali4, Francesca Martelli1, Alessandra Caula1, Federica Landolfini1, Gabriella Cucinotta1, Sofia Giulianelli1, Francesco Girelli2 | 1UOC Medicina Interna, Ospedale Morgagni-Pierantoni; Dipartimento di scienze Mediche e Chirurgiche Università di Bologna; 2UOS Reumatologia, Ospedale Morgagni-Pierantoni, Forlì; 3Università degli Studi di Bologna; 4UOC Radiologia, Ospedale Morgagni-Pierantoni, Forlì, Italy
141 -
PO:08:117 | Association between the use of oral contraceptives and the development of rheumatoid arthritis: a systematic review and meta-analysis Annalisa Marino1, Damiano Currado1|2, Onorina Berardicurti1|2, Marta Vomero2, Lyubomyra Kun1, Letizia Pia Di Corcia2, Erika Corberi2, Francesca Trunfio2, Francesca Saracino2, Ludovica Lamberti2, Leonardo Frasca2, Angelo Battista3, Marta Alfano4, Silvia Schiavone5, Roberto Giacomelli1|2, Luca Navarini1|2. | 1Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Campus Bio-Medico, Roma; 2Rheumatology and Clinical Immunology, Department of Medicine, University of Rome Campus Biomedico, School of Medicine, Roma; 3Department of Maternal Science, Paediatric Emergency Service, Sapienza University of Rome, Roma; 4Department of Experimental Medicine, Sapienza University of Rome, Roma; 5Department of Orthopaedics and Traumatology, Policlinico Tor Vergata Foundation, Roma, Italy
130 -
PO:08:118 | “Posting Arthritis”: rheumatoid arthritis vs. juvenile idiopathic arthritis contents on social media Daniele Domanico1, Saverio La Bella2|3, Angelica Napoletano1, Teresa Caferri1, Angela Carenza1, Armando Di Ludovico2, Marta Rinaldi4, Simone Perniola1, Vincenzo Venerito1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit Department of Precision and Regenerative Medicine Jonian Area, Bari; 2Pediatric Rheumatology Unit University of Chieti-Pescara, Chieti; 3UOC Rheumatology and Autoinflammatory Diseases, IRCCS Istituto Giannina Gaslini, Genova, Italy; 4Paediatric Department, John Radcliffe Hospital Oxford University Hospitalsù, Oxford, UK
153 -
PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis Marco Capodiferro1, Daniele Domanico1, Angelica Napoletano1, Giulia Righetti2, Patrizia Suppressa2, Vincenzo Venerito1, Giuseppe Lopalco1, Florenzo Iannone1, Fabio Cacciapaglia1|2 | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; 2Department of Medicine and Surgery, Miulli General Hospital Acquaviva delle Fonti - LUM University Casamassima Bari Acquaviva delle Fonti, Bari, Italy
14 -
PO:08:121 | Correlation between SENS score and perceived disability in a monocentric cohort of patients affected by rheumatoid arthritis: preliminary analysis of 209 patients Francesco Angius1, Nicoleta Anamari Costin1, Mattia Fadda1, Davide Corradini2, Mattia Congia2, Elisabetta Chessa2, Alberto Floris1, Matteo Piga1 -2, Alberto Cauli1 -2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; 2SC Reumatologia, AOU Cagliari, Italy
118 -
PO:08:124 | An exploratory analysis of risk factors for methotrexate-associated osteopathy: a retrospective study Federico Aldegheri1, Francesca Ruzzon1, Matteo Appoloni1, Maurizio Rossini1, Giovanni Adami1, Davide Gatti1, Ombretta Viapiana1, Angelo Fassio1 | 1Università di Verona, Italy
30 -
PO:08:126 | Use of upadacitinib in real-life: the experience of Calabrian rheumatology Vincenzo Raimondo1, Maurizio Caminiti2, Pietro Gigliotti3, Giuseppe Varcasia4, Massimo L'Andolina5, Domenico Olivo6, Roberta Pellegrini7, Pietro Muto8, Marilena Calabria9, Laura Massaro10, Jessica Maria El Luppino11, Salvatore De Bonis12, Giuseppa Pagano Mariano2, Stefania Sorbara3, Virginia Caira4, Mariateresa Cirillo5, Caterina Bruno9, Clodoveo Ferri11 | 1UOC di Reumatologia, Dipartimento SCIAC, Sapienza Università di Roma; 2Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; 3UOC Medicina Interna e Nefrologia, Dipartimento MeSVA, Università degli Studi di L'Aquila; 4UniCamillus, San Camillo Università Internazionale di Scienze della Salute di Roma, Italy; 5Ambulatorio di Reumatologia, Ospedale di Tropea, Tropea, Italy; 6ASP Crotone, Ambulatorio di Reumatologia, Crotone, Italy; 7Ambulatorio di Reumatologia, Ospedale Annunziata di Cosenza, Cosenza, Italy; 8Ambulatorio di Reumatologia, Ospedale di Paola, Paola, Italy; 9Ambulatorio di Reumatologia, SOC di Medicina Interna, AOU Dulbecco, Catanzaro, Italy; 10Ambulatorio di Reumatologia, Ospedale di Praia a Mare, Praia a Mare, Italy; 11Casa di Cura Madonna dello Scoglio, Reparto di Reumatologia, Cotronei, Italy - Affiliazione 12: Ambulatorio di Reumatologia, ospedale di Acri, Acri, Italy
138 -
PO:09:134 | The impact of intra-articular hyaluronic acid injections on osteoarthritis synovitis: a study on synovial tissue of total knee arthroplasty patients Orazio De Lucia1, Laura Giudice1|2, Carolina Artusi1, Luca Ingrao1|2, Giorgia Trignani1|2, Matteo Ferrito1, Andrea Amati1|2, Marta Arese1|2, Camilla Riboldi1|2, Isabella Scotti1, Antonella Murgo1, Ennio Giulio Favalli1|2, Antonina Parafioriti3, Elisabetta Armiraglio3, Andrea Di Bernardo3, Filippo Calanna4, Chiara Fossati4, Pietro Simone Randelli4|5, Roberto Felice Caporali1|2 | 1Dipartimento di Reumatologia e Scienze Mediche,ʁSST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO, Milano; 2Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano; 3UOC Anatomia Patologica, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO, Milano; 4UOC 1° Clinica Ortopedica, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO, Milano; 5Università degli Studi di Milano, Dipartimento di Scienze Biomediche per la Salute, Milano, Italy
140 -
PO:09:139 | Comparative evaluation of GPT-4.0, Claude 4, and MedGEMMA in automatic Kellgren-Lawrence grading of knee osteoarthritis Teresa Caferri1, Vincenzo Venerito1, Angela Carenza1, Daniele Catamerò1, Daniele Domanico1, Sergio Del Vescovo1, Lucia Cristiana Colaprico1, Lavista Marlea1, Maria Giannotta1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area, University of Bari, Bari, Italy.
176 -
PO:10:141 | A Case Study: Navigating the VEXAS Syndrome Mimickers Erika Montabone1, Richard Borrelli1, Nicolò Rashidy1, Fabiana Giannoccaro2, Giuseppe Guida2, Federico Itri3, Renato Carignola4, Simone Negrini1, Stefania Nicola1, Luca Lo Sardo1, Iuliana Badiu1, Federica Corradi1, Ambra Bonvicino5, Maurizio Balbi6, Luisa Brussino1 | 1SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino Torino, Italy; 2SSD Asma grave, malattie rare del polmone e fisiopatologia respiratoria, AOU San Luigi Gonzaga Orbassano, Italy; 3SCDU Medicina Interna ad indirizzo Ematologico, AOU San Luigi Gonzaga Orbassano, Italy; 4SCDU Medicina Interna, Scleroderma Unit, AOU San Luigi Gonzaga Orbassano, Italy; 5SCDU Dermatologia, Città della Salute e della Scienza di Torino Torino, Italy; 6SCDU Radiodiagnostica, AOU San Luigi Gonzaga, Dipartimento di Oncologia Orbassano, Italy
43 -
PO:10:144 | Management of pure red cell aplasia as the onset of systemic lupus erythematosus: a case report Chrystel Carolin Navarrete Cadena1, Marika Tardella1 | 1Università Politecnica delle Marche Jesi, Ancona, Italy
40 -
PO:10:146 | Dorsal myelopathy in a patient with radiographic axial spondyloarthritis Chiara Nobili1, Siria Ripiccini1, Marco Panetta1, Elisabetta Greco1, Barbara Kroegler1, Paola Conigliaro1, Alberto Bergamini1, Maria Sole Chimenti1 | 1Università degli Studi di Roma-Tor Vergata, Italy
125 -
PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement Fabio Brandolino1, Giulia Pazzola1, Luca Ronzoni3, Andreina Teresa Manfredi1|2, Carlo Salvarani1|2 | 1SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; 2Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; 3SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy
185 -
PO:10:150 | A case of pulmonary hypertension in Whipple's disease Alba Chiara Pozzi1|2, Giulia Fontana1|2, Francesca Crisafulli1|2, Guarino Daniele3, Monica Salvi3, Massimiliano Palazzini3, Francesco Biagi4|5, Ilaria Cavazzana1|2, Franco Franceschini1|2, Micol Frassi1. | 1Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, Brescia, Italy; 2Department of Clinical Experimental Sciences, University of Brescia, Brescia; 3IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Cardiology Unit, DIMEC, Bologna; 4University of Pavia, Department of Internal Medicine and Therapeutics, Pavia; 5Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.
133 -
PO:10:153 | Isolated sarcoidosis of the parotid gland: a rare case of unilateral presentation Irene Carlino1, Giorgio Carlino2, Silvia Lombardo3, Luigi Gennari1 | 1Internal Medicine Unit, Department of Medicine Surgery and Neuroscience, University of Siena; 2ASL Lecce, Rheumatology Service DSS Casarano-Gallipoli-Gagliano del Capo, Gallipoli (LE); 3ASL Lecce, DSS Gagliano del Capo, Ugento (LE); Italy
154 -
PO:10:154 | Pudendal nevralgia as an unusual presenting symptom of axial spondyloarthritis Benedetta Bongiovanni1, Gabriele Amati1, Gilda Sandri1|2, Giovanni Ciancio2, Dilia Giuggioli1|2 | 1Struttura complessa di Reumatologia, azienda ospedaliera universitaria Policlinico di Modena; 2Cattedra di Reumatologia, università degli studi di Modena e Reggio Emilia, Modena, Italy
163 -
PO:10:155 | Etanercept-induced lupus in a patient with rheumatoid arthritis: diagnostic challenges and multidisciplinary therapeutic approach Camilla Riboldi1|2, Claudia Iannone1|2, Maria Gerosa1|2, Roberto Felice Caporali1|2 | 1ASST G. Pini-CTO, U.O.C. di Clinica Reumatologica, Milano; 2Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Italy
141 -
PO:10:157 | Sjögren’s syndrome with cryoglobulinemia associated with POEMS syndrome Andrea Mazzon1, Elena Bianchi1, Virginia Berlengiero1, Luca Cantarini1, Bruno Frediani1, Enrico Selvi1 | 1Azienda Ospedaliera Universitaria Senese Le Scotte, Siena, Italy
158 -
PO:11:158 | Osteomyelitis of the jaw: a rare mimick of giant cell arteritis Laura Gigante1, Giovanni B. Canestrari1, Olga Addimanda1, Francesca Bergossi1, Angela Buffa1, Francesco Cianci1, Daniela Chiarini1, Niccolò Girolimetto1, Daniele Lini1, Luca Magnani1, Mirco Magnani1, Erika Meleddu1, Francesca Pignataro1, Sofia Testoni1, Alarico Ariani1, Rita Mulè1, Elisa Rossi1, Enrica Vandelli1, Gentiana Vukatana1, Antonella Gamberini1, Massimo Reta1 | 1UO interaziendale Medicina Interna ad Indirizzo Reumatologico - AUSL Bologna - AOSP Sant'Orsola Bologna, Italy
143 -
PO:11:162 | DRESS syndrome: a case treated with mepolizumab Alessandro Belotti Masserini1, Stefania Bertocchi1, Eleonora Bruschi1, Silvia Breda1, Valeria Rossi1, Elide Lupi1, Tania Ubiali1, Fabrizio Angeli1, Massimiliano Limonta1 | 1ASST Papa Giovanni XXIII, Bergamo, Italy
173 -
PO:11:165 | Clinical mimicry and therapeutic challenge: A Case of Rapidly Progressive Mixed Connective Tissue Disease Elena Maria Di Virgilio1, Elisabetta Chessa2, Valentina Ibba2, Cosimina Matulli2, Jessica Sorgia1, Andrea Pace1, Matteo Piga1|2, Alberto Cauli1|2 | 1Università degli studi di Cagliari-Reumatologia, Cagliari, Italy; 2Struttura complessa di Reumatologia- AOU Cagliari, Cagliari, Italy
39 -
PO:11:167 | Subtle symptoms masking a challenging diagnosis: a clinical case of intestinal vasculitis in systemic lupus erythematosus Ilaria Pace1, Giulia Rizzo1, Elisabetta Chessa2, Davide Corradini1, Roberta Origa1, Valentina Ibba2, Alberto Floris1|2, Alberto Cauli1|2, Matteo Piga1|2 | 1Sapienza Università di Roma; 2SC Reumatologia, AOU Cagliari, Cagliari, Italy
217 -
PO:11:170 | When Paget Meets Inflammatory Back Pain: A Diagnostic Dilemma Between Bone Remodeling and Spondyloarthritis Marco Capodiferro1, Giuseppe Lopalco1, Giulia Righetti2, Gianluigi Della Corte2, Patrizia Suppressa2, Florenzo Iannone1, Fabio Cacciapaglia1|2 | 1Unit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica DiMePRe-J, University of Bari, Italy; 2Miulli General Hospital Acquaviva - Department of Medicine and Surgery, LUM F. De Gennaro University, Casamassima, Bari, Acquaviva delle Fonti, Italy
47 -
PO:11:171 | Subcutaneous tocilizumab use in a young-onset mixed connective tissue disease patient with multiple treatment failures Rhaysa Araujo Mousinho1, Elide Lupi2, Massimiliano Limonta2 | 1Clinica di Reumatologia, Dipartimento di Medicina and 2Istituto di Anatomia Patologica, Dipartimento di Medicina di Laboratorio, Osp. S. M. della Misericordia, Università di Udine, Italy
146 -
PO:11:172 | Not all vasculitis look the same: a difficult diagnosis Marta Arese1|2, Miriam Perino1|2, Sofia Aliprandi1|2, Antonella Murgo2, Maria Gerosa1|2, Roberto Felice Caporali1|2 | 1UOC Reumatologia AOR San Carlo, Potenza; 2Reumatologia Clinica, ASST Gaetano Pini-CTO, Milano, Italy
130 -
PO:11:175 | Dermatomyositis and immunosuppressant treatment: a case of Staphylococcus aureus pneumonia in a hospitalized patient Simona Fichera1, Andrea Cito1, Martina Vigilia1, Maria Morrone1, Teresa Caferri1, Crescenzio Scioscia1, Simone Perniola1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Unit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica, University of Bari, Bari, Italy.
139 -
PO:12:177 | Systemic inflammation and QTc interval prolongation in new-onset polymyalgia rheumatica: the effect of corticosteroid therapy Anna Colangelo1, Riccardo Accioli2, Viola Salvini2, Francesco Tromby1, Giulia Cruciani1, Martina Nicchi1, Biancamaria Pianese1, Francesca Lalli1, Anna Cantore2, Caterina Antonini1, Decoroso Verrengia2, Andrea Castellucci1, Giacomo Cafaro1, Carlo Perricone1, Roberto Gerli1, Pietro Enea Lazzerini2, Elena Bartoloni1 | 1SC Reumatologia. Università di Perugia, Italy; 2Dipartimento di Scienze Mediche, Università di Siena, Italy
36 -
PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni1, Silvia Sirotti1|2, Georgios Filippou1|2, Piercarlo Sarzi Puttini1|2, Greta Pellegrino1|2. | 1Università degli Studi di Milano, Milano; 2IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.
143 -
PO:12:179 | Cardiovascular outcomes of treat-to-target urate-lowering therapy in gout: emulated target trials Edoardo Cipolletta1, Davide Rozza2, Abhishek Abhishek3 | 1Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy; 2Società Italiana di Reumatologia, Milano, Italy; 3University of Nottingham Nottingham, United Kingdom
39 -
PO:12:180 | Echocardiographic screening of pulmonary hypertension in a multidisciplinary cohort of patients with interstitial lung disease Lorenzo Mattia Bianchessi1, Veronica Piccin1, Federica Sabatelli1, Lorenzo Cavagna1, Giovanni Zanframundo1, Domenicafederica Briganti2, Mauro Acquaro3, Stefano Ghio3, Domenico Sorace1, Valentina Vertui2, Ilaria Giana2, Andrea Patanè3, Veronica Codullo1 | 1UOC Reumatologia, Fondazione IRCCS Policlinico S. Matteo, Pavia; 2Centro Trapianti, Fondazione IRCCS Policlinico San Matteo, Pavia; 3UOC Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
152 -
PO:12:183 | Acute effect of anti-TNF therapy on atrioventricular conduction in chronic inflammatory arthritis: a prospective cohort study Viola Salvini1, Riccardo Accioli1, Anna Cantore1, Fabio Salvadori1, Enrico Selvi2, Virgina Berlengerio2, Maurizio Acampa3, Alessandra Cartocci1, Decoroso Verrengia1, Kateryna Miedviedieva1, Sciaila Bernardini1, Michele Voglino1, Maurizio Bicchi1, Daniela Merlotti1, Stefania Bisogno1, Pier Leopoldo Capecchi1, Pietro Enea Lazzerini1 | 1Division of Internal Medicine, Electroimmunology Unit, University Hospital of Siena, Italy; 2Division of Rheumatology, University Hospital of Siena, Italy; 3Stroke Unit, University Hospital of Siena, Italy
50 -
PO:12:184 | Atrioventricular conduction in chronic inflammatory arthritis: enhanced assessment by new electrocardiographic parameters Riccardo Accioli1, Viola Salvini1, Anna Cantore1, Fabio Salvadori1, Enrico Selvi2, Virgina Berlengiero2, Maurizio Acampa3, Alessandra Cartocci1, Kateryna Miedviedieva1, Decoroso Verrengia1, Sciaila Bernardini1, Michele Voglino1, Giovanni Donati1, Silvia Petri1, Severino Gallo1, Stefania Bisogno1, Pier Leopoldo Capecchi1, Pietro Enea Lazzerini1 | 1Division of Internal Medicine, Electroimmunology Unit, University Hospital of Siena, Italy; 2Division of Rheumatology, University Hospital of Siena, Italy; 3Stroke Unit, University Hospital of Siena, Italy
30 -
PO:12:186 | Clinical, functional, and microvascular features in the early diagnosis and management of pulmonary hypertension in systemic sclerosis: the importance of multimodal screening strategies Irene Carlino1, Stefania Bisogno1, Alberto Palazzuoli2, Luigi Gennari1 | 1U.O.C. Reumatologia, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, A.O.U. Senese; 2Azienda Sanitaria Locale, Novara, Italy
138 -
PO:12:187 | Maternal Hypertensive Disorders in Pregnant Women with Rheumatic Diseases and long-term Cardiovascular Outcomes: preliminary data of a single centre experience Margherita Rinaldi1, Paolo Semeraro1, Francesca Crisafulli1, Matteo Filippini2, Maria Grazia Lazzaroni1, Cecilia Nalli1, Liala Moschetti1, Marco Taglietti2, Chiara Loardi3, Rossana Orabona3, Francesca Ramazzotto3, Sonia Zatti3, Laura Andreoli1, Angela Tincani1, Micaela Fredi1, Ilaria Cavazzana1, Franco Franceschini1 | 1Department of Clinical and Experimental Sciences, University of Brescia, Italy; 2Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, ERN-ReCONNET Center Brescia, Italy; 3Gynaecology and Obstetrics Unit ASST Spedali Civili di Brescia, Italy
34 -
PO:13:188 | Menstrual alterations among women with rheumatoid arthritis: a comparative study across treatment modalities with focus on JAK inhibitors Angelica Napoletano1, Francesca Arezzo2, Marco Fornaro1, Giuseppe Lopalco1, Gennaro Cormio2, Vincenzo Venerito1, Florenzo Iannone1. | 1University of Bari, Rheumatology Unit Department of Precision and Regenerative Medicine, Jonica Area, Bari; 2Gynecologic Oncology, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
325 -
PO:13:189 | Greater impact of psoriatic arthritis in females: is this mediated primarily by disease activity? Roberta Masnata1, Valentina Boni1, Giusy Peluso1, Giulia Calabrese1, Enrico De Lorenzis1, Gerlando Natalello1, Maria Antonietta D'Agostino1, Augusta Ortolan1. | 1UOC Reumatologia e Immunologia Clinica- Fondazione Policlinico Agostino Gemelli IRCCS-Università Cattolica Sacro Cuore, Roma, Italy.
147 -
PO:14:193 | Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 Trial Megan EB Clowse1, Marta Mosca2, David A Isenberg3, Joan T Merrill4, Thomas Dörner5, Michelle Petri6, Edward M Vital7|8, Eric F Morand9, Teri Jimenez10, Stephen Brookes11, Janine Gaiha-Rohrbach12, Christophe Martin13, Annette Nelde14, Christian Stach15 | 1Duke University - Division of Rheumatology and Immunology Durham, USA; 2University of Pisa - Rheumatology Unit, Department of Clinical and Experimental Medicine Pisa, Italy; 3University College London - Department of Ageing, Rheumatology and Regenerative Medicine, Division of Medicine London, United Kingdom; 4Oklahoma Medical Research Foundation Oklahoma City, USA; 5Charité Universitätsmedizin Berlin - Department of Medicine/Rheumatology and Clinical Immunology Berlin Germany; 6Johns Hopkins University School of Medicine Baltimore, USA; 7University of Leeds - Leeds Institute of Rheumatic and Musculoskeletal Medicine Leeds, United Kingdom; 8Leeds Teaching Hospitals NHS Trust - NIHR Leeds Biomedical Research Centre Leeds, United Kingdom; 9Monash University - Centre for Inflammatory Diseases Melbourne, Australia; 10UCB Raleigh, USA; 11Biogen Maidenhead, United Kingdom; 12Biogen Cambridge, USA; 13UCB Slough, United Kingdom; 14Biogen Baar, Switzerland; 15UCB Monheim am Rhein, Germany
44 -
PO:14:194 | The CORAL Study: Complement levels during pregnancy in prospectively followed systemic Lupus erythematosus patients Irene Cecchi1, Massimo Radin1, Alice Barinotti1, Francesca Crisafulli2, Laura Andreoli2, Cecilia Beatrice Chighizola3, Savino Sciascia1, On Behalf Of The Coral Study Group1 | 1Università di Torino, Italy; 2Università di Brescia, Italy; 3Università di Milano, Italy
16 -
PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study Chiara Cardelli1|2, Chiara Tani1, Luca Moroni3, Filippo Vesentini4, Francesca Bottazzi5, Micaela Fredi6, Ettore Silvagni7, Matteo Piga8, Flavia Riccio9, Fulvia Ceccarelli10, Ginevra De Marchi11, Edoardo Biancalana12, Gianluca Moroncini13, Rita Mulè14, Mariele Gatto15, Laura Coladonato16, Paola Conigliaro17, Maria Gerosa18, Andrea Picchianti Diamanti19, Benedetta Bianchi20, Federica Maiolini20, Michela Gasparotto20, Serena Guiducci20, Maria Ilenia De Andres20, Alberto Lo Gullo20, Silvia Noviello20, On Behalf Of The Reveal Investigators20, Marta Mosca1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; 2Department of Medical Biotechnologies, University of Siena, Siena; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; 4Rheumatology Unit, Department of Medicine, University of Padua, Padova; 5Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 6Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; 7Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; 8Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari; 9Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; 10Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; 11Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; 12Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; 13Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 14Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; 15Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; 16Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; 17Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; 18Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; 19Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; 20Italian REVEAL Study Group Italy, Italy
162 -
PO:14:196 | Photosensitivity in Lupus Erythematosus: The Patients' Perspective in a National Survey Marianna Salis1, Elisabetta Chessa2, Alessandra Oliva1, Marta Paola Pireddu1, Fabio Congiu1, Giulia Rizzo1, Elena Ragusa1, Alberto Cauli1|2, Laurent Arnaud3, Matteo Piga1|2 | 1Università degli Studi di Cagliari, Italy; 2Azienda Ospedaliera Universitaria di Cagliari, Unità Operativa Complessa di Reumatologia Cagliari, Italy; 3Strasbourg University and Academic Hospitals Strasbourg, France
18 -
PO:14:197 | Safety of biologic and conventional immunosuppressants in an Italian cohort of patients with systemic lupus erythematosus: a longitudinal analysis from the Lupus Italian Registry pharmacoepidemiologic study promoted by the Italian Society of Rheumatology Davide Rozza1, Carlo Alberto Scirè1|2, Paola Conigliaro3, Giacomo Emmi4, Laura Coladonato6, Salvatore Scarpato7, Luca Iaccarino8, Serena Guiducci9, Giulia Pazzola10, Francesca Romana Spinelli11, Micol Frassi12, Ilaria Cavazzana12, Chiara Scirocco13, Valeria Orefice13, Immacolata Prevete13, Alessandra Bortoluzzi14, Marcello Govoni14, Elena Bartoloni15, Luca Moroni16, Giuseppe Alvise Ramirez16, Valentina Canti16, Giorgio Pettiti17, Maria Chiara Ditto18, Enrico Fusaro18, Marta Mosca19, Lorenzo Cavagna20, Fabrizio Conti11, Andrea Doria8, Gian Domenico Sebastiani13, Sperimentatori Gruppo Lire5 | 1Centro Studi della Società Italiana di Reumatologia, Milano; 2Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza; 3Università di Roma Tor Vergata; 4Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste; 5https://redcap.reumatologia.it/surveys/?s=LWL7WJM4KHDR97CC; 6Dip di Medicina di Precisione e Rigenerativa e area Jonica, Bari; 7Azienda Sanitaria Locale ASL Salerno; 8Università degli Studi di Padova; 9SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; 10Arcispedale Santa Maria Nuova Reggio Emilia; 11Università degli Studi di Roma La Sapienza; 12Spedali Civili di Brescia; 13Azienda Ospedaliera San Camillo Forlanini, Roma; 14Azienda Ospedaliera Universitaria Sant'Anna, Ferrara; 15SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; 16IRCCS Ospedale San Raffaele, Milano; 17Azienda Ospedaliera S. Croce e Carle, Cuneo; 18AOU Citta' della Salute e della Scienza di Torino; 19AOU Santa Chiara, Pisa; 20Università di Pavia, Italy
145 -
PO:14:198 | Temporal Trends in LLDAS and DORIS Achievement in SLE: Impact of Evolving International Recommendations Laura Coladonato1, Marco Fornaro1, Angelica Napoletano1, Daniele Catamerò1, Giuseppe Lopalco1, Florenzo Iannone1 | 1UOC Reumatologia, Policlinico di Bari, DiMePre-J Bari, Italy
26 -
PO:14:199 | Preliminary data of a multicentric study on safety and efficacy of assisted reproductive techniques in pregnant women with systemic autoimmune diseases Valentina Canti1, Maria Bernadette Cilona1, Giuditta Gorgone1, Federica Pasi1, Antonia Calligaro2, Francesca Ruffilli3, Francesca Crisafulli6, Maria Tonello2, Eleonora Giacobbe4, Alba Chiara Pozzi6, Maria Chiara Gerardi4, Melissa Padovan3, Emanuele Bizzi5, Enrico Papaleo1, Beatrice Maranini3, Marcello Govoni3, Massimiliano Epis4, Angela Tincani6, Andrea Doria2, Patrizia Rovere Querini1 | 1IRCCS Ospedale San Raffaele and VitaSalute San Raffaele Milano, Italy; 2Rheumatology Unit, Departement of Medicine, University Hospital of Padua Padova, Italy; 3Rheumatology Unit, Azienda Ospedaliero Universitaria S. Anna Ferrara, Department of Medical Sciences, University of Fe Ferrara, Italy; 4ASST Grande Ospedale Metropolitano Niguarda Milano, Italy; 5Internal Medicine, Fatebenefratelli Hospital Milano, Italy; 6Rheumatology and Immunology Unit, ASST Spedali Civili Brescia e Università degli Studi di Brescia, Italy
23 -
PO:14:200 | Placental markers of angiogenesis in pregnant women with antiphospholipid syndrome: predictive role of SFLT-1, PLGF, and uterine artery doppler in preeclampsia Maria Bernadette Cilona1, Valentina Canti1, Martina Beschi2, Federica Pasi3, Serena Girardelli3, Mirko Pozzoni3, Maria Teresa Castiglioni3, Paolo Cavoretto3, Patrizia Rovere-Querini1|2 | 1Unit of Internal Medicine and Division of Immunology, Transplantation and Infectious diseases, IRCCS San Raffaele Hospital Milan, Italy; 2Vita-Salute San Raffaele University Milan, Italy; 3Department of Obstetrics and Gynecology, IRCCS San Raffaele Scientific Institute Milan, Italy
12 -
PO:14:201 | Olfactory Assessment in Patients with Systemic Lupus Erythematosus: Correlation with Clinical, Serological, and Imaging Markers Lorenza Bruno1, Giacomo Cafaro1, Marta Di Berardino1, Roberto Dal Pozzolo1, Anna Colangelo1, Francesco Tromby1, Martina Nicchi1, Giulia Cruciani1, Biancamaria Pianese1, Roberto Gerli1, Elena Bartoloni Bocci1, Carlo Perricone1 | 1Università degli Studi di Perugia, Italy
31 -
PO:14:202 | Use of anifrolumab in the treatment of the hematological manifestations of systemic lupus erythematosus: a single-centre case series Gaia Ferracane1|2, Jessika Dichiara1|2, Elena Manna1|2, Lorenzo Mattia Bianchessi1|2, Giovanni Zanframundo1|2, Serena Bugatti1|2, Veronica Codullo1|2, Lorenzo Cavagna1|2, Francesca Bottazzi1|2 | 1Department of Internal Medicine and Therapeutics, Università di Pavia; 2Division of Rheumatology, IRCCS Policlinico San Matteo, Pavia, Italy
195 -
PO:14:203 | Impact of anifrolumab on depressive symptoms in systemic lupus erythematosus: results from a single-centre prospective observational study Luca Moroni1, Biancamaria Venerandi1, Maria Cilona1, Anna Vivona1, Gabriele Gallina1, Giovanni Benanti1, Enrica Bozzolo1, Giuseppe Ramirez1, Marco Matucci-Cerinic1, Lorenzo Dagna1. | 1U.O. di Immunologia, Reumatologia, Allergologia e Malattie Rare - IRCCS Ospedale San Raffaele, Milano, Italy.
134 -
PO:14:204 | Risk stratification in systemic lupus erythematosus patients: improving the performances of a prediction model Lucia Lanzo1, Silvia Laura Bosello1, Livia Lilli2, Laura Antenucci2, Carlotta Masciocchi2, Marco Gorini3, Gabriella Castellino3, Luca Petricca1, Maria Rita Gigante1, Vivianaantonella Pacucci1, Pier Giacomo Cerasuolo1, Silvia Piunno1, Francesco Cristiano1, Cesare Gavotti1, Pier Luigi Rizzuti1, Rebecca Ventura1, Jacopo Lenkowicz2, Alfredo Cesario2, Stefano Patarnello2, Maria Antonietta D'Agostino1. | 1UOC di Reumatologia e Immunologia clinica - Fondazione Policlinico Universitario A. Gemelli IRCSS, UCSC, Roma, Italy; 2Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy; 3AstraZeneca MIND, Milano, Italy.
155 -
PO:14:205 | Primary antiphospholipid antibody syndrome: association between new classification criteria manifestations and a higher-risk disease phenotype Sara Ferrigno1, Vittorio Forte2, Marco Panetta1, Sergio Lisena1, Giorgia Ranucci2, Luigi De Marco1, Elisabetta Greco1, Alberto Bergamini1, Maria Sole Chimenti1, Paola Conigliaro1. | 1Rheumatology, allergology and clinical immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
158 -
PO:14:206 | Factors impacting subjective cognitive impairment in systemic lupus erythematosus patients: clearing away the lupus brain fog Elisabetta Chessa1, Marta Paola Pireddu2, Fabio Congiu2, Giulia Rizzo2, Cristina Serafini3, Elena Ragusa2, Alberto Cauli1|2, Matteo Piga1|2. | 1SC Reumatologia- AOU Cagliari, Cagliari, Italy; 2Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy; 3PO Sirai - Unità di Nefrologia e Dialisi, Carbonia (CA), Italy.
153 -
PO:14:207 | Nailfold capillaroscopy in systemic lupus erythematosus: microvascular alterations and their clinical relevance Giulia Cassone1, Filippo Santoro2, Maria Grazia Malandra2, Bruno Biasi2, Elena Vanni2, Caterina Vacchi1, Alesandra Carobbio3, Dilia Giuggioli1|2. | 1Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 2Università di Modena e Reggio Emilia, Modena, Italy; 3Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Univeristà di Modena e Reggio Emilia, Modena, Italy.
142 -
PO:15:208 | Impact of disease control on organ damage accrual in patients with systemic lupus erythematosus with and extra-renal flares: a 12-month single-center longitudinal study Giorgia Capozzo1, Marco Oliva1, Giancarlo Cascarano1, Chiara Cardelli1, Dina Zucchi1, Chiara Stagnaro2, Viola Signorini2, Elena Elefante2, Chiara Tani1, Marta Mosca1. | 1Università di Pisa, Dipartimento di Medicina Clinica e Sperimentale, Pisa, Italy; 2Azienda Ospedaliero Universitaria Pisana, U.O. Reumatologia, Pisa, Italy.
144 -
PO:15:209 | Attainment of remission or lupus low disease activity state in single center Lupus Clinic Paola Tedoldi1|2, Silvia Ebe Lucia Della Pina1|2, Claudia Barison1|2, Chiara Orlandi1|2, Cecilia Nalli1, Micaela Fredi2, Ilaria Cavazzana1|2, Franco Franceschini1|2 | 1Rheumatology and Clinical Immunology Unit- ERN ReCONNET, ASST Spedali Civili of Brescia Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia Brescia, Italy
37 -
PO:15:212 | Anifrolumab induces a rapid improvement in joint inflammation in Systemic Lupus Erythematosus patients: an ultrasonographic study Valeria Moretti, Fulvia Ceccarelli, Claudia Ciancarella, Valerio Fiorilli, Francesca Romana Spinelli, Fabrizio Conti | Sapienza Università di Roma, Italy
13 -
PO:15:214 | Identification of SLE patients with high-levels Type 2 SLE through the polysymptomatic distress scale (PSD): correlations with other PROs and differences in clinical phenotypes in a multicentric cohort Micaela Fredi1|2, Giorgia Gozzoli1|2, Federica Bonaso1|2, Silvia Ebe Della Pina1|2, Claudia Barison1|2, Irene Lorenzini2, Anna Mattiuzzo2, Raffaele Pericotti2, Marcelo Neto3, Sofia Avedo4, Clàudia Oliveira4, Luis Sousa Ines3, Franco Franceschini1|2 | 1Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, ERN-ReCONNET Center, Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; 3Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; 4Rheumatology Department, ULS Aveiro, Aveiro, Portugal
12 -
PO:15:215 | Evaluating the Prognostic Value of Modified NIH Indices and Total Renal Chronicity Score in Lupus Nephritis: a single center retrospective analysis Alessandra Ida Celia1, Andrea Ascione2, Bruna Cerebelli2, Martina Leopizzi2, Cristiano Alessandri1, Francesca Romana Spinelli1, Fabrizio Conti1 | 1Reumaologia, Scienze Cliniche internistiche, anestesiologiche e cardiovascolari, Università La Sapienza di Roma, Italy; 2Anatomia patologica, Dipartimento di Scienze biotecnologiche medico-chirurgiche, Università La Sapienza di Roma, Italy
13 -
PO:15:216 | Safety and Efficacy of a single dose of Rituximab to manage Pregnancy-Related Severe Flare of Systemic Lupus Erythematosus: A Case Report Eugenio Capparelli1, Daniela Bompane1, Eleonora Zaccara1, Laura Castelnovo1, Antonio Tamburello1, Antonino Mazzone2, Paola Faggioli1 | 1UOC Reumatologia, ASST Ovest Milanese, Legnano, Milano, Italy; 2UOC Medicina Interna, ASST Ovest Milanese, Legnano, Milano, Italy
27 -
PO:15:217 | Improved efficacy and safety outcomes in patients with systemic lupus erythematosus treated with belimumab vs. immunosuppressants, in addition to antimalarials and glucocorticoids: a post-hoc summary of five phase 3 trials Mariele Gatto1, Karen H. Costenbader2, Andreas Schwarting3, Julia Hn Harris4, Ciara O'Shea5, Roger A. Levy6, Andrea Doria7 | 1Centro Accademico Reumatologia, Dipartimento Scienze Cliniche Biologiche, Università degli Studi Torino, Osp. Mauriziano, Italy; 2Brigham and Women's Hospital, Divisione di Reumatologia, Infiammazione e Immunità, Harvard Medical School, Boston, MA, USA; 3Università Johannes Gutenberg di Mainz, Centro medico universitario, Germany; 4GSK, Immunologia Biostatistica London, UK; 5GSK, Global Medical Affairs Reumatologia, Dublin, Ireland; 6GSK, Global Medical Affairs Collegeville, PA, USA; 7Divisione di Reumatologia, Dipartimento di Medicina, Università di Padova, Italy
155 -
PO:15:218 | Evaluation of leukocyte expression of ecto-nucleotidase in patients with systemic lupus erythematosus Luca Rapino1, Simona Truglia1, Fulvia Ceccarelli1, Francesca Romana Spinelli1, Silvia Mancuso1, Giada La Spina1, Hector Rincon Arvalo2, Thomas Doerner2, Ana Luisa Stefanski2, Fabrizio Conti1. | 1La Sapienza Università di, Roma, - Dipartimento di Scienze Cliniche Internistiche Anestesiologiche e Cardiovascolare, Roma, Italy; 2Charité Universitätsmedizin - Department of Rheumatology and Clinical Immunology, Berlino, Germany.
120 -
PO:15:219 | Nailfold capillaroscopic abnormalities in systemic lupus erythematosus: comparison with healthy controls and clinical-immunological correlations. Preliminary data Chiara Orlandi1|2, Alessia Loda2, Cesare Tomasi1|2, Silvia Ebe Lucia Della Pina1|2, Claudia Barison1|2, Cecilia Nalli1, Ilaria Cavazzana1|2, Micaela Fredi1|2, Franco Franceschini1|2. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET , ASST Spedali Civili of Brescia, Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
125 -
PO:15:220 | Outcomes of extra renal flares in systemic lupus erythematosus: longitudinal analysis of a monocentric cohort Marco Oliva1, Giorgia Capozzo1, Giancarlo Cascarano1, Chiara Cardelli1, Dina Zucchi1, Angela Elia1, Elena Elefante2, Viola Signorini2, Chiara Stagnaro2, Chiara Tani1, Marta Mosca1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology Unit, AOUP, Pisa, Italy.
136 -
PO:15:221 | Proteins upregulated in thrombotic antiphospholipid syndrome link to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews Silvia Mancuso1, Claudia Ciancarella1, Luca Rapino1, Simona Truglia1, Cristiano Alessandri1, Fabrizio Conti1. | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari - Rheumatology Unit, Sapienza Univers, Roma, Italy.
154 -
PO:15:222 | Post-hoc analysis of the BeRLiSS-JS registry: efficacy of belimumab on thrombocytopenia Greta Hulej1, Margherita Zen1, Marisol Bracalenti1, Francesca Bottazzi2, Rossella De Angelis3, Giacomo Emmi4, Roberto Gerli5, Marcello Govoni6, Renato Lo Gullo7, Simone Negrini8, Luca Quartuccio9, Maurizio Rossini10, Carlo Salvarani11, Paola Tomietto4, Angelo Vacca12, Andrea Doria1, Luca Iaccarino1. | 1Università degli Studi di Padova, Padova, Italy; 2Università degli Studi di Pavia, Pavia, Italy; 3Università Politecnica delle Marche, Ancona, Italy; 4Università degli Studi di Trieste, Trieste, Italy; 5Università degli Studi Perugia, Perugia, Italy; 6Università degli Studi di Ferrara, Ferrara, Italy; 7Università degli Studi di Catania, Catania, Italy; 8Università degli Studi di Torino, Torino, Italy; 9Università degli Studi di Udine, Udine, Italy; 10Università degli Studi di Verona, Verona, Italy; 11Università degli Studi di Modena e Reggio Emilia, Modena, Italy; 12Università degli Studi di Bari .
137 -
PO:15:224 | Measuring disease activity in Systemic Lupus Erythematosus patients: SLE-DAS usefulness in real-life setting Valeria Moretti, Fulvia Ceccarelli, Claudia Ciancarella, Cristina Garufi, Alessandra Ida Celia, Silvia Mancuso, Angelica Gattamelata, Simona Truglia, Francesca Romana Spinelli, Cristiano Alessandri, Fabrizio Conti | La sapienza Università di Roma, Italy
15 -
PO:16:225 | Belimumab in refractory and/or non-criteria manifestations of antiphospholipid syndrome: ad interim analysis on Quality-of-Life changes from the BLAST trial Alessio Conti1, Lois Ira Capulong1, Irene Cecchi1, Elena Rubini1, Chiara Bova1, Massimo Radin1, Alice Barinotti1, Beatrice Ala1, Silvia Grazietta Foddai1, Daniela Rossi1, Roberta Fenoglio1, Savino Sciascia1 | 1Centro di Eccellenza Universitario per le Malattie Nefrologiche, Reumatologiche e Rare, S.G.Bosco -ASL Città di Torino, Italy
18 -
PO:16:226 | Clinical Phenotypes of Systemic Lupus Erythematosus: An Exploratory Cluster Analysis in a Monocentric Cohort Richard Borrelli1, Stefania Nicola1, Federica Corradi1, Iuliana Badiu1, Luca Lo Sardo1, Marzia Boem1, Valentina Marmora1, Simone Negrini1, Luisa Brussino1 | 1SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino, Italy
17 -
PO:16:227 | Anifrolumab for Systemic Lupus Erythematosus: Preliminary Safety and Efficacy Findings from the Italian Experience Paola Bizioli1|2, Chiara Orlandi1|2, Claudia Barison1|2, Cesare Tomasi3, Alessia Caproli1, Silvia Piantoni1|2, Simona Signorini4, Emirena Garrafa4, Cecilia Nalli1, Micol Frassi1, Ilaria Cavazzana1|2, Micaela Fredi1|2, Franco Franceschini1|2 | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia, Italy; 3Department of Clinical and Experimental Sciences, University of Brescia, Italy; 4Laboratory of Clinical Chemistry, Department of Molecular and Translational Medicine, University of Brescia, Italy
41 -
PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.
136 -
PO:16:232 | Belimumab step-down dose spacing in patients with systemic lupus erythematosus in persistent clinical remission: experience from a multicentric cohort Alice Bartoletti1, Laura Giudice1, Lorenza Maria Argolini1|2, Giuseppe Alvise Ramirez3, Luca Moroni3, Tommaso Schioppo4, Chiara Bellocchi5|6, Annalaura Fasiello6, Lorenzo Beretta6, Lorenzo Dagna3, Roberto Caporali1, Maria Gerosa1. | 1UO Clinica Reumatologica, ASST Gaetano Pini CTO, Milano, Italy; 2UOC Medicina fisica e riabilitazione specialistica, ASST Gaetano Pini CTO, Milano, Italy; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Vita-Salute San Raffa Milano Italy; 4Medicina Generale II, Servizio di Reumatologia, Ospedale San Paolo, ASST Santi Paolo Carlo, Milano, Italy; 5Department of Clinical Sciences and Community Health, University of Milan, Dipartimeto di Eccellenza 2023-2027, Milano, Italy; 6Referral Centre for Systemic Autoimmune DIseases, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
165 -
PO:16:233 | Efficacy of voclosporin on nephritis in patients with variable gain of function of TLR7 affected by lupus: clinical case Veronica Spedicato1, Laura Coladonato1, Marco Fornaro1, Marlea Lavista1, Daniele Sabella1, Marco Capodiferro1, Maria Morrone1, Crescenzio Scioscia1, Giuseppe Lopalco1, Florenzo Iannone1 | 1Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area JonicaJ, University of Bari, Italy
147 -
PO:16:234 | Differential efficacy of induction treatments for lupus nephritis at onset and relapses: an observational study Giuseppe Alvise Ramirez1|2, Gabriele D Gallina1, Chiara Calabrese1|2, Serena Nannipieri1|2, Marta Calatroni3|4, Francesco Reggiani3|4, Giovanni Benanti1, Enrica Paola Bozzolo1, Raffaele Ceniccola2, Luca Moroni1|2, Marco Matucci-Cerinic1|2, Gabriella Moroni3|4, Lorenzo Dagna1|2 | 1IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases Milan, Italy; 2Vita- Salute San Raffaele University Milan, Italy; 3IRCCS Humanitas Research Hospital, Nephrology and Dialysis Division Rozzano, Milan, Italy; 4Humanitas University, Department of Biomedical Sciences Rozzano, Milan, Italy
35 -
PO:16:235 | Anifrolumab in systemic lupus erythematosus: real-life experience of a single-center cohort Filippo Vesentini1, Luca Iaccarino1, Federico Arru2, Greta Hulej1, Anna Giorgia Osele1, Noemi Merra1, Davide Ragno1, Andrea Doria1, Margherita Zen1 | 1UOC Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova; 2UO Medicina, ASL 3 Nuoro, Italy
129 -
PO:16:236 | Achieving a low disease activity state with a corticosteroid dose of 5 mg or less: observational study with anifrolumab in patients with systemic lupus erythematosus in Italy Alessandra Bortoluzzi1, Fulvia Ceccarelli2, Fabio Leo3, Paola Roccatagliata3, Chiara Tani4, Margherita Zen5 | 1Azienda Ospedaliera Universitaria Sant' Anna di Cona, Università di Ferrara Italy; 2Unità di Reumatologia, Università Sapienza Roma Italy; 3AstraZeneca S.p.a. Milano Italy; 4Università di Pisa e Azienda Ospedaliero Universitaria Pisana, Pisa Italy; 5Dipartimento di Medicina DIMED , Divisione di Reumatologia, Università di Padova, Italy
119 -
PO:16:238 | Cardiovascular risk in systemic lupus erythematosus patients: comparison among Framingham Score, QRISK3, and SLECRE Francesca Vignoni1|2, Serena Iodice2, Cesare Tomasi2, Chiara Orlandi1|2, Eleonora Pedretti1, Micaela Fredi2, Franco Franceschini1|2, Ilaria Cavazzana1|2. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
130 -
PO:16:240 | Systemic Lupus Erythematosus Presenting as End-Stage Liver Disease: A Case Report and Literature Review Annamaria Tiso1, Stefania Caccavelli1, Giuseppina Caroppi1, Candida Tarullo1, Gaetano Serviddio1 | 1Policlinico Riuniti Foggia, Italy
44 -
PO:16:241 | Prevalence and associated factors of premature ovarian insufficiency in women with systemic lupus erythematosus: the role of human herpesviruses HHV-7 and HHV-8 Margherita Rizzo1, Francesca Ruffilli1, Silvia Beltrami2, Daria Bortolotti2, Roberta Rizzo2, Carlo Garaffoni1, Ettore Silvagni1, Marcello Govoni1, Alessandra Bortoluzzi1 | 1UOC Reumatologia, Dipartimento di Scienze Mediche, Università di Ferrara e Azienda Ospedaliero-Universitaria S. Anna, Ferrara; 2Dipartimento di Scienze Chimiche, Farmaceutiche e Agrarie, Ferrara Italy
150 -
PO:17:248 | Prevention of human papillomavirus infection in women with systemic lupus erythematosus: a single-center cross-sectional study Clizia Gagliardi1, Maria Chiara Gerardi1, Bianca Lucia Palermo1, Giulia Carrea1, Maria Di Cicco1, Elena Manna1, Giulia Segatto1, Antonella Adinolfi1, Laura Belloli1, Cinzia Casu1, Silvia Cavalli1, Davide Antonio Filippini1, Matteo Longhi1, Gabriella Maioli1, Martina Schettino1, Nicola Ughi1, Elisa Verduci1, Arianna Bertolucci1, Lara Buffa1, Giulia Buonsante1, Claudia Cordini1, Eleonora Giacobbe1, Francesco Molica Colella1, Oscar Epis1 | 1ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
150 -
PO:17:250 | Effectiveness and safety of the recombinant zoster vaccine in patients ≥18 years of age with systemic lupus Giulia Boschi1, Sheryl A. Kluberg2, Sophie E. Mayer2, O'Mareen Spence3, Driss Oraichi3, Harry Seifert3, Omar Ali3, Huifeng Yun3, Andrew L. Simon4, Jenice S. Ko4, Caroline Hugh4, Meg Her4, Kathleen Shattuck4, Richard Platt2, Aziza Jamal-Allial5, Djeneba Audrey Djibo6, Kimberly Daniels5, Qianli Ma7, Cheryl N. Mcmahill-Walraven6, Rachel P. Ogilvie8, Kristin Palmsten9, Mano Selvan7, Najat Ziyadeh8, Alexis Ogdie10, Michael George10 | 1GSK Verona Italy; 2Harvard Medical School and the Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; 3GSK Rockville; 4Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; 5Carelon Research, Wilmington; 6CVS Health, Blue Bell; 7Humana Healthcare Research, Louisville; 8OptumInsight Life Sciences, Boston; 9HealthPartners Institute, Bloomington; 10University of Pennsylvania, Philadelphia, USA
136 -
PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort Fabio Congiu1, Elisabetta Chessa2, Giulia Rizzo1, Elena Ragusa1, Marta Paola Pireddu1, Alessandra Oliva1, Marianna Salis1, Mattia Congia2, Maria Maddalena Angioni1, Micaela Rita Naitza1, Alberto Floris2, Alberto Cauli1|2, Matteo Piga1|2 | 1AOU e Università degli studi di Cagliari; 2SC Reumatologia PO Duilio Casula, Cagliari, Italy
151 -
PO:17:253 | Unveiling the gap: a multicenter study on factors driving patient-physician discrepancies in assessing disease activity in systemic lupus erythematosus Giorgia Ingrid Gozzoli1, Micaela Fredi1, Federica Bonaso1, Silvia Ebe Lucia Della Pina1, Claudia Barison1, Irene Lorenzini4, Raffaele Pericotti4, Anna Mattiuzzo4, Marcelo Neto2, Sofia Azevedo3, Cláudia Oliveira3, Cesare Tomasi4, Luís Sousa Inês2, Franco Franceschini1. | 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 2Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; 3Rheumatology Department, ULS Aveiro, Aveiro, Portugal; 4Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
144 -
PO:17:254 | Systemic lupus erythematosus with pulmonary involvement: clinical insights from an Albanian cohort Arbi Pecani1, Arian Mezini2, Loreta Karaulli2, Laert Gjati2, Silvana Bala2 | 1Reumatologia, Dipartimento di Medicina Interna, Università di Medicina di Tirana, Ospedale Universitario Shefqet Ndroqi, Tirana; 2Pneumologia, Dipartimento di Medicina Respiratoria, Ospedale Universitario Shefqet Ndroqi, Tirana, Albania
157 -
PO:17:255 | Efficacy and safety of voclosporin in the management of lupus nephritis: a case series Alessandra Oliva1, Elisabetta Chessa2, Marta Paola Pireddu1, Marianna Salis1, Giulia Rizzo1, Fabio Congiu1, Elena Ragusa1, Antonello Pani3|4, Alberto Cauli1|2, Nicola Lepori3|4, Matteo Piga1|2 | 1UOC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università degli Studi di Cagliari; 2UOC Reumatologia, AOU Cagliari; 3SC Nefrologia e Dialisi, Università degli Studi di Cagliari; 4SC Nefrologia e Dialisi, Azienda Ospedaliera Brotzu, Cagliari, Italy
149 -
PO:17:259 | Anifrolumab: a new management of SLE Giorgia Montozzi1, Chiara Cocco1, Ramona Santangeli1, Lucia Gamba1, Paola Fioretti1, Letizia Curina1, Chiara Guidoni1, Edoardo Cipolletta3, Gianluca Moroncini2 | 1Scuola di Specializzazione in Medicina Interna, Università Politecnica delle Marche Ancona, Italy; 2Department of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy; 3Rheumatology Unit, Department of Clinical and Molecular Sciences , Università Politecnica delle Marche Ancona, Italy
45 -
PO:18:264 | Anifrolumab in Systemic Lupus Erythematosus: Bridging Clinical Trial Data with Real-World Evidence Giulia Cassone2, Filippo Santoro1, Caterina Vacchi2, Dilia Giuggioli2, Chiara Cabassi1 | 1UOC Reumatologia, AOU Policlinico di Modena, Università degli studi di Modena e Reggio Emilia Modena e Reggio Emilia, Italy; 2UOC Reumatologia, AOU Policlinico di Modena Modena, Italy
70 -
PO:18:268 | Voclosporin as a Steroid-Sparing Agent in Lupus Nephritis Complicated by Central Serous Chorioretinopathy: A Case Report Irene Genovali1|2, Sebastiano Lorusso2, Damiano Currado1|2, Letizia Pia Di Corcia1, Ludovica Lamberti1, Annalisa Marino2, Antonio Orlando1, Maria Quadrini1, Marta Vadacca2, Marta Vomero1, Luca Navarini1|2, Roberto Giacomelli1|2 | 1Rheumatology and Clinical Immunology, Department of Medicine, University of Rome Campus Biomedico, School of Medicine Rome, Italy; 2Clinical and Research Section of Rheumatology and Clinical Immunology Fondazione Policlinico Campus Biomedico Rome, Italy
42 -
PO:18:271 | Managing concomitant sle and psoriasis: the role of anifrolumab in a clinical case Angela Carenza1, Liliana Dinoia2, Sergio De Gioia2, Federica Gatti1, Teresa Caferri1, Lucia Cristiana Colaprico1, Angelica Napoletano1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit, University of Bari, Department of Precision and Regenerative Medicine, Jonian area DiMePRe-J, Bari, Italy; 2Azienda Sanitaria Locale di Taranto, presidio ospedaliero SS. Annunziata, Unità Operativa di Reumatologia, Taranto, Italy.
158 -
PO:18:276 | Use of anifrolumab in the treatment of difficult-to-treat manifestations in systemic lupus erythematosus Antonella Grimaldi1, Giuseppe Alessandrini2, Laura Quarta1, Maria Rita Ricciardi1, Daniela Costanza1, Clara Minerba1, Eugenio Quarta1 | 1UOC Reumatologia Verona; 2Specialista Dermatologo in Libera Professione, Italy
160 -
PO:18:277 | Clinical case report of the management of a patient suffering from systemic lupus erythematosus and associated polyneuropathy Davide Murgia1, Elena Marazzi1, Rosetta Vitetta1, Guido Rovera1. | 1ASLVC SSD reumatologia, Ospedale sant'Andrea Vercelli, Vercelli, Italy.
144 -
PO:19:279 | Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry Jessica Sbalchiero1, Antonio Vitale1, Valeria Caggiano1, Abdurrahman Tufan2, Ezgi Batu3, Gaafar Ragab4, Seza Ozen3, Jurgen Sota1, Carla Gaggiano1, Ali Sahin5, Petros Sfikakis6, Francesca Li Gobbi7, Giacomo Emmi8, Jose Rodriguez9, Piero Ruscitti10, Paolo Sfriso11, Ewa Szewczyk12, Giuseppe Lopalco13, Alberto Balistreri14, Claudia Fabiani15, Bruno Frediani1, Luca Cantarini1 | 1Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy; 2Department of Internal Medicine, Division of Rheumatology, Gazi University Hospital Ankara, Turkey; 3Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University School of Medicine Ankara, Turkey; 4Internal Medicine Department, Rheumatology and Clinical Immunology Unit, Faculty of Medicine, Cairo University Giza, Egypt; 5Division of Rheumatology, Department of Internal Medicine, Sivas Cumhuriyet University Medical Faculty Sivas, Turkey; 6Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens Athens, Greece; 7Rheumatology Unit, Hospital S. Giovanni di Dio, Azienda USL-Toscana Centro Florence, Italy; 8Clinical Medicine and Rheumatology Unit, Cattinara University Hospital Trieste, Italy; 9Department of Autoimmune Diseases, Institut Investigacions Biomediques August Pi I Sunyer, University of Barcelona Barcelona Spain; 10Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; 11Rheumatology Unit, Department of Medicine, University of Padua Padua, Italy; 127Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases, Military Institute o Warsaw, Poland; 13Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J Policlinic Hospital, University of Bari Bari, Italy; 14Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena Siena, Italy; 15Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena Siena, Italy
36 -
PO:19:281 | Mitochondrial dysfunction in Still’s disease: a preliminary analysis of mtDNA copy number and TFAM expression Ludovica Manisera1, Francesca Giansanti2, Andrea Latini3, Francesca Lotito4, Serena Colafrancesco5, Angelica Gattamelata6, Fabrizio Conti7, Cinzia Ciccacci8, Roberta Priori9 | 1|6|7|9La Sapienza, Roma; 2|3|4|8Unicamillus, Roma; 5Humanitas, Milano, Italy
151 -
PO:19:283 | Hospitalization profile and complications in patients with adult-onset Still’s disease: results from a retrospective study of 74 cases Chiara Calabrese1, Alessandro Tomelleri1|2, Corrado Campochiaro1|2, Nicola Farina2, Elena Baldissera2, Marco Matucci-Cerinic1|2, Lorenzo Dagna1|2 | 1Libera Università Vita-Salute San Raffaele, Milano; 2Unità di Immunologia, Allergologia e malattie rare, IRCCS San Raffaele, Milano, Italy
134 -
PO:19:284 | Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: a case series Lucia Trotta1, Marco Quartarone1, Francesco Cavaleri1, Ruggiero Mascolo1, Massimo Imazio3, Vartan Mardygan2, Andreja Cerne Cercek4, Anne-Marie Claveau2, Ludovico Luca Sicignano5, Massimo Pancrazi1, Alida Caforio6, Andrea Silvio Giordani6, Serdal Ugurlu7, Alessandro Andreis8, Valentino Collini3, Enrico Tombetti9, Antonio Brucato9 | 1Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Milan, Italy; 2Division of Cardiology, Department of Medicine, Jewish General Hospital, Montréal, Québec, Canada; 3Cardiology, Cardiothoracic Department, University Hospital Santa Maria della Misericordia, Udine, Italy; 4Department of Cardiology, University Medical Centre Ljubljana, Ljubljana, Slovenia; 5Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; 6Division of Cardiology, Centro Gallucci, University of Padova-Policlinico, Padova, Italy; 7Division of Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey; 8University Cardiology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy; 9Department of Biomedical and Clinical Sciences, Fatebenefratelli Hospital, University of Milan, Milan, Italy
38 -
PO:19:286 | Genetic testing reveals an unexpected case of mevalonate kinase deficiency in a 37-year-old patient with AA renal amyloidosis and good response to colchicine Francesca Crisafulli1, Paolo Airò2, Federica Mescia3, Gianmarco Lugli3, Gianfranco Savoldi4, Claudia Izzi3|5, Federico Alberici3, Marco Cattalini6, Franco Franceschini1, Micol Frassi2. | 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy; 2Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 3U.O Nefrologia, ASST Spedali Civili di Brescia e Università degli Studi di Brescia, Brescia, Italy; 4Medical genetics Laboratory, Laboratory Department ASST Spedali Civili di Brescia, Brescia, Italy; 5Struttura Complessa di Genetica Clinica, ASST Spedali Civili di Brescia, Brescia, Italy; 6Pediatrics Clinic, University of Brescia and ASST Spedali Civili of Brescia, Brescia, Italy.
148 -
PO:19:287 | Cardiac involvement in Still’s disease: a challenge in differential diagnosis Ludovica Manisera1, Martina Dodaro2, Giuseppe Norcia3, Angelica Gattamelata4, Nicola Galea5, Concetta Torromeo6, Gaetano Tanzilli7, Fabrizio Conti8, Roberta Priori9 | 1Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Università degli Studi di Roma La Sapienza, Roma; 2Dipartimento di Medicina Traslazionale e di Precisione, Università degli Studi di Roma La Sapienza, Roma; 3Dipartimento di Medicina Molecolare, Università degli Studi di Roma La Sapienza, Roma, Italy
152 -
PO:20:002 | Respiratory function tests predict bone mineral density in autoimmune rheumatic disease patients Andrea Zoli1, Panagiotis Garantziotis2, Sebastian Böltz2, Janina Auth2, Sara Bayat2, Jule Taubmann2, Anna-Maria Liphardt2, Maria Antonietta D'Agostino1, Christina Bergmann2, Georg Schett2. | 1Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; 2Department of Medicine 3, Rheumatology and Immunology, Friedrich Alexander Universität FAU, Erlangen, Germany.
143 -
PO:20:003 | Romosozumab effect on neutrophil-to-lymphocyte ratio in post-menopausal women at high risk of fracture Giorgia Scagliosi1, Mariana Diaz Lopez1, Martina Teoni1, Francesco Pollastri1, Anna Piccinelli1, Camilla Benini1, Valeria Messina1, Emma Pasetto1, Davide Gatti1, Ombretta Viapiana1, Maurizio Rossini1, Giovanni Adami1. | 1Università di Verona, Dipartimento di Medicina, Verona, Italy; 2Università di Verona, Dipartimento di Medicina, Verona, Italy; 3Università di Verona, Dipartimento di Medicina, Verona, Italy; 4Università di Verona, Dipartimento di Medicina, Verona, Italy; 5Università di Verona, Dipartimento di Medicina, Verona, Italy; 6Università di Verona, Dipartimento di Medicina, Verona, Italy; 7Università di Verona, Dipartimento di Medicina, Verona, Italy; 8Università di Verona, Dipartimento di Medicina, Verona, Italy; 9Università di Verona, Dipartimento di Medicina, Verona, Italy; 10Università di Verona, Dipartimento di Medicina, Verona, Italy; 11Università di Verona, Dipartimento di Medicina, Verona, Italy; 12Università di Verona, Dipartimento di Medicina, Verona, Italy.
141 -
PO:20:004 | Increase in serum Dkk1 levels attenuates the anabolic response to romosozumab in postmenopausal osteoporosis Giovanni Adami1, Filippo Montanari1, Angelo Fassio1, Francesco Pollastri1, Anna Piccinelli1, Davide Gatti1, Ombretta Viapiana1, Maurizio Rossini1. | 1Università degli Studi di Verona, Verona, Italy.
126 -
PO:20:005 | Sarcopenia and fracture risk in rheumatoid arthritis: correlation between SACR-F and fragility score measured by radiofrequency echographic multi-spectrometry Sara Torracchi1, Pamela Bernardini1, Daniela Melchiorre1, Bianca Bossi1, Dorilda Zeka1, Francesca Nacci1, Lorenzo Tofani1, Serena Guiducci1 | 1SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Italy
155 -
PO:20:006 | Efficacy of denosumab in glucocorticoid-induced osteoporosis patients with prior exposure to intravenous aminobisphosphonates Kiren Khalid1, Alessandro Giollo1, Mariangela Salvato1, Francesca Frizzera1, Lorenzo Di Luozzo1, Bernd Raffeiner2, Andrea Doria1 | 1Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy; 2Department of Rheumatology, Bolzano Central Hospital, Bolzano, Italy
16 -
PO:20:007 | Mind the rebound: ctx dynamics after denosumab discontinuation and zoledronate rescue in patients with postmenopausal osteoporosis or with cancer treatment-induced bone loss Federico Aldegheri1, Francesca Ruzzon1, Matteo Appoloni1, Giovanni Adami1, Davide Gatti1, Maurizio Rossini1, Angelo Fassio1, Ombretta Viapiana1 | 1Università di Verona, Italy
41 -
PO:20:010 | Coordinated outpatient pathway for osteoporosis: a new organizational model for osteoporosis management Domenico Birra1, Ornella Romano2, Vincenza Sara Suppa2, Mariavittoria Guerra1, Carmine Fierarossa1, Benedetta Tartaglia1, Antonietta De Sena1, Fabio Granato Corigliano1, Serena Ippolito2, Vincenzo Nuzzo1 | 1UOC Medicina Generale, P.O. Ospedale del Mare, Asl Napoli 1 Centro; 2U.O.S.D. Malattie Endocrine del ricambio e della nutrizione, P.O. Ospedale del Mare, Asl Napoli 1 Centro, Italy
161 -
PO:20:011 | Suspected tumor-induced osteomalacia in a patient with polymyalgia rheumatica and persistent hyperphosphaturic hypophosphatemia Andrea Faggiano1|2, Francesco Goatelli1|2, Lucia Dardani2, Carlo Salvarani3 | 1Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area Jonica, University of Bari; 2Scuola di Specializzaione in Reumatologia, Università degli Studi di Modena e Reggio Emilia, Modena, Italy; 3Direttore SOC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL REGGIO EMILIA, Italy
154 -
PO:20:012 | Inflammatory markers and nutritional status in patients with osteoporotic fractures: preliminary analysis of a pilot study Domenico Birra1, Manuela Maione2, Carolina Bologna1, Carmela Pierce2, Paolo Tirelli1, Gianluigi Cuomo1, Carolina Sepe2, Pasquale Madonna1, Claudio De Luca1, Federica Coretti2, Vincenzo Nuzzo1 | 1S.C. Reumatologia, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; 2U.O.S.D. Malattie Endocrine del ricambio e della nutrizione - P. O. Ospedale del Mare - Asl Napoli 1 centro, Napoli, Italy
122 -
PO:20:014 | Post-partum osteoporosis: severe clinical presentation in absence of known risk factors Domenico Birra1, Ludovica Frances Grasso2, Vittoria Gammaldi1, Antonietta De Sena1, Carmine Pio Petrosino2, Rosalia Boccia2, Gabriella Oliva1, Vincenzo Nuzzo1 | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Istituto Superiore di Sanità, Roma
163 -
PO:21:018 | The role of rheumatologists in the diagnosis and monitoring of Whipple's disease Mariangela Salvato1, Alessandro Giollo1, Marco Cola2, Francesca Frizzera1, Kiren Khalid1, Lorenzo Di Luozzo1, Annamaria Cattelan2, Andrea Doria1 | 1UOC Reumatologia, AOUI Padova, Italy; 2UOC Malattie infettive, AOUI Padova, Italy
42 -
PO:21:019 | Clinical phenotypes in IgG4-related disease: ACR/EULAR classification and practical limitations Mattia Caliste1, Flavia D'Auria2, Linda Mastromanno1, Francesca Carfora2, Carla Giordano3, Cristiano Alessandri1, Marcella Visentini2, Fabrizio Conti1, Roberta Priori1|4 | 1Dipartimento Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Dipartimento Medicina Traslazionale e di Precisione, Sapienza Università di Roma; 3Dipartimento Scienze Radiologiche, Oncologiche e Anatomo-patologiche, Sapienza Università di Roma; 4Saint Camillus International University of Health Science, UniCamillus, Roma, Italy
123 -
PO:21:021 | The eyes tell the story: a clinical case of Rosah syndrome Nicolò Sabbion1, Sofia Vitale1, Claudia Balicchia1, Barbara Troise1, Francesca Mascia1, Eleonora Bassanello2, Jacopo Croce2, Federica Maiolini2, Filippo Mazzi2, Elisa Tinazzi2, Francesca Bosello1, Simonetta Friso1, Lucia De Franceschi1 | 1Università degli Studi di Verona; 2Azienda Ospedaliera Universitaria Integrata, Verona, Italy
252 -
PO:21:026 | Identifying patient profiles to personalize care and improve quality of life in italian EGPA patients Francesca Torracca1, Roberto Padoan2, Giacomo Emmi3|4, Lara Bernardi5, Maria Rosaria Mollo5, Omar Shalby5, Fabio Tedone6, Davide Cafiero6, Eugenia Durante1 | 1APACS APS ETS - Associazione Pazienti Sindrome di Churg Strauss EGPA Arosio, Italy; 2Rheumatology Unit, Department of Medicine DIMED, University of Padua, Italy; 3Department of Medical, Surgical and Health Sciences, University of Trieste, Italy; 4Clinical Medicine Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; 5GlaxoSmithKline Medical Department Verona, Italy; 6Helaglobe SRL Firenze, Italy
19 -
PO:21:028 | A difficult case of VEXAS syndrome: management of myelodysplastic syndrome associated with systemic inflammation and infectious complications Sandra Lombardi1, Monica Regis1, Stefano De Luca1, Monica Poiani2, Rossella Stella2, Elisa Lucchini2, Francesco Zaja2, Fabio Fiammengo1 | 1SC Medicina Interna, Azienda Sanitaria Universitaria Giuliano Isontina, Gorizia; 2SC Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
152 -
PO:22:029 | Impact of mepolizumab on idiopathic hypereosinophilic syndromes: analysis of a monocentric retrospective cohort Jacopo Mora1, Francesca Regola1, Paola Toniati2, Ilaria Cavazzana1, Franco Franceschini1. | 1ASST Spedali Civili e Università degli Studi di Brescia, Brescia, Italy; 2ASST Spedali Civili di Brescia, Brescia, Italy.
130 -
PO:22:032 | Beyond the joints: a rare case of subcorneal pustular dermatosis in Rheumatoid Arthritis Sara Casella1|2, Carlo Smirne1|2, Roberta Zaira Pedrazzoli3, Mattia Perazzi1|3, Edoardo Cammarata4, Francesca Zottarelli4, Paola Savoia5, Renzo Boldorini6, Mario Pirisi1|2, Pier Paolo Sainaghi1|3 | 1Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale Novara, Italy; 2Unità di Medicina Interna, Azienda Ospedaliera Maggiore della Carità Novara, Italy; 3Unità di Medicina Interna e Reumatologia, Azienda Ospedaliera Maggiore della Carità Novara, Italy; 4Unità di Dermatologia, Azienda Ospedaliera Maggiore della Carità Novara, Italy; 5Dipartimento di Scienze della salute, Università del Piemonte Orientale Novara, Italy; 6Unità di Anatomia Patologica, Azienda Ospedaliera Maggiore della Carità Novara, Italy
37 -
PO:22:033 | Unraveling VEXAS syndrome: when skin manifestations and monoclonal gammopathy precede hematological myeloid alterations Laura Di Centa1, Simone Longhino1, Valeria Manfrè1, Stefania Sacco1, Luca Quartuccio1 | 1ASST Papa Giovanni XXIII, Bergamo, Italy
153 -
PO:22:038 | Recurrent Pneumonias and Persistent Inflammation in VEXAS Syndrome: The Role of BAL in Differential Diagnosis Francesco Ghellere1, Bernardo D'Onofrio1, Maria Chiara Ditto1, Salvatore Panaro1, Francesca Piccione1|2, Giacomo Tanti1, Enrico Fusaro1, Simone Parisi1 | 1SC Reumatologia, Città della Salute e della Scienza Torino, Italy; 2Fondazione Ricerca Molinette Torino, Italy
19 -
PO:22:039 | A rare form of interstitial lung disease: granulomatous and lymphocytic interstitial lung disease Francesca Cozzini1|2, Francesco Falco1, Alberto Cavazza1, Lucia Spaggiari3, Chiara Marvisi1, Francesca Petrillo1|2, Caterina Ricordi1|2, Francesco Muratore1|2, Fabio Brandolino1, Ilaria Chiapparoli1, Carlo Salvarani1|2, Andreina Manfredi1|2 | 1IRCCS Policlinico San Matteo, UO di Reumatologia, Pavia; 2Università degli studi di Modena e Reggio Emilia, Modena, Italy
125 -
PO:23:044 | Understanding fatigue through patients' eyes: development of a novel questionnaire capturing the complexity of real-life fatigue in Sjögren's disease Flavia Riccio1, Mariachiara Visconti1, Corrado Parlati1, Nicola Della Rossa1, Sabrina Marrone1, Enrico Tirri2, Francesco Ciccia1, Saviana Gandolfo2. | 1UOC di Reumatologia, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy; 2UO di Reumatologia, Ospedale del Mare, Napoli, Italy.
144 -
PO:23:046 | Histopathological comparison between minor salivary gland biopsies from pediatric and adult patients with Sjögren’s disease: evidence of a more severe inflammatory profile in early-onset cases Flavia Riccio1, Mattia Neri2, Martina Mellone1, Immacolata Cozzolino3, Jacopo Ferro4, Valerio Gaetano Vellone4, Ciro Emiliano Boschetti5, Giuseppe Colella5, Nicola Laffi6, Pietro Buono7, Enrico Tirri8, Renato Franco3, Marco Gattorno2, Francesco Ciccia1, Clara Malattia2, Saviana Gandolfo8 | 1UOC di Reumatologia, Università degli Studi della Campania Luigi Vanvitelli, Napoli; 2UOC di Reumatologia e Malattie Autoinfiammatorie, Istituto Giannina Gaslini, Genova; 3UO di Anatomia Patologica, Università degli Studi della Campania Luigi Vanvitelli, Napoli; 4UOC di Anatomia Patologica, Istituto Giannina Gaslini Genova; 5UOC di Chirurgia Maxillo-facciale, Università degli Studi della Campania Luigi Vanvitelli, Napoli; 6UO di Odontoiatria, Istituto Giannina Gaslini, Genova; 7UOD Attività consultoriali e assistenza materno-infantile, Direttorato Generale per la Salute, Regione Campania, Napoli; 8UO di Reumatologia, Ospedale del Mare, Napoli, Italy
164 -
PO:23:048 | Clinical and serological differences of an Italian Sjögren’s disease cohort according to three geographic macro-area localization Maria Letizia Currò1, Roberto Dal Pozzolo2, Giacomo Cafaro2, Valeria Manfrè3, Gaetano La Rocca4, Alessia Alunno5, Francesco Carubbi5, Nicoletta Del Papa6, Viktoriya Pavlych7, Angelica Gattamelata8, Letizia Pia Di Corcia9, Pamela Bernardini10, Luca Quartuccio3, Chiara Baldini4, Paola Cipriani7, Roberta Priori8, Onorina Berardicurti9, Serena Guiducci10, Fabiola Atzeni1, Elena Bartoloni2 | 1Unità di Reumatologia. Università di Messina, Italy; 2SC Reumatologia. Università di Perugia, Italy; 3Unità di Reumatologia. Università di Udine, Italy; 4Unità di Reumatologia. Università di Pisa, Italy; 5Divisione di Medicina Interna e Nefrologia. Università di L'Aquila, Italy; 6Dipartimento di Reumatologia. Università di Milano, Italy; 7Unità di Reumatologia. Università di L'Aquila, Italy; 8UOC Reumatologia. Università Sapienza Roma, Italy; 9Unità di Reumatologia. Università Campus Biomedico Roma, Italy; 10Unità di Reumatologia. Università di Firenze, Italy
20 -
PO:23:051 | Quantitative high-resolution computed tomography analysis in Sjögren’s disease-associated interstitial lung disease: CALIPER-derived imaging biomarkers for prognostic assessment Gaetano La Rocca1, Francesco Ferro1, Vincenzo Uggenti2, Beatrice Dei1, Giovanni Fulvio1, Michele Moretti1, Chiara Romei2, Marta Mosca1, Chiara Baldini1. | 1University of Pisa, Rheumatology Unit, Clinical and Experimental Medicine Department, Pisa, Italy; 2Department of Diagnostic Imaging, Pisa University Hospital, Pisa, Italy.
159 -
PO:23:052 | Muscular and myocardial involvement in antisynthetase syndrome: a retrospective real-life study Giulia Buonsante1|2|3, Giacomo De Luca1|2|3, Veronica Batani1|2, Daniele Scaramuzzi1|2|3, Lorenzo Dagna1|2|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and aging Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; 3Vita-Salute San Raffaele University, Milan, Italy, Milano, Italy.
152 -
PO:23:055 | Overlap of systemic sclerosis and Sjögren’s disease: insights from an Italian case-control study Stefano Stano1, Fabio Cacciapaglia1|2, Maria Morrone1, Simone Perniola1, Marco Capodiferro1, Marco Fornaro1, Laura Coladonato1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari, Bari, Italy; 2Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima Italy.
210 -
PO:24:056 | Major salivary gland ultrasonographic features of lymphoma and high lymphoproliferative risk lesions in Sjögren’s disease: a systematic review Alessia Nano1, Valeria Manfrè1, Maria Teresa Rizzo1, Garifallia Sakellariou2, Alen Zabotti1, Luca Quartuccio1. | 1Division of Rheumatology, Department of Medicine DMED, ASUFC, University of Udine, Udine, Italy; 2Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
136 -
PO:24:057 | Qualitative and quantitative analysis of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies: focus on muscle histology Jacopo Landro1, Marius Cadar1, Davide Mohammad Reza Beigi1|2, Ilaria Bisconti1, Francesca Romana Di Ciommo1, Elena Platania1, Martina Salerno1, Beatrice De Girolamo1, Annalisa Villa1, Angelica Gattamelata1, Simona Truglia1, Cristiano Alessandri1, Fabrizio Conti1, Valeria Riccieri1. | 1Policlinico Umberto I, Roma, Italy; 2Clinica Reumatologica Madonna dello Scoglio, Cotronei, Italy.
129 -
PO:24:058 | Serum ferritin as a biomarker in idiopathic inflammatory myopathies with interstitial lung disease: baseline levels and longitudinal trends Silvia Grazzini1, Edoardo Conticini1, Marco Fornaro2, Chiara Rizzo3, Federica Camarda3, Paolo Cameli4, Miriana D'Alessandro4, Lidia La Barbera3, Stefano Stano2, Maria Rosa Pellico5, Latika Gupta6, Florenzo Iannone2, Giuliana Guggino3, Elena Bargagli4, Nicoletta Del Papa5, Luca Cantarini1, Bruno Frediani1. | 1Reumatologia, Dipartimento di Scienze Mediche, Chirugiche e Neuroscienze, Università di Siena, Siena, Italy; 2Reumatologia, Dipartimento di Emergenza e Trapianto d'Organo, Università di Bari, Bari, Italy; 3Reumatologia, Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica, Università di Palermo, Palermo, Italy; 4Pneumologia, Dipartimento di Scienze Mediche, Chirugiche e Neuroscienze, Università di Siena, Siena, Italy; 5Reumatologia Clinica e Scienze Mediche, ASST Gaetano Pini CTO, Milano, Italy; 6University of Manchester, Manchester, United Kingdom.
128 -
PO:24:059 | Sjögren's disease-associated Fibromyalgia: pitfalls in disease assessment using ESSDAI and ESSPRI Lucia Cristiana Colaprico1, Stefano Stano1, Daniele Domanico1, Maria Iacovantuono2, Eduardo Urgesi3, Fabio Cacciapaglia1|4, Maria Giannotta1, Paola Conigliaro2, Vincenzo Venerito1, Maria Sole Chimenti2, Giuseppe Lopalco1, Florenzo Iannone1 | 1Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari, Bari, Italy; 2University of Rome Tor Vergata, Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Roma, Italy; 3University Cardiologic Unit - Interdisciplinary Department of Medicine - Policlinico University Hospital, University Bari, Italy; 4Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima, Italy
30 -
PO:24:060 | Evaluation of a Large Language Model Performance in Rating Cutaneous Manifestations of Dermatomyositis: A Comparison with Expert Assessors Gianmarco Roselli1, Marco Fornaro1, Swapnasha Panigrahi2, Sara Sabbagh3, Florenzo Iannone1, Vincenzo Venerito1, Latika Gupta4 | 1Università degli Studi di Bari, Unità di Reumatologia, DiMePRe-J Bari, Italy; 2University of Birmingham Birmingham, United Kingdom; 3Medical College of Wisconsin, Unit of Rheumatology, Department of Paediatrics Milwaukee, USA; 4University of Manchester, Manchester Academic Health Centre, Division of muscoloskeletal and deramatological sciences Manchester, United Kingdom
15 -
PO:24:061 | Allodynia is highly prevalent in patients with Sjögren’s disease and correlates with immunobiological disease markers: preliminary results from the sjnapse project Flavia Riccio1, Maria Chiara Visconti1, Corrado Parlati1, Nicola Della Rossa1, Sabrina Marrone1, Enrico Tirri2, Francesco Ciccia1, Saviana Gandolfo2 | 1UOC di Reumatologia, Università degli Studi della Campania Luigi Vanvitelli, Napoli; 2UO di Reumatologia, Ospedale del Mare, Napoli, Italy
150 -
PO:24:062 | Transcriptomic profile of salivary glands in patients with primary Sjögren’s syndrome and interstitial lung disease: implications for pathogenesis and risk stratification Elisa Pignatti1, Monia Maccaferri1, Alessandra Bisagni2, Alberto Cavazza2, Marco Sebastiani3|4, Luca Keller2, Luca Magnani5, Claudio Galluzzo2, Tommaso Fasano6, Lucia Nota6, Giulia Canu6, Andreina Manfredi1|2, Carlo Salvarani1|2 | 1Dipartimento Chimomo, Università di Modena e Reggio Emilia Modena; 2Struttura Complessa di Reumatologia, Azienda Unità Sanitaria Locale di Reggio Emilia-IRCCS; 3Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma; 4Divisione di Reumatologia, AUSL di Piacenza; 5UOC Medicina Interna ind. reumatologico, AUSL di Bologna, Ospedale Maggiore, Bologna; 6Dipartimento Interaziendale ad Attività Integrata Medicina di Laboratorio ed Anatomia Patologica AUSL di Modena, Italy
138 -
PO:24:063 | Interstitial lung disease in idiopathic inflammatory myopathy patients: efficacy and safety of nintedanib Giulia Buonsante1|2|3, Giacomo De Luca1|2|3, Veronica Batani1|2, Lorenzo Dagna1|2|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3 | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital Milano, Italy; 2Inflammation, Fibrosis and aging Initiative INFLAGE, IRCCS San Raffaele Hospital Milano, Italy; 3Vita-Salute San Raffaele University, Milano, Italy
35 -
PO:24:064 | IPF vs CTD-ILD: Survival and Lung Function from an Italian Real-World Cohort Marco Fornaro1, Donato Lacedonia2, Lorenzo Cavagna3, Paolo Airò4, Marco Sebastiani5, Gianluca Sambataro6, Fabio Cacciapaglia7, Angelica Napoletano1, Cosimo De Pace2, Pasquale Tondo2, Giulia Scioscia2, Eleonora Pedretti4, Maria Grazia Lazzaroni4, Carlo Vancheri8, Andreina Manfredi9, Lorenzo Binchessi3, Rocco Capece3, Michele De Ceglie10, Massimo Giotta11, Florenzo Iannone1 | 1Unit of Rheumatology, Department of Precision and Regenerative Medicine - Area Jonica DiMePRe-J, University of Bari, Bari, Italy; 2Department of Medical and Surgical Sciences, University of Foggia Foggia, Italy; 3Department of Internal Medicine and Therapeutics, University of Pavia, Division of Rheumatology, Fondazione IRCCS, Pavia, Italy; 4Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili Brescia, Italy; 5Rheumatology Unit, AUSL Piacenza, Department of Medicine and Surgery, University of Parma, Parma, Italy; 6Department of Medicine and Surgery, University of Enna Kore, Enna, Italy; 7Rheumatology Service, F. Miulli Hospital and Department of Medicine and Surgery, LUM University, Casamassima, Italy; 8Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Diseases, Catania, Italy; 9Rheumatology Unit, IRCCS Santa Maria Nuova Reggio Emilia, University of Modena, Modena, Italy; 10DIM, Interdisciplinary Department of Medicine, Section of Diagnostic Imaging, University of Bari, Bari, Italy; 11Health Prevention Department, Local Health Authority of Brindisi, Brindisi, Italy
27 -
PO:24:065 | Nailfold capillaroscopic in primary Sjögren's syndrome, clinical and serological correlations; a preliminary report from a reference center Caterina Vacchi1, Filippo Santoro1, Maria Grazia Malandra1, Giulia Cassone1, Alessandra Carobbio2, Martina Orlandi1, Dilia Giuggioli1 | 1Reumatologia Modena, Italy; 2Statistica Medica Modena, Italy
17 -
PO:24:066 | Antibody profile in myositis and early risk of interstitial lung disease: clinical and laboratory correlations in patients with suspected rheumatologic disease Lindsay Brooke Boling1, Gaia Deleonardi2, Alarico Ariani3, Tania Silvestri2, Ana Gabriela Grondona2, Marica Trevisani3, Rita Mulè3, Enrica Vandelli3, Gentiana Vukatana3, Elisa Rossi3, Olga Addimanda3, Francesca Bergossi3, Angela Buffa3, Giovanni B. Canestrari3, Francesco Cianci3, Daniela Chiarini3, Laura Gigante3, Nicolò Girolimetto3, Daniele Lini3, Luca Magnani3, Mirco Magnani3, Erika Meleddu3, Francesca Pignataro3, Sofia Testoni3, Massimo Reta3 | 1Scuola di Allergologia ed Immunologia Clinica-Università di Bologna; 2LUM Laboratorio Unico Metropolitano - Immunologia Clinica, Ospedale Maggiore, Bologna; 3UO Medicina Interna ad indirizzo reumatologico SC interaziendale - IRCCS AOU, AUSL Bologna, Italy
162 -
PO:24:068 | Case Report: ‘Spontaneous Pneumomediastinum in a Patient with MDA5-Positive Dermatomyositis and Severe Pulmonary Fibrosis’ Carlotta Braga1, Margherita Rizzo1, Marta Raschellà1, Beatrice Maranini1, Gioacchino Schifino2, Aldo Carnevale3, Marcello Govoni1, Andrea Lo Monaco1 | 1Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna Ferrara, Italy; 2Respiratory Medicine Unit, Department of Cardio-Thoracic-Vascular Pathologies, Arcispedale Sant'Anna, Ferrara, Italy; 3Radiology Unit, Department of Translational Medicine, University of Ferrara, Italy
25 -
PO:24:070 | Preliminary descriptive data from a single-centre cohort of patients with idiopathic inflammatory myopathy: focus on paraneoplastic and non-paraneoplastic patients Silvia Ebe Lucia Della Pina1, Paola Bizioli1, Samantha Mazza2, Caproli Alessia1, Cesare Tomasi1, Ilaria Cavazzana1, Franco Franceschini1. | 1S.C.O. Reumatologia ed Immunologia Clinica, ASST Spedali Civili di Brescia, Università degli Studi di Brescia, Brescia, Italy; 2Università degli Studi di Brescia, Brescia, Italy.
133 -
PO:25:071 | Gender differences in Sjögren’s disease: clinical activity, illness perception, and emotional impact Ilenia Fischetti1, Martina Salerno1, Linda Mastromanno1, Angelica Gattamelata1, Martina Villa1, Ludovica Manisera1, Emanuele Grilli1, Luca Quartuccio2, Valeria Manfrè2, Francesco Carubbi3, Evy Di Ruscio3, Fabrizio Conti1, Roberta Priori1|4 | 1UOC di Reumatologia, Dipartimento SCIAC, Sapienza Università di Roma; 2Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; 3UOC Medicina Interna e Nefrologia, Dipartimento MeSVA, Università degli Studi di L'Aquila; 4UniCamillus, San Camillo Università Internazionale di Scienze della Salute di Roma, Italy
135 -
PO:25:073 | Pulmonary involvement and progressive interstitial lung disease in anti-synthetase syndrome: a single-center retrospective study Daniele Scaramuzzi1|3, Giacomo De Luca1|3, Veronica Batani1, Giulia Buonsante1|3, Lorenzo Dagna1|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3 | 1Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare, IRCCS Ospedale San Raffaele, Milano; 2Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano; 3Università Vita-Salute San Raffaele, Milano, Italy
138 -
PO:25:074 | Capillaroscopic assessment in interstitial lung disease: a comparative study between connective tissue disease-associated interstitial lung disease, interstitial pneumonia with autoimmune features, and idiopathic pulmonary fibrosis Daniele Vito Andrea Sabella1, Marco Fornaro1, Laura Coladonato1, Marlea Lavista1, Veronica Spedicato1, Giuseppe Lopalco1, Florenzo Iannone1. | 1University of Bari, Rheumatology Unit Department of Precision and Regenerative Medicine - Jonica Area DiMePRe-J, Bari, Italy.
128 -
PO:25:075 | Cancer occurence in patients with idiopathic inflammatory myopathies: new insights from the analysis of a monocentric cohort Michele Diomedi1, Federico Fattorini1, Simone Barsotti2, Chiara Cardelli1|3, Elenia Laurino4, Alessandra Tripoli4, Linda Carli4, Marta Mosca1|4. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology, Versilia Hospital, Viareggio, Italy; 3Department of Medical Biotechnologies, University of Siena, Siena, Italy; 4Rheumatology Unit, AOUP, Pisa, Italy.
138 -
PO:25:079 | Anifrolumab in refractory dermatomyositis: a case report Chiara Calabrese1, Corrado Campochiaro1|2, Giacomo De Luca 1|2, Veronica Batani1, Marco Matucci-Cerinic1|2, Lorenzo Dagna 1|2 | 1Dipartimento di Reumatologia e Scienze Mediche, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO Milano; 2Università degli Studi di Milano, Dipartimento di Fisiopatologia Medico-Chirurgica e Trapianti, Milano, Italy
147 -
PO:25:081 | Atypical onset of anti-SAE-1 positive dermatomyositis: paraneoplastic flame hemorrhages in urothelial carcinoma Valentina Morandi1, Alessandro Biglia2, Francesco Maggiore1, Sofia Chiricolo1, Silvia Sammorì1, Maria Cristina Sacchi3|4, Edoardo Cammarata5, Maria Rosa Pellico6, Luigi Mario Castello2|3|7. | 1Dipartimento di Medicina Interna, SSD Reumatologia, AOUAL Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; 2 Dipartimento di Medicina Interna, AOUAL Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; 3Dipartimento di laboratorio di tecnologia, ricerca e innovazione DAIRI, AOUAL Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; 4AOUAL Santi Antonio e Biagio e Cesare Arrigo, Laboratorio Analisi, Alessandria, Italy; 5AOUAL Santi Antonio e Biagio e Cesare Arrigo, Dipartimento di Medicina Interna, SSD Dermatologia, Alessandria, Italy; 6ASST Gaetano Pini, divisione di Reumatologia Clinica, Milano, Italy; 7Università del Piemonte orientale, dipartimento di Medicina Traslazione, Novara, Italy.
160 -
PO:25:082 | Progressive interstitial lung disease secondary to Sjögren's disease in a patient with inclusion body myositis complicated by dysphagia: a multidisciplinary approach and therapeutic challenges Emanule Cocchiara1, Francesco Falco1, Lucia Spaggiari3, Francesca Cozzini1|2, Lucia Dardani1, Gianluigi Bajocchi1, Andreina Manfredi1|2, Carlo Salvarani1|2 | 1Dipartimento di Medicina, Clinica Reumatologica, Udine; 2Università degli studi di Modena e Reggio Emilia, Modena; 3AUSL area NORD, Guastalla-Montecchio, Italy
143 -
PO:25:083 | Overlap between Sjögren’s syndrome and lichen sclerosus: beyond coincidence? Emanuele Giovanni Grilli1, Ludovica Manisera1, Ilenia Fischetti1, Linda Mastromanno1, Martina Villa1, Angelica Gattamelata1, Fabrizio Conti1, Roberta Priori1|2, Serena Colafrancesco3|4 | 1Dipartimento di Medicina e Chirurgia, Università Milano-Bicocca; 2U.O. Reumatologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; 3U.O. Pneumologia, IRCCS Fondazione San Gerardo dei Tintori, Monza; 4Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS Humanitas Research Hosp, Rozzano, Milano, Italy
176 -
PO:25:085 | Anti-MDA5 antibody syndrome, a life-threatening condition for rheumatologist and pulmonologist A case series Francesca Cozzini1|2, Cecilia Burattini1, Elena Bravi1, Chiara Nani1, Eugenio Arrigoni1, Fabia Cavallotti1, Ilaria Platè1, Marco Sebastiani1|3 | 1Ospedale Guglielmo da Saliceto Piacenza, Italy; 2Università degli studi di Modena e Reggio Emilia, Italy; 3Università degli Studi di Parma, Italy
40 -
PO:26:087 | Rituximab versus glucocorticoids for IgG4-related disease: a European retrospective multi-center study of 167 patients Marco Lanzillotta1, Jens Vikse2, Elisabetta Goni3, Jasmin Mahajne1, Veronica Batani1, Lorenzo Dagna1, Emanuel Della-Torre1 | 1Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale san Raffaele Milano, Italy; 2Department of Rheumatology, Stavanger University Hospital, Stavanger, Norway; 3Department of Medicine II, University Hospital, Ludwig Maximilian University Munich, Munich Germany
50 -
PO:26:088 | Rheumatologic immune-related adverse events from immune checkpoint inhibitors: a monocentric retrospective study Giulio Fraticelli1|2, Nicola Farina1|2, Alessandro Tomelleri1|2, Marco Matucci Cerinic1|2, Corrado Campochiaro1|2, Lorenzo Dagna1|2. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and Ageing Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy.
137 -
PO:26:092 | Early antiproteinuric effect of voclosporine in patients with lupus nephritis in real life setting: preliminary results from the VoRLiSS (Voclosporine in Real Life Setting Study) Aurora Di Gregorio1, Marta Calatroni2, Marco Allinovi3, Alessandra Bortoluzzi4, Giorgio Buscetta5, Rossella De Angelis6, Ginevra De Marchi7, Giacomo Emmi8, Pasquale Esposito9, Paride Fenaroli10, Micaela Fredi11, Giovanni Orsolini12, Giulia Pazzola13, Domenico Santoro14, Andrea Doria1, Gabriella Moroni2, Luca Iaccarino1 | 1Azienda Ospedaliera Universitaria Padova, Italy; 2Ospedale IRCCS Humanitas Milano, Italy; 3Azienda Ospedaliero Universitaria Careggi Firenze, Italy; 4Azienda Ospedaliero Universitaria di Ferrara, Italy; 5Policlinico Universitario Paolo Giaccone Palermo, Italy; 6Università Politecnica delle Marche Ancona, Italy; 7Università di Udine, Italy; 8Università di Trieste, Italy; 9Università di Genova, Italy; 10Unità di Nefrologia AUSL IRCCS di Reggio Emilia, Italy; 11Università di Brescia, Italy; 12Università di Verona Verona, Italy; 13Università di Reggio Emilia, Italy; 14Azienda Ospedaliera Universitaria G. Martino di Messina, Italy
35 -
PO:26:095 | Educational online webinars of European Reference Network on rare and complex connective tissue and musculoskeletal diseases for patients, caregivers and healthcare professionals: six years' experience Emanuele Gotelli1|2, Rosanna Campitiello1|3, Eric Hachulla4|5|6, Vanessa Smith7|8|9, Joao Eurico Fonseca10|11, Tadej Avcin12|13, Gabriele Simonini14|15, Silvia Aguilera16, Lisa Matthews17, Charissa Frank18, Wiebke Lautré19, Monica Testoni20, Diana Marinello20, Rosaria Talarico20, Marta Mosca20, Maurizio Cutolo1|2. | 1Department of Internal Medicine and Specialties, University of Genova, Genova, Italy; 2IRCCS Ospedale Policlinico San Martino, Genova, Italy; 3Department of Experimental Medicine DIMES, University of Genova, Genova, Italy; 4Institute for Translational Research in Inflammation INFINITE, Université de Lille, Lille, France; 5INSERM, Lille, France; 6Centre de référence des maladies autoimmunes systemiques rares du Nord et Nord-Ouest de France CeRAINO, Lille, France; 7Department of Internal Medicine, University of Ghent, Ghent University Hospital, Ghent, Belgium; 8Department of Rheumatology, University of Ghent, Ghent University Hospital, Ghent, Belgium; 9Unit for Molecular Immunology and Inflammation, Flemish Institute for Biotechnology, Inflammation Research Center, Ghent, Belgium; 10Centro Hospitalar Universitário Lisboa Norte EPE, Serviço de Reumatologia e Doenças Ósseas Metabólicas Lisboa Portugal; 11Universidade de Lisboa, Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular João Lobo Antunes Lisboa Portugal; 12University Children Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia; 13University of Ljubljana, Department of Paediatrics, Ljubljana, Slovenia; 14University of Florence, NEUROFARBA Department, Firenze, Italy; 15Meyer Children Hospital IRCCS, Rheumatology Unit, Firenze, Italy; 16Spanish Association for Antiphospholipid Syndrome, Elche, Spain; 17Relapsing Polychondritis Awareness and Support, Worcester, United Kingdom; 18Flemish Association for Hereditary Connective Tissue Disorders, Koersel, Belgium; 19CHU Bordeaux Pellegrin, Centre de Références Maladies Auto-Immunes Systémiques Rares, Bordeaux, France; 20Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
126 -
PO:26:096 | From free text to diagnosis: a Natural Language Processing approach for identifying rheumatoid and psoriatic arthritis in the Emergency Department Antonio Tonutti1|2, Pierandrea Morandini3, Cosimo Faeti3, Nicoletta Luciano1|2, Saverio D'Amico3, Antonio Voza1|4, Victor Savevski3, Carlo Selmi1|2 | 1Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3Artificial Intelligence Unit, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 4Emergency Department, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy
30 -
PO:26:097 | Ultrasound evaluation of temporomandibular disorders: comparative analysis between inflammatory and degenerative patterns in patients with and without rheumatological pathologies Beatrice Maranini1, Stefano Mandrioli2, Fabio Fabbian3, Tommaso Bianchi1, Manlio Galiè2, Marcello Govoni1 | 1UO di Reumatologia, Dipartimento di Scienze Mediche, Università di Ferrara; 2UO di Chirurgia Maxillo-Facciale, Dipartimento Testa-Collo, Università di Ferrara; 3Dipartimento di Scienze Mediche, Università di Ferrara, Italy
150 -
PO:27:105 | Sleep disturbances in patients with polymyalgia rheumatica: correlations with disease activity, fatigue, and glucocorticoid dosage Ilaria Franch1, Lorenzo Di Sanzo1, Chiara Castellani2, Giulia Bevignani1, Lucia Colella1, Veronica Alò1, Fabrizio Conti1, Rossana Scrivo1 | 1Università La Sapienza, Roma; 2Ospedale San Camillo De Lellis, Rieti, Italy
207 -
PO:27:106 | Role of histology in interstitial lung involvement of rheumatic diseases in real life scenario Francesca Cozzini1|2, Francesco Falco1, Lucia Spaggiari1|3, Alberto Cavazza1, Adele Del Giudice1|2, Lucia Dardani1, Fabio Brandolino1, Emanuele Cocchiara1, Ilaria Chiapparoli1, Luca Magnani4, Gianluigi Bajocchi1, Carlo Salvarani1|2, Andreina Manfredi1|2 | 1IRCCS Arcispedale Santa Maria Nuova Reggio Emilia, Italy; 2Università degli Studi di Modena e Reggio Emilia Modena, Italy; 3AUSL area NORD Montecchio-Guastalla, Italy; 4UOC di Medicina Interna ad Indirizzo Reumatologico, Azienda USL Bologna, Ospedale Maggiore Bologna, Italy
40 -
PO:27:108 | Delphi consensus on the shared management of patients with rheumatologic and oncologic diseases Luigi De Marco1, Augusta Ortolan2, Antonio Carletto3, Fulvia Ceccarelli4, Lorenzo Dagna5, Ginevra De Marchi6, Ennio Giulio Favalli7, Alessandro Inno8, Giuseppe Lopalco9, Francesco Ciccia10, Ennio Lubrano11, Luca Quartuccio12, Immacolata Prevete13, Roberta Ramonda14, Nicola Silvestris15, Marcello Tiseo16, Michelina Turri1, Maria Sole Chimenti1 | 1Reumatologia, allergologia e immunologia clinica, dipartimento di medicina dei sistemi, Università di Roma Tor Vergata; 2UOC Reumatologia e immunologia clinica, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma; 3Unità di Reumatologia, Dipartimento di medicina, AOUI università di Verona; 4Reumatologia, Dipartimento di Scienze Cliniche, Anestesiologiche Internistiche e Cardiovascolari, Sapienza Università di Roma; 5Unità di Immunologia, Reumatologia, Allergologia e malattie rare UnIRar, IRCSS San Raffaele, Milano; 6Unità di Reumatologia, Dipartimento di medicina, Azienda Sanitaria Universitaria Integrata, Università di Udine; 7Dipartimento di Reumatologia e scienze mediche, Istituto Gaetano Pini, Università di Milano; 8Oncologia Medica, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella (VR); 9UOC Reumatologia, Dipartimento di Medicina di Precisione e Rigenerativa e Area Ionica, Università di Bari "Aldo Moro"; 10Unità di Reumatologia, Dipartimento di Medicina di Precisione, Università della Campania L. Vanvitelli, Napoli; 11Unità di Reumatologia, Università degli Studi del Molise, Campobasso; 12SOC Clinica Reumatologica - ASUFC, Dipartimento di Medicina, Università degli Studi di Udine; 13UOC Reumatologia Azienda Ospedaliera San Camillo-Forlanini, Roma; 14UOC di Reumatologia, Dipartimento di Medicina DIMED, Azienda Ospedale Università di Padova; 15UOC Oncologia Medica e Dipartimento Area Medica - IRCCS Istituto Tumori Giovanni Paolo II, Bari; 16UOC di Oncologia Medica, Azienda Ospedaliero-Universitaria di Parma, Italy
142 -
PO:27:112 | The impact of rurality in chronic inflammatory rheumatic diseases in the province of Udine (2014-2023): analysis of clinical outcomes and potential complications Simone Longhino1, Luigi Castrista2, Yvonne Beorchia2, Marco Driutti2, Elena Treppo1, Silvio Brusaferro3, Luca Quartuccio1 | 1Clinica di Reumatologia, Dipartimento di Medicina Specialistica; 2Istituto di Igiene ed Epidemiologia Valutativa; 3Accreditamento, Gestione del Rischio Clinico e Valutazione delle Performance Sanitarie, ASUFC, Udine, Italy
155 -
PO:28:116 | Glandular involvement in autoimmune diseases: a spectrum of differential diagnosis Francesca Petrillo1, Caterina Ricordi1, Caterina Tomassini1, Luca Cimino3, Giorgia Citriniti2, Fabio Brandolino2, Chiara Marvisi1, Carlo Salvarani1 | 1S.C. Reumatologia; 2S.C. Reumatologia; 3S.S.D. Immunologia Oculare, Università di Modena e Reggio Emilia, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
149 -
PO:28:126 | Effectiveness of the new AMEL system in the treatment of simple painful shoulder syndrome Antonietta Albanese1, Emilio Battisti1, Federico Filippi2 | 1Dipartimento SFTA, Università di Siena, Siena; 2Sanimed, Fisiomed, Vicenza, Italy
188 -
PO:28:127 | Efficacy of b/ts-DMARDS therapy on depressive and anxiety symptoms in patients with chronic inflammatory joint diseases: preliminary results of a prospective study Nikita Pecani1, Christian D'Elia1, Francesca Bartoli1, Sabrina Aliberti1, Francesco Rotella2, Arianna Ida Altomare2, Francesco Vinci2, Lorenzo Cortoni2, Davide Benedetti3, Camilla Ferrari4, Gemma Lepri1, Silvia Bellando Randone1, Serena Guiducci1 | 1SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; 2Unità di Psichiatria, Dipartimento di Scienze della Salute, Università degli Studi di Firenze; 3Dipartimento Salute Mentale, USL Umbria, Città di Castello (PG); 4Scuola di Scienze della Salute Umana - Università degli Studi di Firenze, Italy
177 -
PO:28:128 | Rheumatic fever: an atypical case Giovanni Italiano1, Melania Coscia1, Arianna Monteforte1 | 1AORN S. Anna e S. Sebastiano Caserta, Italy
32 -
PO:29:131 | Early effect of auricular acupuncture on pain modulation in patients with fibromyalgia: findings from a real-life experience Benedetta Bianchi1, Edoardo Cipolletta1, Sonia Farah1, Fausto Salaffi1, Marco Di Carlo1 | 1Clinica Reumatologica, Università Politecnica delle Marche, ospedale Carlo Urbani Jesi, Ancona, Italy
31 -
PO:29:132 | Autonomic Dysfunction in Fibromyalgia: A Cross-Sectional Study and Cluster Analysis of Clinical Phenotypes Sergio Del Vescovo1, Vincenzo Venerito1, Maria Giannotta1, Marco Fornaro1, Greta Giulia Dipietrangelo1, Andrea Cito1, Maria Morrone1, Giuseppe Lopalco1, Florenzo Iannone1 | 1UOC Reumatologia, Policlinico di Bari, DiMePre-J Bari, Italy
40 -
PO:29:138 | Cetylated fatty acids and fibromyalgia: efficacy and tolerability in a prospective study Anna Capogna1, Marco Bardelli1, Luca Cantarini1, Bruno Frediani1 | 1UOC Reumatologia, Dipartimento di Scienze mediche, chirurgiche e neuroscienze, Università degli Studi di Siena, Italy
144 -
PO:29:139 | Modulation of autonomic dysfunction in fibromyalgia through auricular vagal nerve stimulation: preliminary results Sonia Farah1, Marco Di Carlo1, Maria Giovanna Lommano1, Benedetta Bianchi1, Piercarlo Sarzi Puttini2, Fausto Salaffi1. | 1Rheumatology Clinic, Università Politecnica delle Marche, Ospedale Carlo Urbani, Jesi, Italy; 2Rheumatology Unit, IRCCS Galeazzi-Sant Ambrogio Hospital, Milano State University School of Medicine, Milano, Italy.
159 -
PO:29:141 | Assessing psychosomatic diagnoses and psychological distress in patients with fibromyalgia. The clinical utility of a multidisciplinary approach Sara Ceccatelli1, Francesca Nacci2, Ginevra Fiori2, Gemma Lepri2, Fiammetta Cosci3, Serena Guiducci2 | 1Dipartimento di Medicina Sperimentale e Clinica; 2Divisione di Reumatologia, Dipartimento di Medicina Sperimentale e Clinica; 3Dipartimento di Scienze della Salute, Università di Firenze, Italy
130 -
PO:29:144 | Refractory localized pain in fibromyalgia and the importance of differential diagnosis: two cases of Bertolotti’s syndrome and avascular necrosis successfully treated with targeted therapy Andrea Lacarpia1, Riccardo Terribili1, Silvia Valentini1, Marta Fabbroni1, Stefano Barbagli1, Stefano Gentileschi1, Caterina Baldi1, Luca Cantarini1, Bruno Frediani1 | 1Azienda Ospedaliera Universitaria Senese, Università degli Studi di Siena, Italy
151 -
PO:29:145 | Fibromyalgia in idiopathic inflammatory myopathies: is it time for rheumatologists to investigate it? Federico Fattorini1, Michele Diomedi1, Simone Barsotti2, Elenia Laurino3, Chiara Cardelli1|4, Alessandra Tripoli3, Linda Carli3, Marta Mosca1|3. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Rheumatology, Versilia Hospital, Viareggio, Italy; 3Rheumatology Unit, AOUP, Pisa, Pisa, Italy; 4Department of Medical Biotechnologies, University of Siena, Siena, Italy.
145 -
PO:30:151 | Clinical characteristics and evolution of juvenile undifferentiated connective tissue diseases: results of a single-center study Nicoletta D'Angelo1|2, Stefania Costi3, Achille Marino3, Francesco Baldo3, Cecilia Beatrice Chighizola1|3, Roberto Felice Caporali1|2|3. | 1Università degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunità, Milano, Italy; 2ASST G. Pini-CTO, UOC di Clinica Reumatologica, Milano, Italy; 3ASST G. Pini-CTO, UOC di Clinica Reumatologica Pediatrica, Milano, Italy
123 -
PO:30:152 | An altered immunometabolic profile characterizes B cells of patients with oligoarticular- and polyarticular- juvenile idiopathic arthritis Emiliano Marasco1, Angela Aquilani1, Rebecca Nicolai1, Maria Isabella Petrone1, Giusyda Tarantino1, Ivan Caiello1, Sabina Barresi2, Silvia Magni Manzoni1, Fabrizio De Benedetti1 | 1Unità di Reumatologia, Ospedale Pediatrico Bambino Gesù Roma, Italy; 2UO di Anatomia Patologica, Ospedale Pediatrico Bambino Gesù Roma, Italy
37 -
PO:30:153 | Long-term outcomes of JIA-associated uveitis: a systematic review and meta-analysis Laura Scagnellato1, Giacomo Cozzi1, Matteo Molfese1, Mariagrazia Lorenzin1, Jamie Alexander King1, Gianluca Poncina1, Stefano Rizzetto1, Roberta Ramonda1 | 1UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Italy
43 -
PO:30:155 | The role of nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases Marco Binda1, Beatrice Moccaldi1, Francesca Tirelli2, Anna Cuberli1, Andrea Benini1, Meneghel Alessandra2, Andrea Doria1, Francesco Zulian2, Elisabetta Zanatta1 | 1U.O.C. Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova Padova, Italy; 2U.O.S.D. Reumatologia Pediatrica, Dipartimento per la Salute della Donna e del Bambino, Azienda Ospedaliera di Padova, Italy
35 -
PO:30:157 | Radiographic assessment of measurable osteoarticular damage in juvenile idiopathic arthritis (JIA) patients transitioning to adult care Serena Pastore4, Marta Klanmjsceck3, Andrea Guiotto1, Laura De Nardi5|6, Alessia Pin4, Lorenzo Cereser1|2, Andrea Taddio3|4, Luisa Occhipinti1, Luca Quartuccio1|2, Alberto Tommasini3|4, Alen Zabotti2 | 1Università degli Studi di Udine Udine, Italy; 2Ospedale Santa Maria della Misericordia Udine, Italy; 3Università degli Studi di Trieste Trieste, Italy; 4IRCCS Materno Infantile Burlo Garofolo Trieste, Italy; 5Università Tor Vergata Roma, Italy; 6Ospedale Pediatrico Bambino Gesù Roma, Italy
33 -
PO:30:160 | A rare case of juvenile systemic sclerosis Marta Arese1|2, Francesco Baldo3, Stefania Costi3, Achille Marino3, Cecilia Chighizola1|3, Roberto Felice Caporali1|2 | 1Azienda Ospedaliera Universitaria Senese, Università degli Studi di Siena; 2Reumatologia Clinica, ASST Gaetano Pini-CTO, Milano, Italy
228 -
PO:31:161 | First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: clinical associations from the SPRING-SIR registry Antonio Tonutti1|2, Francesca Motta1|2, Rossella De Angelis3, Valeria Riccieri4, Silvia Laura Bosello5, Fabio Cacciapaglia6, Veronica Codullo7, Giacomo De Luca8, Francesca Ingegnoli9, Dilia Giuggioli10, Clodoveo Ferri10, Marco Matucci-Cerinic8, Carlo Selmi1|2, Maria De Santis1|2 | 1Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3Università Politecnica delle Marche Ancona, Italy; 4Università degli Studi di Roma La Sapienza Roma, Italy; 5Università Cattolica del Sacro Cuore Roma, Italy; 6Università degli Studi di Bari Aldo Moro Bari, Italy; 7Reumatologia, Fondazione IRCCS Policlinico San Matteo Pavia, Italy; 8Università Vita-Salute San Raffaele Milano, Italy; 9Università degli Studi di Milano, Italy; 10Università degli Studi di Modena e Reggio Emilia, Italy
32 -
PO:31:163 | Safety and tolerability of home-based prostacyclin analogue therapy in vascular manifestations of the scleroderma spectrum: results of a monocentric study Alice Dionisi1, Lucrezia Verardi2, Annacarla Finucci2, Paola Volpe2, Anna Cinzia Raspa2, Paola Cipriani1, Raffaele Zicolella2 | 1Reumatologia,Dipartimento di Sscienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila; 2UOC Reumatologia, Ospedale Civile di Pescara, Italy
156 -
PO:31:165 | Prevalence and incidence of skin telangectasia and their association with clinical features: analysis of the European Scleroderma Trials and Research cohort Gemma Lepri1, Lorenzo Tofani2, Silvia Bellando Randone1, Veronica Batani3, Paolo Airò4, Patricia Carreira5, Joerg Henes6, Alexandra Balbir Gurman7, Florenzo Iannone8, Antonella Marcoccia9, Luc Mouthon10, Branimir Anic11, Carolina De Souza Müller12, Armine Haroyan13, Ana Cristina Cordeiro14, Serena Guiducci And Eustar Coll1. | 1University of Florence, Dept of Experimental and Clinical Medicine, AOU Careggi, Division of Rheumatology Florence Italy; 2University of Florence, Dept of Statistics, Informatics, Applications, Florence, Italy; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR, IRCCS San Raffaele, Milano, Italy; 4Scleroderma Unit, UOC Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy; 5Dept of Rheumatology, 12 de Octubre University Hospital, Madrid, Spain; 6Centre for Interdisciplinary Rheumatology, Immunology and autoimmune diseases INDIRA, University Hospital Tuebingen, Tuebingen, Germany; 7Rheumatology Institute, Rambam Health Care Campus Haifa Israel; 8Dept of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy; 9Interdisciplinary Reference Center for Systemic Sclerosis CRIIS Sandro Pertini Hospital, Rome, Italy; 10Dept of Internal Medicine, Cochin Hospital, Paris Cité University, Paris, France; 11Div Clinical Immunology and Rheumatology, Dept Internal Medicine, School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia; 12Rheumatology Division, Hospital de Clínicas da Universidade Federal do Parana, Curitiba, Brazil; 13Dept of Rheumatology, Yerevan State Medical University of Armenia, Yerevan, Armenia; 14Servico Reumatologia Hospital Garcia de Orta Almada, Almada, Portugal.
149 -
PO:31:166 | S'/PAPs ratio in systemic sclerosis: a promising non-invasive index for early detection and prognosis of pulmonary hypertension. A step toward more accurate screening? Marco De Pinto1, Amelia Spinella1, Pierluca Macripò2, Alessia Laneri1, Benedetta Bongiovanni1, Maria Grazia Malandra1, Martina Orlandi1-3, Gianluca Pagnoni2, Arianna Maini2, Rosario Rossi2-4, Clodoveo Ferri1, Francesca Coppi2-3, Dilia Giuggioli1-3. | 1Rheumatology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy; 2Cardiology Division, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 3Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy; 4Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
139 -
PO:31:167 | Increased M2 pro-fibrotic marker expression in circulating monocytes and cultured monocyte-derived macrophages in systemic sclerosis patients with progressive interstitial lung disease Vanessa Smith1|2, Stefano Soldano3, Rosanna Campitiello3|5, Emanuele Gotelli3|4, Paola Montagna3, Elvis Hysa3|5, Tamara Vojinovic3|4, Carmen Pizzorni3|4, Sabrina Paolino3|4, Alberto Sulli3|4, Maurizio Cutolo3|4. | 1Department of Internal Medicine and Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; 2Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre, Ghent, Belgium; 3Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, Genova, Italy; 4IRCCS Ospedale Policlinico San Martino, Genova, Italy; 5Department of Experimental Medicine DIMES, University of Genova, Genova, Italy.
133 -
PO:31:168 | Risk factors for cancer in systemic sclerosis, impact on disease phenotype and prognosis, and proposal of machine learning-based personalized screening strategies: insights from an EUSTAR study Antonio Tonutti1|2, Francesca Motta1|2, Stefano Erba1|2, Britta Maurer3, Cristiana Sieiro Santos3, Duygu Temiz Karadag3, Elena Rezus3, Elisabetta Zanatta3, Fabiola Atzeni3, Francesco Benvenuti3, Gabor Kumanovics3, Gabriella Szucs3, Gianluca Moroncini3, Gonçalo Boleto3, Leila Caillault3, Lilian Maria Lopez Nunez3, Masataka Kuwana3, Massimiliano Limonta3, Maurizio Cutolo3, Oliver Distler3, Radim Bevcar3, Roberto Giacomelli3, Rossella De Angelis3, Serena Guiducci3, Stefano Stano3, Valeria Riccieri3, Yasser El Miedany3, Sophie Blaise3, Carlo Selmi1|2, Maria De Santis1|2 | 1Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3EUSTAR collaborators EUSTAR * OTHER
21 -
PO:31:169 | From Crisis to Chronicity: A Real-World Study of Renal Dysfunction in Systemic Sclerosis Stefano Stano1, Fabio Cacciapaglia1|2, Giorgia Campanale1, Simone Perniola1, Maria Morrone1, Andrea Cito1, Vincenzo Venerito1, Maria Grazia Anelli1, Giuseppe Lopalco1, Florenzo Iannone1 | 1Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari Bari, Italy; 2Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima, Italy
18 -
PO:31:171 | Uncovering subclinical cardiac involvement in VEDOSS: An echocardiographic driven study Eugenio Capparelli1, Eleonora Zaccara1, Irene Rota2, Sara Facetti2, Daniela Bompane1, Laura Castelnovo1, Antonino Mazzone3, Paola Faggioli1 | 1UOC Reumatologia, ASST Ovest-Milanese, Legnano Milano Italy; 2UOC Cardiologia, ASST Ovest-Milanese, Legnano Milano, Italy; 3UOC Medicina Interna, ASST Ovest-Milanese, Legnano, Milano, Italy
8 -
PO:31:172 | Age and timing of onset of Raynaud's phenomenon and first non-Raynaud sign/symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the systemic sclerosis progression investigation registry of the Italian Society for Rheumatology Silvia Peretti1, Cosimo Bruni2, Silvia Laura Bosello3, Fabio Cacciapaglia4-5, Corrado Campochiaro6-7, Veronica Codullo8, Lorenzo Dagna6-7, Rossella De Angelis9, Giacomo De Luca6-7, Dilia Giuggioli10, Serena Guiducci1, Florenzo Iannone4, Francesca Ingegnoli11, Valeria Riccieri12, Marco Matucci Cerinic6-7, Clodoveo Ferri10-13, Silvia Bellando Randone1. | 1Division of Rheumatology, Scleroderma Unit, Department of Experimental and Clinical Medicine, University of Florence, AO, Firenze, Italy; 2Division of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 3Rheumatology Division, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli- IRCCS, Roma, Italy; 4Rheumatology Unit, Department of Precision and Regenerative Medicine-Ionian Area, University of Bari Aldo Moro, Bari, Italy; 5Reumatology Service, Internal Medicine Unit F.Miulli General Hospital, Acquaviva delle Fonti -Department of Medicine a, Bari, Italy; 6Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR, Inflammation, Fibrosis and Ageing initiative INFL, Milano, Italy; 7Vita-Salute San Raffaele University, Milano, Italy; 8Department of Internal Medicine and Therapeutics, Università di Pavia, Italy; Division of Rheumatology, Fondazione IRCCS, Pavia, Italy; 9Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 10Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy; 11Division of Clinical Rheumatology, ASST Pini, Dept. of Clinical Sciences and Community Health, Research Center for Adul, Milano, Italy; 12Department of Rheumatology, Sapienza University of Rome, Roma, Italy; 13Rheumatology Clinic Madonna dello Scoglio Crotonei, Crotone, Italy.
155 -
PO:31:173 | Methotrexate monotherapy in early systemic sclerosis: a real-life monocentric Italian experience Claudia Iannone1|2, Ilaria Magi1|2, Antonina Minniti2, Giuseppe Armentaro2, Silvia Cavalli1|2, Manuel Sette1|2, Laura Giudice1|2, Maria Rosa Pellico1|2, Cristina Bochicchio1|2, Roberto Felice Caporali1|2, Nicoletta Del Papa1|2. | 1Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milano, Italy; 2Dipartimento di Reumatologia e Scienze Mediche, ASST G. Pini-CTO, Milano, Italy.
141 -
PO:31:174 | Increased frequency of anti-RNA polymerase 3 antibodies in patients with systemic sclerosis and silicone breast implants: a multicentre study from the international European Scleroderma Trials and Research cohort Maria Grazia Lazzaroni1, Yolanda Braun-Moscovici2, Elda Piovani1, Claudia Barison1, Liala Moschetti1, Veronica Batani3, Corrado Campochiaro3, Michal Tomcik4, Francesca Motta5, Maria De Santis5, Petros P. Sfikaki6, Masataka Kuwana7, Brigitte Granel8, Roberta Foti9, Virginia Berlingiero10, Joana Caetano11, Yannick Allanore12, Alexandra Balbir-Gurman2, Marco Matucci Cerinic3, Franco Franceschini1, Paolo Airò1. | 1ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy; 2Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israeli Institute of Tecnology, Haifa, Israel; 3Vita-Salute San Raffaele University, San Raffaele Hospital, Milano, Italy; 4Institute of Rheumatology, Praga, Czech Republic; 5IRCCS Humanitas Research Hospital; Humanitas University, Milano, Italy; 6Joint Rheumatology Program, Medical School, National Kapodistrian University of Athens Atene GREECE; 7Nippon Medical School Hospital Tokyo Japan; 8Hôpital Nord de Marseille; Aix-Marseille Université Marsiglia France; 9AOU Policlinico G. Rodolico San Marco, Catania, Italy; 10Azienda Ospedaliera Universitaria Senese, Siena, Italy; 11Fernando Fonseca Hospital, Amadora, Portugal; 12Université Paris Cité, Cochin Hospital, Parigi, France.
141 -
PO:31:175 | Characterizing gastrointestinal involvement in systemic sclerosis: insights from the national systemic sclerosis progression investigation registry of the Italian Society of Rheumatology Francesco Bonomi1, Cosimo Bruni1|2, Silvia Laura Bosello3, Fabio Cacciapaglia4|5, Corrado Campochiaro6, Roberto Caporali7, Veronica Codullo8, Maria Antonietta D'Agostino3, Lorenzo Dagna6, Rossella De Angelis9, Giacomo De Luca6, Dilia Giuggioli10, Serena Guiducci1, Florenzo Iannone4, Francesca Ingegnoli7, Carlomaurizio Montecucco8, Valeria Riccieri11, Clodoveo Ferri10, Marco Matucci Cerinic6, Silvia Bellando Randone1. | 1Scleroderma Unit, Division of Rheumatology AOUC, and Department of Experimental and Clinical Medicine, Uni. of Florence, Firenze, Italy; 2Department of Rheumatology, University Hospital Zurich, University of Zurich Zurigo Switzerland; 3UOC of Rheumatology and Clinical Immunology, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Roma, Italy; 4Rheumatology Unit, Department of Emergency Surgery and Organ Transplantations, University of Bari, Bari, Italy; 5Rheumatology Service, F. Miulli General Hospital - Department of Medicine and Surgery, LUM 'G. De Gennaro', Casamassima, Italy; 6Unit of Immunology, Rheumatology, Allergy and Rare Diseases and Inflammation, fibrosis and ageing initiative, UniSR, Milano, Italy; 7Division of Clinical Rheumatology, ASST Pini and Università degli studi di Milano, Milano, Italy; 8Department of Rheumatology, Policlinico San Matteo, Pavia, Italy; 9Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 10Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy; 11Department of Rheumatology, Sapienza University of Rome, Roma, Italy.
151 -
PO:32:176 | Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease: results from a European Scleroderma Trials and Research cohort study Devis Benfaremo1, Corrado Campochiaro2, Gábor Kumánovics3, Christina Bergmann4, Elisabetta Zanatta5, David Launay6, Serena Guiducci7, Mickael Martin8, Carolina De Souza Müller9, Carlomaurizio Montecucco10, Luc Mouthon11, Gabriella Szucs12, Kastriot Kastrati13, Marie-Elise Truchetet14, Madelon Vonk15, Francesco Del Galdo16, Marco Matucci-Cerinic2, Gianluca Moroncini1, Yannick Allanore17. | 1Department of Clinical and Molecular Sciences, Marche Polytechnic University, Marche University Hospital, Ancona, Italy; 2Vita-Salute San Raffaele University, San Raffaele Hospital, Milano, Italy; 3University of Pécs, Department Of Rheumatology And Immunology, Pécs, Hungary; 4University Hospital Erlangen, Department Internal Medicine 3, Erlangen, Germany; 5Padova University Hospital, Rheumatology Unit, Padova, Italy; 6Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Lille, France; 7University of Florence, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy; 8Poitiers University Hospital, Department of Internal Medicine Poitiers France; 9Hospital de Clinicas da Universidade Federal do Parana Curitiba Brazil; 10Università di Pavia e IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; 11Hôpital Cochin, Department of Internal Medicine, Paris, France; 12University of Debrecen, Faculty of Medicine, Department of Rheumatology, Debrecen, Hungary; 13Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria; 14CHU de Bordeaux, Rheumatology department, Bordeaux, France; 15Radboudumc, Department of Rheumatology Nijmegen The Netherlands; 16Leeds Raynauds and Scleroderma Program, NIHR Biomedical Research Centre, Leeds, United Kingdom; 17Université Paris Cité, Cochin Hospital, Rheumatology Department, Paris, France.
152 -
PO:32:178 | Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study Nicola Farina1, Silvia Bellando-Randone1, Hilde Jenssen-Bjørkekjær2, David Launay3, Patricia Carreira4, Paolo Airò5, Serena Guiducci1, Dilia Giuggioli6, Gabriela Riemekasten7, Carmen-Pilar Simeón Aznar8, Christina Bergmann9, Elise Siegart10, Ivan Castellví11, Lesley Ann Saketkoo12, Jeska De Vries-Bouwstra13, Philipp Klemm14, Ulf Müller-Ladner14, Alexandra Balbir-Gurman15, Vanessa Smith16, Florenzo Iannone17, Luca Idolazzi18, Christopher Denton19, Edoardo Rosato20, Britta Maurer1, Yannick Allanore1, Yoshiya Tanaka1, Elisabetta Zanatta1, Oliver Distler1, Marco Matucci-Cerinic1, Cosimo Bruni1 | 1Department of Experimental and Clinical Medicine, Scleroderma Unit, Division of Rheumatology, University of Florence, Az Firenze, Italy; 2Department of Rheumatology, Hospital of Southern Norway Kristiansand, Norway; 3National Reference Center for Pulmonary Arterial Hypertension Pulmotension Lille, France; 4Hospital Universitario 12 de Octubre, Rheumatology Department Madrid Spain; 5ASST Spedali Civili of Brescia, University of Brescia, Rheumatology and Clinical Immunology Unit Brescia, Italy; 6Scleroderma Unit, Rheumatology Unit, University Hospital of Modena and Reggio Emilia Modena, Italy; 7Universitätsklinikum Schleswig-Holstein, Klinik für Rheumatologie und klinische Immunologie Lübeck Germany; 8Hospital Universitario Vall d'Hebron, Department of Internal Medicine, Systemic Autoimmune Diseases Unit Barcelona Spain; 9University Hospital Erlangen, Department Internal Medicine 3 Erlangen Germany; 10Charité University Hospital, Department of Rheumatology Berlin Germany; 11Hospital de la Santa Creu i Sant Pau Baercelona Spain; 12New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center New Orleans, USA; 13Leiden University Medical Center, Department of Rheumatology Leiden, The Netherlands; 14JLU Giessen, Campus Kerckhoff, Department of Rheumatology and Clinical Immunology Center Bad Nauheim Germany; 15Rambam Health Care Campus, Rheumatology Institute Haifa, Israel; 16University of Ghent, Department of Rheumatology Ghent, Belgium; 17Rheumatology DiMePReJ, University of Bari, School of Medicine Bari, Italy; 18University of Verona, Section of Rheumatology, Department of Medicine Verona, Italy; 19Royal Free London and University College London Medical School, Centre for Rheumatology London, United Kingdom; 20Sapienza University of Rome, Department of Translational and Precision Medicine Azienda Ospedaliero-Universitaria Policl Roma, Italy
15 -
PO:32:180 | Clinical and hemodynamic profile of patients with SSC-PAH with and without pulmonary veno-occlusive disease: a single-center study Anna Cuberli1, Michele Strosio2, Alessandro Magi2, Beatrice Moccaldi1, Marco Binda1, Andrea Benini1, Andrea Doria1, Martina Perazzolo Marra2, Giulia Famoso2, Laura De Michieli2, Elisabetta Zanatta1|2 | 1UOC Reumatologia, DIDAS Medicina Dei SIstemi, Azienda Ospedale Università di Padova; 2UOC Cardiologia, DIDAS Medicina Dei Sistemi, Azienda Ospedale Università di Padova, Italy
118 -
PO:32:181 | Digital ulcers predict enhanced Peak Systolic Velocities at internal and external Carotid in Systemic Sclerosis Patients Eugenio Capparelli1, Francesco Lapia2, Luca Clerici2, Eleonora Zaccara1, Giusy Cinzia Moltisanti2, Francesca Capelli2, Daniela Bompane1, Paola Faggioli1, Antonino Mazzone2 | 1UOC Reumatologia, ASST Ovest Milanese, Legnano, Milano, Italy; 2UOC Medicina Interna, ASST Ovest Milanese, Legnano, Milano, Italy
14 -
PO:32:182 | Disease characteristics of anti-centromere positive systemic sclerosis patients and risk factors for organ involvement: data from the EUSTAR cohort Corrado Campochiaro1, Jelena Colic2, Del Papa Nicoletta3, Oliver Distler4, Serena Guiducci5, Florenzo Iannone6, David Launay7, Yair Levy8, Britta Maurer9, Arsene Mekinian10, Predrag Ostojic2, Gabriela Riemekasten11, Petros Sfikakis12, Bojana Stamenkov13, Ulrich Walker14, Marie Elise Truchetet15, Madelon Vonk16, Francesco Del Galdo17, Giacomo De Luca1, Lorenzo Dagna1, Marco Matucci Cerinic1, Yannick Allanore18 | 1IRCCS San Raffaele Hospital; Vita Salute San Raffaele University Milan, Italy; 2University of Belgrade Belgrade, Serbia; 3UOC Reumatologia Clinica, ASST G. Pini CTO Milan, Italy; 4University Hospital Zurich Zurich, Switzerland; 5Department of Rheumatology, University of Florence Florence, Italy; 6Rheumatology Unit Bari, Italy; 7CHU Lille Lille, France; 8Department of Medicine Kfar Saba, Israel; 9Department for BioMedical Research, University of Bern Bern, Switzerland; 10Service de medecine interne Paris, France; 11Department of Rheumatology University of Lubeck Lubeck Germany; 12National and Kapodistrian University of Athens Athens, Greece; 13University School of Medicine, Nis Nis, Serbia; 14University Hospital Basel, Basel Basel, Switzerland; 15Bordeaux Hospital and University Bordeaux, France; 16Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 17Leeds Institute of Rheumatic and Muskuloskeletal Medicine Leeds, United Kingdom; 18Cochin Hospital Paris, France
16 -
PO:32:183 | Innovative use of integra dermal regeneration template on systemic sclerosis digital ulcers: a case report Elena Vanni1, Martina Orlandi1|2, Amelia Spinella2, Valentina Pinto3, Massimo Pinelli3, Dilia Giuggioli1|2 | 1Reumatologia, Università di Modena e Reggio Emilia; 2Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena; 3Chirurgia Plastica, Università di Modena e Reggio Emilia e Azienda Ospedaliero-Universitaria, Policlinico di Modena, Italy
142 -
PO:32:184 | Assessing the burden of Sars-Cov2 in systemic sclerosis-related interstitial lung disease patients: functional, clinical and therapeutic outcomes from an Italian cohort, a retrospective study Andrea Cito1, Greta Giulia Dipietrangelo1, Daniele V. A. Sabella1, Marco Fornaro1, Fabio Cacciapaglia1, Giuseppe Lopalco1, Florenzo Iannone1. | 1AOUC Policlinico di Bari - Reumatologia Universitaria, Bari, Italy.
159 -
PO:32:185 | Deep-learning analysis of high-resolution computed tomography images predicts progression and mortality in systemic sclerosis related interstitial lung disease Valentina Boni1, Rosa D'Abronzo2, Piergiacomo Cerasuolo1, Lucio Calandriello2, Giuseppe Cicchetti2, Gerlando Natalello1, Bruno Iovene5, Francesco Varone5, Giacomo Sgalla5, Luca Richeldi5, Anna Rita Larici2|4, Maria Antonietta D'Agostino1|3, Silvia Laura Bosello1|3, Enrico De Lorenzis1. | 1Division of Rheumatology and Clinical Immunology Catholic Univeristy of the Sacred Heart, Rome, Italy; 2Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Diagnostic Imaging Area, Catholic University, Rome, Italy; 3Department of Geriatric and Orthopaedic Sciences, Catholic Univeristy of the Sacred Heart, Rome, Italy; 4Department of Radiological and Hematological Sciences, Section of Radiology, Catholic Univeristy of the Sacred Heart, Rome, Italy; 5Division of Pulmonary Medicine, Catholic University of the Sacred Heart, Roma, Italy.
134 -
PO:32:187 | AI-assisted reading outperforms visual scoring of pulmonary CT scans to predict interstitial lung disease progression in systemic sclerosis Francesca Motta1, Antonio Tonutti1, Federica Catapano2, Gianluca Sellaro2, Francesco Amati3, Anna Stainer3, Calogero Messana2, Stefano Erba1, Stefano Aliberti3, Marco Francone2, Carlo Selmi1, Maria De Santis1 | 1Humanitas University and IRCCS Humanitas Research Hospital, Department of Rheumatology and Clinical Immunology Rozzano, Milan, Italy; 2IRCCS Humanitas Research Hospital, Department of Radiology Rozzano, Milan, Italy; 3IRCCS Humanitas Research Hospital, Respiratory Unit Rozzano, Milan, Italy
19 -
PO:32:189 | Salivary gland alterations in systemic sclerosis: a comprehensive ultrasound study and autoantibody correlation Bixio Riccardo1, Francesca Pistillo1, Luca Idolazzi1, Francesca Nava1, Beatrice Gabrielli1, Emanuela Perrucchini2, Ombretta Viapiana1, Maurizio Rossini1. | 1Rheumatology Unit, University of Verona VERONA Italy; 2WellAgeing DESENZANO DEL GARDA Italy.
163 -
PO:33:190 | Travel distance to tertiary healthcare reflects disease severity and medication access in systemic sclerosis patients: insights from the Italian systemic sclerosis progression investigation registry of the Italian Society of Rheumatology Camilla Teresa Magnanimi1, Enrico De Lorenzis1, Gerlando Natalello1, Fabio Cacciapaglia2, Rossella De Angelis3, Edoardo Cipolletta3, Maria Antonietta D'Agostino1, Veronica Cudullo4, Giacomo De Luca5, Dilia Giuggioli6, Francesca Ingegnoli7, Valeria Riccieri8, Lorenzo Dagna5, Fiorenzo Iannone9, Clodoveo Ferri6, Marco Matucci Cerinic5, Silvia Laura Bosello1. | 1Division of Rheumatology and Clinical Immunology, Catholic University of the Sacred Heart, Fondazione Policlinico Univer, Roma, Italy; 2Department of Medicine and Surgery, LUM University Giuseppe De Gennaro Casamassima e Rheumatology Service Miulli Ge, Bari, Italy; 3Rheumatology Unit - Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 4Department of Rheumatology, Policlinico San Matteo, Pavia, Italy; 5Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR, IRCCS San Raffaele Scientific Institute, Vita-Salu, Milano, Italy; 6Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Italy; 7Division of Clinical Rheumatology, ASST Pini, Dept. of Clinical Sciences e Community Health, Research Center for Adult a, Milano, Italy; 8Department of Rheumatology, La Sapienza University of Rome, Roma, Italy; 9Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy.
160 -
PO:33:191 | Evaluation of the living with pulmonary fibrosis questionnaire in patients with systemic sclerosis associated interstitial lung disease: monocentric results Claudia Barison1, Elda Piovani1, Eleonora Pedretti1, Eleonora Pazzi1, Liala Moschetti1, Ilaria Cavazzana1, Franco Franceschini1, Maria Grazia Lazzaroni1, Paolo Airò1. | 1Rheumatology and Clinical Immunology, Scleroderma Unit, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy.
133 -
PO:33:192 | Hand Microvascular Damage Is Associated with Hand Bone Loss in Systemic Sclerosis Rosanna Campitiello1|3, Sabrina Paolino1|2, Andrea Casabella1|2, Giulia Davoli1|2, Elisa Caratto1|2, Emanuele Gotelli1|2, Elvis Hysa1|2, Carmen Pizzorni1|2, Vanessa Smith4|5, Alberto Sulli1|2, Maurizio Cutolo1|2 | 11. Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medic Genova, Italy; 2IRCCS Ospedale Policlinico San Martino Genova, Italy; 3Department of Experimental Medicine DIMES, University of Genova Genova, Italy; 4Department of Internal Medicine and Department of Rheumatology, Ghent University Hospital Ghent, Belgium; 5Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre, Ghent, Belgium
22 -
PO:33:193 | Self-reported oropharyngeal dysphagia and swallowing-related quality of life in people with systemic sclerosis: preliminary results of a cross-sectional study Nikla Pacenti1, Devis Benfaremo2, Federica Lucia Galli2, Andrea Colangelo3, Gianluca Moroncini2 | 1Internal Medicine Residency Program, Marche Polytechnic University Ancona, Italy; 2Department of Clinical and Molecular Sciences, Marche Polytechnic University Ancona, Italy; 3Medical student, Marche Polytechnic University Ancona, Italy
12 -
PO:33:194 | The role of anti-g protein-coupled receptors antibodies in the assessment of systemic sclerosis-primary heart involvement Beatrice Moccaldi1, Giovanni Civieri2, Annagrazia Cecere2, Marco Binda1, Marta Vadori2, Laura Iop2, Marta Tonello1, Anna Cuberli1, Andrea Benini1, Emanuele Cozzi2, Andrea Doria1, Francesco Tona2, Elisabetta Zanatta1|2. | 1Unità di Reumatologia, Dipartimento di Medicina DIMED, Università di Padova, Padova, Italy; 2Dipartimento di Scienze Cardio-Toraco-Vascolari e Sanità Pubblica, Università di Padova, Padova, Italy.
153 -
PO:33:195 | Evaluation of prevalence and role of anti-endothelin type a-receptor and anti-angiotensin ii type 1-receptor antibodies in a cohort of systemic sclerosis patients Clara Minerba1, Sara Ferrigno1, Antonella Grimaldi2, Noemi Aprile3, Daniela Costanza2, Laura Quarta2, Maria Rita Ricciardi2, Daniela Stasi3, Paola Conigliaro1, Alberto Bergamini1, Eugenio Quarta2, Maria Sole Chimenti1. | 1U.O.C. Reumatologia, Dipartimento di Medicina dei Sistemi, Università di, Roma, Tor Vergata, Roma, Italy; 2U.O.S.D. Reumatologia, P.O. Vito Fazzi Lecce Italy; 3U.O.C. Patologia clinica e Microbiologia, P.O. Vito Fazzi Lecce Italy.
128 -
PO:33:197 | Systemic sclerosis and endothelial dysfunction: the passive leg movement technique in the assessment of no-mediated vascular impairment Silvia Guella1, Giovanni Baldassarre3, Alessandro Gratton2|3, Lucrezia Zuccarelli3, Elena Treppo2, Emma Di Poi2, Bruno Grassi3, Luca Quartuccio2|3 | 1SS Reumatologia-CMID Ospedale San Giovanni Bosco, Torino; 2Clinica di Reumatologia Ospedale Santa Maria della Misericordia, ASUFC, Udine; 3Dipartimento di Medicina, Università di Udine, Italy
151 -
PO:33:199 | Prevalence and clinical associations of antiphospholipid antibodies in patients with systemic sclerosis in the SPRING-SIR registry Antonio Tonutti1|2, Ilaria Cavazzana3, Angela Ceribelli1|2, Maria De Santis1|2, Giacomo De Luca4|5, Maria Grazia Lazzaroni3, Franco Franceschini3, Carlo Selmi1|2, Valeria Riccieri6, Silvia Laura Bosello7, Fabio Cacciapaglia8, Veronica Codullo9, Francesca Ingegnoli10, Dilia Giuggioli11, Rossella De Angelis12, Clodoveo Ferri11, Marco Matucci-Cerinic4|5 | 1Department of Biomedical Sciences, Humanitas Universityce Pieve Emanuele, Milan, Italy; 2Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; 3Rheumatology and Clinical Immunology - ASST Spedali Civili Brescia - Department of Clinical and Experimental Sciences - Brescia, Italy; 4Vita-Salute San Raffaele University Milan, Italy; 5Unit of Immunology, Rheumatology, Allergy and Rare Diseases UnIRAR and INFLAGE Initiative, IRCCS San Raffaele Hospital Milan, Italy; 6University of Rome La Sapienza Rome, Italy; 7Catholic University of Sacred Heart Rome, Italy; 8LUM University Bari, Italy; 9Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo Pavia, Italy; 10University of Milan Milan, Italy; 11University of Modena and Reggio Emilia Modena, Italy; 12Politechnic University of Marche Ancona, Italy
15 -
PO:33:200 | Analysis of risk factors associated with vertebral fractures in systemic sclerosis: evidence from the "Sclero-RER" study group Alessandra Bezzi1, Federica Lumetti2, Martina Orlandi3, Fabio Mascella1, Maria Cristina Focherini1, Eugenio Arrigoni4, Elena Bravi4, Andrea Lo Monaco5, Amelia Spinella3, Ottavio Secchi3, Gianluigi Bajocchi6, Francesco Girelli7, Francesco Ursini8, Pierluigi Cataleta9, Massimo Reta10, Alarico Ariani11|12, Dilia Giuggioli3 | 1Internal Medicine and Rheumatology Unit, AUSL Romagna, Rimini 2AUSL of Modena and Rheumatology Unit, University Hospital Policlinico of Modena; 3Rheumatology Unit, University of Modena and Reggio Emilia; 4Rheumatology Unit, Guglielmo da Saliceto Hospital, Piacenza; 5Rheumatology, department of medical sciences, University of Ferrara; 6Rheumatology Unit, IRCCS Arcispedale Santa Maria Nuova Reggio Emilia; 7Rheumatology Unit, G.B. Morgagni - L. Pierantoni Hospital, Forlì; 8Rizzoli Orthopedic Institute, Rheumatology Unit, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum Bologna; 9Hospital Santa Maria delle Croci, Rheumatology Unit, Department of Internal medicine, AUSL-Romagna Ravenna; 10Rheumatology Unit, AUSL of Bologna, Sant'Orsola Polyclinic Hospital, AOU IRCCS of Bologna; 11Internal Medicine and Rheumatology Unit, University Hospital of Parma; 12AUSL Bologna and University of Bologna, IRCCS Policlinico Sant'Orsola, Bologna, Italy
131 -
PO:33:201 | Metabolic and functional state of circulating platelets in patients with systemic sclerosis Annalisa Villa1, Simona Truglia1, Francesca Maiorca2, Annamaria Sabetta2, Ludovica Lombardi2, Silvia D'Orso2, Lucia Stefanini2, Fabrizio Conti1, Marcella Visentini2, Valeria Riccieri1 | 1Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Università degli Studi di Roma La Sapienza; 2Dipartimento di Medicina Traslazionale e di Precisione, Università degli Studi di Roma La Sapienza
132 -
PO:33:202 | Assessment of Retinal Arteriolar Wall-to-Lumen Ratio and Renal Resistive Index in patients with Systemic Sclerosis Eleonora Pazzi1|2, Elda Piovani1|2, Claudia Barison1|2, Liala Moschetti1|2, Eleonora Pedretti1|2, Mariagrazia Lazzaroni1|2, Carolina De Ciuceis3, Claudia Agabiti-Rosei3, Giacomo Buso3|4, Paolo Baggi3, Claudia Rossini3, Cristina Bevacqua3, Maria Lorenza Muiesan3, Ilaria Cavazzana1, Franco Franceschini1, Paolo Airò2 | 1Rheumatology and Clinical Immunology, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy; 2Scleroderma Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 3Department of Clinical and Experimental Sciences, Division of Internal Medicine, ASST Spedali Civili of Brescia, Univers Brescia, Italy; 4University of Lausanne, Lausanne Switzerland
17 -
PO:33:203 | Efficacy and safety of rituximab in eosinophilic fasciitis: report of three cases and systematic literature review Andrea Benini1, Beatrice Moccaldi1, Marco Binda1, Anna Cuberli1, Mariangela Favaro1, Andrea Doria1, Elisabetta Zanatta1 | 1UOC Reumatologia, Azienda Ospedale, Università di Padova, Italy
175 -
PO:34:204 | Impact of anti-centromere antibodies on immunosuppressive therapy persistence in systemic sclerosis: a single-center case-control study Martina Salerno1, Marius Cadar1, Ilaria Bisconti1, Francesca Romana Di Ciommo1, Elena Platania1, Jacopo Landro1, Beatrice De Girolamo1, Davide Mohammad Reza Beigi1|2, Simona Truglia1, Fabrizio Conti1, Valeria Riccieri1 | 1Rheumatology unit, AOU and Università di Cagliari; 2Asl Biella, Ospedale degli Infermi, Ponderano (BI), Italy
147 -
PO:34:205 | Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy Martina Orlandi1, Tommaso Verdina2, Filippo Santoro1, Alessandra Carobbio3, Amelia Spinella1, Marco De Pinto1, Giorgia Roveta1, Dilia Giuggioli1 | 1Internal Medicine Residency Program, Marche Polytechnic University, Ancona; 2Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 3Department of Interna, Ancona, Italy
138 -
PO:34:207 | When the Lungs Speak in Squeaks: Chronic Bird-Related HP in SSc-ILD with Incidental Lymphoma Mariagrazia Nuara1, Marco De Pinto2, Amelia Spinella2, Stefania Cerri1|2, Enrico Clini1|2, Dilia Giuggioli1|2 | 1Università degli Studi di Modena e Reggio Emilia, Italy; 2AOU, Policlinico di Modena, Italy
18 -
PO:34:209 | Increased liver stiffness and fibrosis in systemic sclerosis: a single-center transient elastography cohort study. Nicola Ortalli1|2, Simone Aldo Lari1|2, Alessandra Vacca3, Erika Meleddu1|2, Alberto Civolani4, Emanuela Vargiu4, Alberto Floris1|2, Massimo Claudio Fantini4, Alberto Cauli1|2. | 1Rheumatology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy; 2Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; 3Rheumatology Unit, Presidio Ospedaliero CTO di Iglesias Iglesias Italy; 4Gastroenterology Unit, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.
147 -
PO:34:211 | Gynecological health and ultrasound evaluation among fertile women affected by Systemic sclerosis: an observational study Martina Orlandi1, Sofia Gambigliani Zoccoli2, Mariagrazia Nuara1, Riccardo Cuoghi Costantini2, Amelia Spinella1, Marco De Pinto1, Antonio La Marca2, Dilia Giuggioli1 | 1Dipartimento di Scienze Mediche e Chirurgiche, Università di Modena e Reggio Emilia, Italy; 2Dipartimento Materno Infantile. Università di Modena e Reggio Emilia, Italy
18 -
PO:34:212 | Orofacial manifestations in systemic sclerosis: preliminary observational study and update of a single-center experience Amelia Spinella1, Marco De Pinto1, Giacomo Setti2, Martina Orlandi1|3, Samuele Veronesi2, Federica Lumetti1, Alessia Laneri1, Luca Keller Sarmiento1, Giorgia Roveta1, Gilda Sandri1|3, Pierantonio Bellini2, Ugo Consolo2, Dilia Giuggioli1|3 | 1Università degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunità, Milano; 2ASST G. Pini-CTO, UOC di Clinica Reumatologica, Milano; 3UOC di Reumatologia Clinica Pediatrica, ASST Gaetano Pini-CTO, Milano, Italy
139 -
PO:34:214 | Autonomic Symptoms Are Associated with Neuropathic Pain Features and Disease Impact in Systemic Sclerosis: Results From a Cross-Sectional Study Benedetta Bianchi1, Francesca Francioso1, Mariachiara Mangiafico1, Fausto Salaffi1, Rossella De Angelis1, Marco Di Carlo1 | 1U.O. Reumatologia, Ospedale Carlo Urbani, Università Politecnica delle Marche Jesi, Italy
18 -
PO:34:217 | Possible role of phosphodiesterase type 5 inhibitors in the prevention of digital ulcers and videocapillaroscopic changes in patients with systemic sclerosis Elena Platania1, Marius Cadar1, Ilaria Bisconti1, Davide Mohammad Reza Beigi1|2, Francesca Romana Di Ciommo1, Jacopo Landro1, Martina Salerno1, Beatrice De Girolamo1, Simona Truglia1, Fabrizio Conti1, Valeria Riccieri1 | 1S.C. Reumatologia; 2S.C. Reumatologia
168 -
PO:35:218 | Switching the dose of mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European retrospective multicentre real-world study Edoardo Biancalana1, Irene Mattioli1, Emanuele Chiara2, Danilo Malandrino1, Maria Canfora1, Palmerini Miki1, Maria Paola Lisi1, Michela Gasparotto3, Paola Tomietto3, Maria Letizia Urban1, Giacomo Bagni1, Elena Silvestri1, Alessandra Bettiol3, Augusto Vaglio3, Giacomo Emmi2 | 1Department of Experimental and Clinical Medicine, University of Florence Firenze, Italy; 2Department of Medical, Surgery and Health Sciences, University of Trieste Trieste, Italy; 3Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Trieste, Italy; 4Department of Biomedical, Experimental and Clinical Sciences Mario Serio, University of Florence Firenze, Italy
26 -
PO:35:219 | Real-world effectiveness of mepolizumab on gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a multicentre retrospective study Alessia Gatti1, Francesca Regola1, Giulia Fontana1, Mario Addrea Piga2, Gianluca Moroncini2, Palma Carlucci3, Angelo Vacca3, Paolo Delvino4, Enrico Heffler5, Emanuele Nappi5, Jakub Moll6, Laura Losappio6, Jan Schroeder6, Federica Davanzo7, Roberto Padoan7, Edoardo Conticini8, Paolo Cameli8, Greta Pacini9, Alvise Berti9, Lorenzo Vrola10, Paola Tomietto10, Luca Quartuccio11, Jan Willem Cohen Tervaert12, Sabrina Arnold13, Peter Lamprecht13, Florence Roufosse14, Ilaria Cavazzana1, Franco Franceschini1, Giacomo Emmi15, Paola Toniati1. | 1Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia, Italy, Brescia, Italy; 2Università Politecnica delle Marche and Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy, Ancona, Italy; 3Section of Internal Medicine 'Guido Baccelli', DiMePRe-J, University of Bari 'Aldo Moro', Bari, Italy, Bari, Italy; 4Rheumatology Unit, IRCCS San Gerardo dei Tintori, Monza, Italy Monza Italy; 5Department of Biomedical Sciences, Humanitas University and Personalized Medicine, Asthma and Allergy IRCCS Humanitas, Milano, Italy; 6Division of Allergy and Clinical Immunology, ASST GOM Niguarda, Milan, Italy, Milano, Italy; 7Rheumatology Unit, Department of Medicine DIMED, University of Padua, Padova, Italy, Padova, Italy; 8University of Siena, Siena, Italy, Siena, Italy; 9Santa Chiara Hospital and University of Trento, Unit of Rheumatology, Trento, Italy Trento Italy; 10UCO Medicina Clinica, ASUGI, Cattinara Teaching Hospital, Trieste, Italy, Trieste, Italy; 11Division of Rheumatology, Department of Medicine DMED, University of Udine, Udine, Italy, Udine, Italy; 12University of Alberta, Edmonton, Alberta, Canada and Maastricht University, Maastricht, The Netherlands Maastricht The Netherlands; 13Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany Lubeck Germany; 14Department of Internal Medicine, Hôpital Universitaire de Bruxelles - Erasme, Université Libre de Bruxelles, Belgium Brussels Belgium; 15Clinical Medicine and Clinical Immunology and Rheumatology Unit Cattinara University Hospital and University of Trieste, Trieste, Italy.
183 -
PO:35:220 | IgG anti-pentraxin 3 autoantibodies distinguish eosinophilic granulomatosis with polyangiitis from severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps Eleonora Fiorin1, Anna Ghirardello1, Federica Davanzo1, Luca Iorio1, Marta Codirenzi1, Roberta Prevedello1, Roberto Padoan1, Andrea Doria1. | 1Università di Padova, Dipartimento di Medicina DIMED, UOC di Reumatologia, Padova, Italy.
126 -
PO:35:221 | Cryofibrinogen: a cold case. Characteristics and clinical outcomes from a cryofibrinogen positive cohort Daniele Catameró1, Andrea Cito1, Cristiana Colaprico1, Teresa Caferri1, Teresa Troiano1, Anna Marinaccio1, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Unit of Rheumatology , Department of Precision and Regenerative Medicine, Area Jonica DiMePRe-J, University of Bari, Bari, Italy.
145 -
PO:35:222 | Distinctive Features of Localized Vasculitis of the Gastrointestinal Tract Compared to Takayasu Arteritis: Insights from a Multicenter Cohort Study Vittorio Dibenedetto1|2|3, Alessandro Tomelleri1|2, Corrado Campochiaro1|2, Elena Baldissera1|2, Luca Moroni1|2, Padoan Roberto4, Marco Matucci-Cerinic1|2|3, Lorenzo Dagna1|2|3 | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital Milan, Italy; 2Inflammation, Fibrosis and Ageing Intitiative INFLAGE, IRCCS San Raffaele Hospital Milan, Italy; 3Vita-Salute San Raffaele University, Milan, Italy Milan, Italy; 4University Hospital of Padova, Department of Internal Medicine and Rheumatology Padova, Italy
14 -
PO:35:223 | Biologic therapy for sustained remission in eosinophilic myocarditis: real-world evidence from a tertiary center experience Federica Davanzo1, Caterina Menghi2, Andrea Silvio Giordani2, Anna Baritussio2, Federico Scognamiglio2, Cristina Vicenzetto2, Luca Iorio1, Renzo Marcolongo2, Cristina Basso3, Andrea Doria1, Roberto Padoan1, Alida Linda Patr Caforio2 | 1Rheumatology Unit, Department of Medicine, University of Padua Padova, Italy; 2Cardiology Unit, Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua Padova, Italy; 3Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Padova, Italy
23 -
PO:35:224 | Capturing What BVAS Misses: Patient-Reported Outcomes Reflect Disease Activity and Burden in EGPA Marta Codirenzi1, Federica Davanzo1, Luca Iorio1, Eleonora Fiorin1, Roberta Prevedello1, Roberto Padoan1, Andrea Doria1 | 1Unità di reumatologia, dipartimento di medicina DIMED,Università degli studi di Padova, Italy
14 -
PO:35:226 | Red flags raising suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): results from the European EGPAware Delphi study Gabriele Brembilla1, Bernhard Hellmich2|3, Apostolos Bossios4|5, Chistian Domingo-Ribas6|7, Giacomo Emmi8, Cristina Ponte9|10, Maria Roser Solans-Laque11, Íñigo Jesus Rúa-Figueroa12, Augusto Vaglio13, Dimitrios Vassilopoulos14, Konstantina Kallinikou15, Benjamin Terrier16 | 1GSK Verona, Italy; 2Medius Klinik Kirchheim Kirchheim unter Teck Germany; 3Teaching Hospital of the University of Tübingen Tübingen Germany; 4Karolinska University Hospital Stockholm, Sweden; 5Karolinska Institutet Solna, Sweden; 6Parc Taulí University Hospital. Parc Taulí Research and Innovation Institute I3PT-CERCA Barcelona Spain; 7Department of Medicine, Universitat Autònoma de Barcelona UAB Barcelona Spain; 8University of Trieste, UNITS, Trieste, Italy; 9Santa Maria Hospital Lisbon, Portugal; 10Lisbon Academic Medical Center Lisbon, Portugal; 11Vall d'Hebron University Hospital Barcelona Spain; 12Gran Canaria Doctor Negrín Hospital Las Palmas de Gran Canaria Spain; 13University of Florence Florence, Italy; 14National and Kapodistrian University of Athens School of Medicine Athens, Greece; 15GSK Athens, Greece; 16Cochin Hospital Paris, France
29 -
PO:35:227 | Long-term renal and survival outcomes in microscopic polyangiitis: data from an observational monocentric cohort Roberta Prevedello1, Federica Davanzo1, Luca Iorio1, Eleonora Fiorin1, Marta Codirenzi1, Roberto Padoan1, Andrea Doria1. | 1Unità di Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova, Padova, Italy.
138 -
PO:35:228 | Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors for cancer treatment: a systematic review and meta-analysis highlighting differences from the idiopathic forms Elvis Hysa1, Andrea Casabella2, Emanuele Gotelli1, Rosanna Campitiello1, Carlo Genova3, Enrica Teresa Tanda4, Carmen Pizzorni1, Alberto Sulli1, Vanessa Smith5, Marco Amedeo Cimmino6, Sabrina Paolino1, Maurizio Cutolo1. | 1Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, Genova, Italy; 2IRCCS Ospedale Policlinico San Martino, Genova, Italy; 3Academic Oncology Unit; IRCCS Ospedale Policlinico San Martino, Genova, Italy; 4UOC Medical Oncology Clinic 2, Department of Internal Medicine, University of Genova, Genova, Italy; 5Department of Internal Medicine, Ghent University, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; 6Rheumatology Outpatient Clinic, Villa Ravenna Chiavari Italy.
143 -
PO:35:233 | Tocilizumab is associated with improved relapse-free survival in polymyalgia rheumatica: a multicentre retrospective study Milena Bond1, Giovanni Adami2, Marianna Tamussin3, Mario Frasca4, Sara Zandonella Callegher1, Marcello Govoni3, Maurizio Rossini2, Lorenzo Dagna4, Marco Matucci Cerinic4, Christian Dejaco1, Alessandro Tomelleri4 | 1Department of Rheumatology, Brunico Hospital ASAA-SABES, Teaching Hospital of the Paracelsius Medical University Bunico, Italy; 2Rheumatology Unit, University of Verona, Policlinico Borgo Roma Verona, Italy; 3Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna Ferrara, Italy; 4Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital Milano, Italy
19 -
PO:35:234 | Sustained Vasculitis Quiescence and CS Reduction with Mepolizumab 100 mg Francesca Mascia1, Angelo Fassio2, Marco Zurlo1, Davide Chesini3, Francesco Pollastri2, Giovanni Adami2, Davide Gatti4, Maurizio Rossini4, Matteo Maule5, Gianentrico Senna1, Marco Caminati1 | 1University of Verona - Allergology and Clinical Immunology Verona, Italy; 2Policlinico G. B. Rossi - Rheumatology Verona, Italy; 3University of Verona - Faculty of Medicine and Surgery Verona, Italy; 4University of Verona - Rheumatology Verona, Italy; 5Policlinico G. B. Rossi - Allergology and Clinical Immunology Verona, Italy
18 -
PO:36:238 | Clinical, functional, and radiological similarities between interstitial lung disease–anti–myeloperoxidase and idiopathic pulmonary fibrosis Enrico Colombo1, Jessica Gozzi2, Paolo Francia3, Giulia Cervi2, Marilena Frigato1, Martina Garuti2, Francesca Bartoli1, Irene Gavioli1, Caterina Cerbone2, Massimiliano Beccaria2, Maria Teresa Costantino1 | 1SC Allergologia, Immunologia Clinica e Reumatologia, ASST Mantova; 2SC Pneumologia, ASST Mantova; 3SC Radiologia, ASST Mantova, Italy
146 -
PO:36:242 | Bilateral central retinal artery occlusion as the first manifestation of eosinophilic granulomatosis with polyangiitis during benralizumab therapy Benedetta Fazzi1, Elena Treppo1, Lucia Finocchio2, Maria Pillon1, Luca Quartuccio1 | 1Clinica di Reumatologia, Dipartimento di Medicina, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine; 2SOC Oculistica, Presidio Ospedaliero Universitario Santa Maria della Misericordia, ASUFC, Udine, Italy
145 -
PO:36:243 | Drug survival, discontinuation reasons and disease activity in patients with Behçet's disease treated with infliximab - a real-life study Antonello Sulis1, Federica Di Cianni1, Maria Laura Manca2, Rosaria Talarico1, Marta Mosca1. | 1Rheumatology Unit of Pisa, University of Pisa, Pisa, Italy, Pisa, Italy; 2Department of Clinical and Experimental Medicine and Department of Mathematics, University of Pisa, Italy, Pisa, Italy.
150 -
PO:36:244 | Early diagnosis in eosinophilic granulomatosis with polyangiitis: a multidisciplinary approach Federico Giuseppe Lazzaro1, Elena Chiaradia2, Chiara Lombardi2, Flavia Leone1, Massimo Nucci2, Roberta Masnata2, Flora Niedda2, Maria Rita Gigante1, Pietro Rubortone1, Silvia Laura Bosello1|2, Maria Antonietta D'Agostino1|2, Augusta Ortolan1|2. | 1Divisione di Reumatologia ed Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; 2Università Cattolica del Sacro Cuore, Roma, Italy.
133 -
PO:36:245 | Uncovering clinical and demographic differences in major organ involvement versus benign Behçet’s disease: insights from a single-centre study Federica Di Cianni1, Antonello Sulis1, Maria Laura Manca2, Rosaria Talarico1, Marta Mosca1. | 1Rheumatology Unit, University of Pisa, Pisa, Italy; 2Department of Clinical and Experimental Medicine and Department of Mathematics, University of Pisa, Pisa, Italy.
147 -
PO:36:246 | Early real-world outcomes with benralizumab in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective Richard Borrelli1, Stefania Nicola1, Federica Corradi1, Iuliana Badiu1, Marzia Boem1, Valentina Marmora1, Simone Negrini1, Luisa Brussino1. | 1SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino, Torino, Italy.
141 -
PO:36:250 | Eosinophilic granulomatosis with polyangiitis associated to Alpha-1 Antitrypsin Deficiency: a land still unexplored Maria Grazia Malandra1, Vacchi Caterina1, Santoro Filippo1, Cassone Giulia1, Martina Orlandi1, Stefania Cerri1, Dilia Giuggioli1 | 1Università di Modena - Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; 2S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; 3Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; 4S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; 5Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; 6Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy; 7Università di Modena e Reggio Emilia, S.C. Reumatologia Azienda Ospedaliera Universitaria Policlinico di Modena Modena, Italy
14 -
PO:36:251 | Rheumatoid factor predicts vasculitis relapse in eosinophilic granulomatosis with polyangiitis: a machine learning approach Luca Iorio1, Federica Davanzo1, Giulia Lorenzoni2, Eleonora Fiorin1, Marta Codirenzi1, Roberta Prevedello1, Debora Campaniello1, Dario Gregori2, Roberto Padoan1, Andrea Doria1. | 1Rheumatology Unit, DIMED, University of Padova, Padova, Italy; 2Unit of Biostatistics, Epidemiology and Public Health, DCTV, University of Padova, Padova, Italy.
160 -
PO:36:252 | Long-Term Outcomes of Patients with Takayasu Arteritis in the Era of Biological Agents: a Multicenter International Study Alessandro Tomelleri1, Durga Prasanna Misra2, Fatma Alibaz-Oner3, Chiara Marvisi4, Chiara Calabrese1, Upendra Rathore2, Aysegul Avcu3, Adele Del Giudice4, Elisabetta Olivi4, Caterina Ricordi4, Corrado Campochiaro1, Elena Baldissera1, Marco Matucci-Cerinic1, Haner Direskeneli3, Carlo Salvarani4, Lorenzo Dagna1 | 1IRCCS Ospedale San Raffaele, Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare Milano, Italy; 2Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS, Clinical Immunology and Rheumatology Lucknow Country, India; 3Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey; 4Azienda USL-IRCCS di Reggio Emilia, Unità di Reumatologia Reggio Emilia, Italy
24 -
PO:36:253 | Lifestyle and Behçet's syndrome: a preliminary study on gender differences Pietro Leccese1, Angela Anna Padula1, Nancy Lascaro1, Salvatore D'Angelo1, Maria Carmela Padula1 | 1UOC Reumatologia AOR San Carlo, Potenza, Italy
160 -
PO:37:254 | Absence of ciliary artery occlusion does not exclude arteritic anterior ischemic optic neuropathy (A-AION): diagnostic and pathophysiologic implications Ruggiero Mascolo Mascolo1, Stefano Erba2, Alba Xhepa2, Martina Martelli1, Gabriella Marinaro1, Giulia Dieguez1, Giacomo Iacomelli1, Chiara Facoetti1, Michel Chevallard3, Bruno Lucchino3, Mariaeva Romano3, Andrea Locatelli3, Giuliana La Paglia3, Donatella Ventura3, Giovanna Randisi3, Alessandra Mutti3, Alessandro Invernizzi2, Stefano De Angelis2, Giovanni Staurenghi2, Antonio Brucato4, Enrico Tombetti4 | 1Dipartimento di Medicina Interna, ASST Fatebenefratelli-Sacco, Università degli studi di Milano, Italy; 2U.O. Oculistica, ASST Fatebenefratelli-Sacco Milano, Italy; 3U.O. Reumatologia, ASST Fatebenefratelli-Sacco Milano, Italy; 4Dipartimento di Scienze cliniche e biomediche, ASST Fatebenefratelli-Sacco, Università degli studi di Milano, Italy
18 -
PO:37:256 | Spontaneous renal artery dissection: a subtle presentation of a “vasculitis-mimicker” Federdo Nogarin1, Alfonso Valerio Massara1, Zairo Ferrante2, Filippo Furicchia3, Riccardo Bertola1, Elena Pollicelli1, Ilaria Calciolari1, Sopie Secka1, Andrea Lo Monaco1, Marcello Govoni1 | 1UOC Reumatologia; 2UOC Radiologia Ospedaliera; 3UOC Radiologia Vascolare e Interventistica, Arcispedale Sant'Anna, Ferrara, Italy
152 -
PO:37:257 | Giant cell arteritis debuting with aortic involvement: the importance of integrated diagnostics in fever of unknown origin Alessandro Gratton1, Giovanni Striani1, Luisa Occhipinti1, Stefania Sacco1, Enrico Pegolo2, Luca Quartuccio1 | 1Rheumatology Clinic and 2 Institute of Anatomical Pathology, Department of Laboratory Medicine, University of Udine, Hospital “Santa Maria della Misericordia”, Udine, Italy
128 -
PO:37:258 | Neutrophil and eosinophil extracellular traps in eosinophilic granulomatosis with polyangiitis: phenotype-based characterization and response to mepolizumab Michele Moretti1, Francesco Ferro2, Francesco Pisani1, Elisa Ferrigno1, Gaetano La Rocca1, Federica Di Cianni3, Rosaria Talarico2, Marta Mosca1, Chiara Baldini1, Ilaria Puxeddu1. | 1University of Pisa - Department of Clinical and Experimental Medicine, Pisa, Italy; 2Azienda Ospedaliero Universitaria Pisana - Rheumatology Unit, Pisa, Italy; 3University of Siena, Siena, Italy.
138 -
PO:37:259 | Is there a seasonal pattern in giant cell arteritis? Revisiting the evidence in a large monocentric cohort of 1203 patients Milena Bond1, Philipp Bosch2, Aaron Juche3, Hans Bastian3, Wolfgang Schmidt4. | 1Department of Rheumatology, Hospital of Bruneck ASAA-SABES, Teaching Hospital of the Paracelsius Medical University Brunico Italy; 2Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria; 3Medical Centre for Rheumatology Berlin-Buch, Immanuel Krankenhaus Berlin Berlin Germany; 4Waldfriede Hospital, Rheumatology, Berlin, Germany.
137 -
PO:37:260 | Mepolizumab in the treatment of patients with eosinophilic granulomatosis with polyangiitis: real-life experience from a single-center cohort Eleonora Bruschi1, Fabrizio Angeli1, Alessandro Belotti Masserini1, Stefania Bertocchi1, Silvia Breda1, Elide Lupi1, Valeria Rossi1, Tania Ubiali1, Massimiliano Limonta1 | 1ASST Papa Giovanni XXIII Bergamo Italy
147 -
PO:37:263 | First non invasive visualization of vasculitis in the retinal arteries by high resolution optical coherence tomography in a patient with giant cell arteritis Ruggiero Mascolo1, Chiara Facoetti1, Claudia Nardi2, Stefano Erba2, Martina Martelli1, Gabriella Marinaro1, Giulia Dieguez1, Giacomo Iacomelli1, Chiara Carollo1, Michel Chevallard3, Bruno Lucchino3, Mariaeva Romano3, Andrea Locatelli3, Donatella Ventura3, Giovanna Randisi3, Giuliana La Paglia3, Alessandra Mutti3, Alessandro Invernizzi2, Stefano De Angelis2, Giovanni Staurenghi2, Antonio Brucato4, Enrico Tombetti4. | 1Dipartimento di Medicina Interna, ASST Fatebenefratelli-Sacco, Università degli studi di Milano, Milano, Italy; 2U.O. Oftalmologia, ASST Fatebenefratelli-Sacco, Università degli studi di Milano, Milano, Italy; 3U.O. Reumatologia, ASST Fatebenefratelli-Sacco, Università degli studi di Milano, Milano, Italy; 4Dipartimento di scienze cliniche e biomediche, ASST Fatebenefratelli-Sacco, Università degli studi di Milano, Milano, Italy.
178 -
PO:37:266 | Long-term manifestation of graft-versus-host disease presenting as a vasculitic-like syndrome: a rare case report Camilla Mazzanti1, Gianluca Santoboni1, Claudio Angrisani1, Massimiliano De Simone1, Giuliana Marciani1, Alessandra Fiorentini1 | 1Ospedale Santa Rosa Viterbo, Italy
20 -
PO:37:267 | Mimickers of polyarteritis nodosa: a case of segmental arteriolar mediolysis Filippo Santoro1, Caterina Vacchi2, Giulia Cassone2, Maria Grazia Malandra1, Dilia Giuggioli1|2 | 1UOSD Reumatologia, Ospedale San Camillo De Lellis, Rieti; 2UOC Igiene e Sanità Pubblica, ASL Rieti; 3Direzione Sanitaria, ASL Rieti, Italy
167 -
PO:37:268 | Antineutrophil cytoplasmic antibodies-associated vasculitis mimicking giant cell arteritis: a diagnostic dilemma Bruno Biasi1, Elena Vanni1, Marco De Pinto2, Giulia Cassone2, Dilia Giuggioli1|2. | 1Rheumatology Unit, School of Medicine, University of Modena and Reggio Emilia, Modena, Modena, Italy; 2Rheumatology Unit, Azienda Ospedaliera-Universitaria Policlinico di Modena, Modena, Italy, Modena, Italy.
139 -
PO:37:269 | Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis Davide Bertelle, Riccardo Bixio, Francesco Pollastri, Maurizio Rossini, Angelo Fassio, Alessandro Giollo | Unità di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa
147 -
PO:37:270 | Efficacy of iloprost as a therapy for skin ulcers in cryofibrinogenemia and cryoglobulinemia: a complex case in a fragile patient Luca Keller Sarmiento1, Amelia Spinella2, Marco De Pinto2, Giorgia Roveta1, Dilia Giuggioli1|2. | 1Università degli Studi di Modena e Reggio Emilia, Modena, Italy; 2Unità di Reumatologia del Policlinico di Modena, Modena, Italy.
141 -
PO:38:278 | Cognitive behavioural therapy vs. physical therapy for chronic primary low back pain: a systematic review with meta-analysis of randomised controlled trials Luca Castioni1, Stefano Salvioli2 | 1Università degli studi di Ferrara; 2Scuola di fisioterapia Claudiana, Bolzano, Italy
151 -
PO:38:280 | Accuracy of generative artificial intelligence in risk of bias assessment using RoB 2.0 tool and extracting data in exercise therapy for chronic low back pain randomised controlled trials Luca Carrer1, Marco Pozzati2, Dario Taborelli1, Niccolò Maschi1, Tiziano Innocenti1|3, Stefano Salvioli1 | 1DINOGMI, Università di Genova, Savona; 2Dipartimento di Neuroscienze e Riabilitazione, Università di Ferrara; 3GIMBE Foundation, Bologna, Italy
144 -
PO:38:281 | Therapeutic exercise in temporomandibular disorders: a scoping review of the literature Federico Amateis<sup>1</sup>, Gabriele Aimini<sup>1</sup>, Paolo Mastromarchi<sup>1</sup>, Lorenzo Lo Russo<sup>1</sup>, Marco Chiodini<sup>1</sup>, Roberta Giova Bazzacchi<sup>1</sup>, Noemi Corbetta<sup>1</sup>, Stefano Salvioli<sup>1</sup>. | <i> <sup>1</sup>Department of Neurosciences, Rehabilitation, Opthalmology, Genetics, Maternal and Child Health, University of Genoa Italy; <sup>3</sup>Scuola Universitaria per la Svizzera Italiana, DEASS Manno Switzerland; <sup>6</sup>Department of Maxillo-Facial Surgery, Santi Paolo e Carlo Hospital, University of Milan Italy; <sup>7</sup>Department of Neurosciences, Rehabilitation, Opthalmology , Genetics, Maternal and Child Health, University of Genoa Italy; <sup>8</sup>Department of Neurosciences, Rehabilitation, Opthalmology , Genetics, Maternal and Child Health, University of Genoa Italy. </i>
141 -
PO:38:283 | Accuracy of chatgpt 4 omni in providing clinical recommendations in musculoskeletal care: a valuable support for clinicians and patients? Dario Taborelli1, Silvia Negro1, Federico Padovani2, Tiziano Innocenti1|3, Stefano Salvioli1 | 1DINOGMI, Università di Genova, Savona; 2Dipartimento di Neuroscienze e Riabilitazione, Università di Ferrara; 3GIMBE Foundation, Bologna, Italy
139 -
PO:38:285 | Cross-sectional analysis: interpretation of nonstatistically significant results in randomised controlled clinical trials in rehabilitation Caterina Mugnai1, Luca Falsiroli Maistrello2|3|4, Giacomo Fiacca3, Michele Perrucchini3, Noemi Corbetta3, Federico Amateis3, Stefano Salvioli3 | 1University of Ferrara; 2ULSS 9 Scaligera, Department of Physical Medicine and Rehabilitation, G. Fracastoro Hospital, San Bonifacio VR; 3Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa; 4School of Physiotherapy, Department of Neuroscience, Biomedicine and Movement, University of Verona, Italy
121 -
S02:5 | Combined anti-IL-5/IL-5r and dupilumab therapy in eosinophilic granulomatosis with polyangiitis: a European retrospective study Miriam Guerini1, Pavel Novikov2, Roberto Padoan3, Georgina Espigol Frigolé4, Jan Willem Cohen Tervaert5, Vincent Grobost6, Laurent Guilleminault7, Jan Walter Schroeder8, Bernhard Hellmich9, Joana Martins Martinho10, Camillo Ribi11, Matthieu Groh12, Benjamin Terrier13. | 1IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy; 2Sechenov University, Moscow, Russia; 3University of Padova, Padova, Italy; 4Hospital Clinic, University of Barcelona, Barcelona, Spain; 5University of Alberta, Edmonton, Canada; 6CHU Estaing Clermont-Ferrand France; 7Toulouse University Toulouse France; 8ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; 9Medius Kliniken Kirchheim-Teck Germany; 10ULS Santa Maria, Lisbon, Portugal; 11Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 12Hopital Foch, Suresnes, France; 13Service de Medecine interne, Hopital Cochin, AP-HP, Paris, France.
186 -
S02:6 | Monocyte-Driven Inflammation and Inflammasome Activation in ANCA-Positive EGPA: Evidence of Persistent Immune Activation During Remission Chiara Baggio1, Luca Iorio1, Carlotta Boscaro2|3, Federica Davanzo1, Marta Tonello1, Mattia Albiero4, Andrea Doria1, Paolo Sfriso1, Roberto Padoan1, Francesca Oliviero1 | 1Rheumatology Unit, Department of Medicine, University of Padova, Italy; 2Department of Medicine, University of Padova, Italy; 3Veneto Institute of Molecular Medicine, Laboratory of Experimental Diabetology, Italy; 4Department of Surgery, Oncology, and Gastroenterology, University of Padova, Italy
19 -
S05:5 | Romosozumab in Post-Menopausal Women with Multiple Myeloma, a Prospective 12-Month Study Giovanni Adami1, Mariana Diz Lopes1, Camilla Benini1, Davide Gatti1, Ombretta Viapana1, Elena Marchetti2, Martina Tinelli2, Maurizio Rossini1 | 1UOC Reumatologia, Università degli Studi di Verona Verona, Italy; 2UOC Ematologia, Università degli Studi di Verona Verona, Italy
18 -
S05:6 | Prevalence of osteoporosis and bone mineral metabolism disorders in an Italian cohort of patients with microcrystalline arthritis: results from the PREMIA observational study of the Italian Society of Rheumatology Silvia Grignaschi1, Sonia Farah2, Silvia Balduzzi1, Bernd Raffeiner3, Carlomaurizio Montecucco4, Fausto Salaffi2, Enrico Selvi5, Annamaria Iagnocco6, Fabiola Atzeni7, Serena Guiducci8, Rosario Foti9, Maria Manara10, Marcello Govoni11, Carlo Selmi12, Francesca Oliviero13, Roberta Ramonda13 | 1ASST Pavia; 2Ospedale Carlo Urbani Jesi Italy; 3Azienda Sanitaria dell'Alto Adige, Bolzano; 4IRCCS Fondazione Policlinico San Matte, Pavia; 5AOU Senese, Siena; 6Ospedale MAuriziano, Torino; 7Università di Messina; 8AOU Careggi, Firenze; 9AOU Policlinico G. Rodolico, Catania; 10ASST Gaetano Pini-CTO Milano; 11AUSL Ferrara; 12Humanitas San Pio X, Milano; 13AOU Padova, Italy
139 -
S07:5 | Ankle ultrasound patterns may in the identification of Löfgren’s syndrome in patients with acute-onset erythema nodosum Davide Corradini1, Alberto Floris1, Andrea Carta2, Mattia Congia1, Elisabetta Chessa1, Matteo Piga1, Alberto Cauli1. | 1Rheumatology Unit, AOU and University of Cagliari, Cagliari, Italy; 2Department Economics and Business, University of Cagliari, Cagliari, Italy.
150 -
S13:5 | Association between vasoactive-vasodilating therapy and reduced detection of pulmonary arterial hypertension in systemic sclerosis: evidence from a European Scleroderma Trials and Research study Nicola Farina1, Silvia Bellando-Randone1, Sebastien Sanges2, Hilde Jenssen Bjørkekjær3, Lorenzo Tofani4, Marie-Elise Truchetet5, Vanessa Smith6, Andra Balanescu7, Christina Bergmann8, Yannick Allanore9, Philipp Klemm10, Simona Truglia11, Luca Idolazzi12, Christopher Denton13, Roberta Foti14, Anna Wojteczek15, Emmanuel Chatelus16, Madelon Vonk17, Serena Guiducci1, David Launay2, Eric Hachulla2, Jeska De Vries-Bouwstra18, Anna-Maria Hoffmann-Vold19, Oliver Distler20, Marco Matucci-Cerinic1, Cosimo Bruni1. | 1Department of Experimental and Clinical Medicine, Scleroderma Unit, Division of Rheumatology, University of Florence, Az, Firenze, Italy; 2Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Reference Center for Rare Autoi, Lille, France; 3Department of Rheumatology, Hospital of Southern Norway, Kristiansand, Norway; 4Department of Statistics, Informatics and Applications, University of Florence, Firenze, Italy; 5Rheumatology department, CHU de Bordeaux, Bordeaux, France; 6University of Ghent, Department of Rheumatology, Gent, Belgium; 7Department of Rheumatology, St. Maria Hospital, Carol Davila, University of Medicine and Pharmacy Bucharest Romania; 8Department Internal Medicine 3, University Hospital Erlangen, Erlangen, Germany; 9Rheumatology Department, Université Paris Cité, Cochin Hospital, Paris, France; 10Department of Rheumatology and Clinical Immunology Center, JLU Giessen, Campus Kerckhoff Bad Nauheim Germany; 11Reumatologia, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma, Italy; 12Section of Rheumatology, Department of Medicine, University of Verona, Verona, Italy; 13Centre for Rheumatology, Royal Free London and University College London Medical School, London, United Kingdom; 14Division of Rheumatology, A.O.U. Policlinico-San Marco, Catania, Italy; 15Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Univers Gdansk Poland; 16Department of Rheumatology, University Hospital Strasbourg Strasbourg France; 17Department of rheumatology, Radboud University Nijmegen Medical Center Nijmegen The Netherlands; 18Department of Rheumatology, Leiden University Medical Center Leiden The Netherlands; 19Department of Rheumatology, Oslo University Hospital, Oslo, Norway; 20Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
123 -
S13:6 | Investigating the intricate interplay between pulmonary functionality and advanced microangiopathy in very early diagnosis of systemic sclerosis Eugenio Capparelli1, Eleonora Zaccara1, Daniela Bompane1, Elisabetta Ricchiuto2, Giorgio Bonardi2, Laura Castelnovo1, Antonio Tamburello1, Antonino Mazzone3, Paola Faggioli1. | 1Rheumatology Unit; 2Pneumology Unit; 3Internal Medicine Unit, ASST Ovest Milanese, Legnano, Italy.
120 -
S14:5 | Erosive hand osteoarthritis: premenopausal onset and more severe disease progression Marta Favero1, Giacomo Cozzi1, Clarissa Benvoluti1, Laura Scagnellato1, Gianluca Poncina1, Stefano Rizzetto1, Mariagrazia Lorenzin1, Roberta Ramonda1 | 1UOC di Reumatologia, Dipartimento di Medicina-DIMED, Università di Padova, Italy
140

